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SUMMARY 
Candida albicans and related Candida species are frequently found in the 
normal microbiota of humans; this facilitates their encounter with most implanted 
biomaterials and host surfaces. The major complication associated with the use of 
medical implants such as catheters or prostheses is infection. It is now clear that 
this type of infection is usually due to the development of drug-resistant biofilms 
on the surface of implanted devices. The aim of this project was to investigate the 
possible role of the biofilm matrix as a barrier to drug diffusion in Candida 
biofilms and in mixed species fungal-bacterial biofilms. 
The penetration of antifungal agents through single- and mixed-species 
biofilms containing Candida was investigated using a novel filter disk bioassay. 
Fluconazole permeated all single-species Candida biofilms more rapidly than 
flucytosine. Drug penetration was more extensive with C. albicans than with the 
other species and the rates of diffusion of either drug through biofilms of three 
strains of C. albicans were similar. However, the rates of drug diffusion through 
biofilms of C. glabrata or C. krusei were faster than those through biofilms of C. 
parapsilosis or C. tropicalis. In all cases, after 3 to 6h the drug concentration at 
the distal edge of the biofilm was very high (many times the MIC). Nevertheless, 
drug penetration failed to produce complete killing of biofilm cells. These results 
indicate that poor antifungal penetration is not a major drug resistance mechanism 
for Candida biofilms under these conditions. The abilities of flucytosine, 
fluconazole, amphotericin B, and voriconazole to penetrate mixed-species 
biofilms containing C. albicans and Staphylococcus epidennidis (a slime-
producing wild-type strain, RP62A, and a slime-negative mutant, M7) were also 
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investigated. All four antifungal agents diffused very slowly through the mixed-
species biofilms. In most cases, diffusion was slower with biofilms containing S. 
epidermidis RP62A, but amphotericin B penetrated biofilms containing the M7 
mutant more slowly. However, the drug concentrations reaching the distal edges 
of the biofilms always substantially exceeded the MIC. Thus, although the 
presence of bacteria and bacterial matrix material undoubtedly retarded the 
diffusion of the antifungal agents, poor penetration does not wholly account for 
the drug resistance of Candida biofilm cells, even in these mixed-species 
biofilms. 
Matrix material was extracted from biofilms of C. albicans and C. 
tropicalis and analysed chemically. Both preparations contained carbohydrate, 
protein, hexosamine, phosphorus and uronic acid. However, the major component 
in C. albicans matrix was glucose (32.2 %), whereas in C. tropicalis matrix it was 
hexosamine (27.4 %). Further characterization of the matrix material was 
achieved by enzymatic digestion of biofilms. Biofilms of C. albicans were more 
easily detached from plastic surfaces by treatment with the enzyme lyticase (fJ-
1,3-glucanase) than were those of C. tropicalis. Biofilms of C. albicans were also 
partially detached by treatment with proteinase K, chitinase, DNase I, or fJ-N-
acetylglucosaminidase, whereas C. tropicalis biofilms were only affected by 
lipase type VII or chitinase. 
It has been reported that the production of extracellular matrix by Candida 
biofilms growing under static incubation conditions is relatively minimal, but 
increases dramatically when developing biofilms are subjected to a liquid flow. In 
this study, Candida biofilms were grown under flow conditions in a modified 
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Robbins device (MRD). Biofilms of C. albicans grown in the MRD produced 
more matrix material than those grown statically, and were significantly more 
resistant (P<O.OOl) to amphotericin B. Biofilms of C. tropicalis synthesized large 
amounts of matrix material even when grown statically, and such biofilms were 
completely resistant to both amphotericin B and fluconazole. Mixed-species 
biofilms of C. albicans and S. epidermidis RP62A, when grown statically or in the 
MRD, were also completely resistant to amphotericin B and fluconazole. Mixed-
species biofilms of C. albicans and S. epidermidis M7, on the other hand, were 
completely drug resistant only when grown under flow conditions. Overall, these 
findings demonstrate that the matrix can make a significant contribution to drug 
resistance in Candida biofilms, especially under conditions similar to those found 
in catheter infections in vivo, and that the composition of the matrix material is an 





1 Candida and candidosis 
1.1 Candida species 
The genus Candida includes around 196 species. Yeasts belonging to this 
genus are unicellular fungi that reproduce mainly by budding. In the fifth century 
Hippocrates described thrush and was the first to describe a yeast infection 
(Ainsworth, 1986). Since then, the primary etiologic agent of thrush, C. albicans, 
has been demonstrated to cause many forms of disease, some of which are life 
threatening. By 1963, approximately five medically important species of Candida 
had been described. The species were C. albicans, C. stellato idea (which is now 
considered synonymous with C. albicans) , C. parapsilosis, C. tropicalis, and C. 
guilliermondii (Emmons et ai., 1963). However, the appearance in the 1960s of 
new modalities to treat cancer, increasing use of central venous catheters, increases 
in average life expectancy, and other developments in medicine resulted in a 
parallel increase in the number of serious Candida infections. There are now at 
least 17 species of Candida that have been shown to cause disease in humans 
(Rinaldi, 1993). 
C. albicans IS a fungus which may develop into a number of different 
morphological forms, including yeasts, hyphae and pseudohyphae. This change 
depends on environmental conditions. The ability to form hyphae is generally 
considered to be an important virulence factor since hyphae are able to penetrate 
tissue more easily. Recent studies identified a widely distributed yeast species that 
is closely related to C. albicans (Coleman et ai., 1997) This newly described 
species was isolated from oropharyngeal lesions in HIV -positive patients in Dublin. 
In fact, C. dubliniensis was initially difficult to distinguish from C. albicans and 
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was often misidentified as such in standard clinical laboratory examinations 
because both species are closely related and share phenotypic and genotypic 
characteristics (Odds et aI., 1998; Sullivan and Coleman, 1998; McCullough et aI., 
1999). 
C. glabrata was considered a relatively non-pathogenic saprophyte of the 
normal flora of healthy persons, rarely causing serious infection in humans (Haley, 
1961; Stenderup and Pedersen, 1962). However, following the widespread and 
increased use of immunosuppressive drugs, together with broad-spectrum 
antimycotic therapy, the frequency of infections caused by C. glabrata has 
increased significantly (Komshian et aI., 1989; Hitchcock et aI., 1993; Knoke et 
aI., 1997). C. glabrata is now the second or third most common cause of 
candidosis after C. albicans (Wingard, 1995). It is a non-dimorphic yeast that exists 
as small blastoconidia (yeasts) under all environmental conditions. In fact, C. 
glabrata is the only Candida species that does not form pseudohyphae at 
temperatures above 37°C. 
C. krusei forms pseudohyphae with elongated blastoconidia, creating a 
crossed matchsticks or treelike appearance. C. krusei is an emerging non-albicans 
Candida species, with a particular predilection for neutropenic adult cancer patients 
(Wingard, 1995). 
C. parapsilosis forms blastoconidia, singly or in small clusters, which are 
seen under a microscope along the pseudohyphae. This organism is identifiable by 
the crooked or curved appearance of relatively short pseudohyphae and the 
occasional presence of large hyphal elements called giant cells (Davise, 1987). The 
available data suggest that the role of C. parapsilosis as an exogenous pathogen 
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results from its introduction via contaminated intravenous fluids or biomaterials. 
The numbers of infections due to this organism are accordingly on the increase 
(Weems, 1992; Branchini et a!., 1994; Price et a!., 1994). 
C. tropicalis forms blastoconidia singly, or in very small groups, all along 
the pseudohyphae. True hyphae may also be present. Also, a few teardrop-shaped 
chlamydospores maybe produced irregularly (Davise, 1987). C. tropicalis is one of 
the three most commonly isolated non-albicans Candida species. It accounts for 4 
to 25% of all Candida species isolated and a higher proportion (approximately 20-
45%) of non-albicans Candida species isolated from patients with candidemia 
(Fraser et a!., 1992; Viscoli et a!., 1999). 
1.2 Candida Infections 
The pathogenic Candida species are all opportunistic pathogens capable of 
inflicting disease only when most defences are in some way impaired, locally or 
systemically. The principal pathogen of the genus, C. albicans, can grow either as 
oval, budding yeasts or as continous septate hyphae, and both morphological forms 
are usually seen in infected tissues. Disease states range from common, superficial 
infections, especially those of the mouth and vaginal, to rarer, but frequently fatal, 
deep-seated infections. 
1.2.1 Superficial candidosis 
Candida species are capable of initiating a variety of recurring superficial 
diseases (Odds, 1988). Thrush is a common form of oral candido sis and occurs 
especially with those patients receiving chemotherapy and radiation. It is 
characterized by soft, cream-coloured, elevated plaques that can easily be wiped 
off the buccal mucosa, tongue dorsum, or palate. This infection most frequently 
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affects newborns, the elderly, and diabetics. In the absence of other known causes 
of immunosuppression, oral thrush in an adult is highly suggestive of human 
immuno-deficiency virus (HIV) infection (Dronda et ai., 1996). 
Oral candido sis is not a single clinical entity, but a spectrum of very 
different clinical entities such as pseudomembrane candidosis, erythematous 
candidosis, denture stomatitis and angular cheilitis. 
Denture stomatitis is a term used to describe certain pathological changes of 
the mucosa under complete or partial, removable dentures. The characteristic 
clinical feature is a uniform bright erythema, usually found in both jaws, less 
frequently in the mandible, and it is commonly associated with angular cheilitis 
(Webb et ai., 1998). The prevalence of the condition among denture wearers has 
been variously reported to be 10-75% depending on the population studied 
(Espinoza et ai., 2003; Shulman et ai., 2005). C. albicans is the most commonly 
isolated species associated with denture stomatitis, but other less pathogenic 
species such as C. glabrata, C. tropicalis, C. parapsilosis, and C. krusei are also 
recovered (Barbeau et ai., 2003; Dar-Odeh and Shehabi, 2003). In the oral cavity 
Candida species usually co-exist with commensal bacteria within a biofilm matrix. 
Studies by Budtz-Jorgensen (1999) for instance, showed that, in denture plaque of 
patients with Candida-induced denture stomatitis, 93% of the plaque biofilm is 
composed of yeasts and the remainder comprises oral bacteria. 
Vulvovaginal candidosis is one of the most common female genital tract 
infections encountered in medical practice. Up to 75% of all women will 
experience fungal vulvovaginitis at some point in their lives, and approximately 
40-50% will experience a second episode of this syndrome (Sobel et ai., 1998; 
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Ferrer, 2000). The clinical symptoms most often described in cases of vulvovaginal 
candidosis are external dysuria, vulval pruritus, swelling, or redness (Ferrer, 2000; 
White and Vanthuyne, 2006). Recently, Moreira and Paula (2006) reported a study 
of 130 symptomatic patients examined during the period from 2002 to 2004. 
Among patients with positive laboratory cultures, C. albicans was the most 
frequently isolated species, with 90% of isolations, followed by C. glabrata with 
6%, and C. parapsilosis and C. tropicalis with 2% (Moreira and Paula, 2006). 
1.2.2 Systemic candidosis (Deep seated candidosis) 
The incidence of systemic fungal infections has increased dramatically over 
the past twenty years (Beck-Sague and Jarvis, 1993). Most systemic Candida 
infections are considered to arise from the patient's endogenous flora (Fridkin and 
Jarvis, 1996). Alternatively, they may be transmitted from contaminated equipment 
or solutions and from hospital personnel. For many years C. albicans was the 
species most commonly causing systemic infections, but recently other species 
have emerged. In a review of 36 studies reporting 1479 patients with cancer 
disease, C. albicans was indicated for 54 % of infections and C. tropicalis for 25 % 
(Wingard, 1995). C. tropicalis has an apparently greater capacity than C. albicans 
to invade the deep tissues of the immunocompromised host; several studies have 
shown positive surveillance cultures for C. tropicalis to be highly predictive of 
subsequent systemic infection (Komshian et aI., 1989). Among children with 
leukaemia, Marina and colleagues (1991) found a higher incidence of colonization 
with C. albicans than with C. tropicalis; however, a higher proportion of those 
colonized by C. tropicalis developed fungaemia (Marina et aI., 1991). This pattern 
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has also been seen III adult oncology and bone marrow transplant patients 
(Wingard, 1995). 
Several other Candida species can cause serious infections in hospitals; C. 
glabrata causes about 8 %, C. parapsilosis 7-11 % while C. krusei accounts for 4 
% of infections (Wingard et aI., 1991; Girmenia et aI., 1996; Nguyen et aI., 1996). 
Systemic infection with Candida albicans or related species presents clinically 
different challenges depending on the site of invasion, the effectiveness of the 
host's immune responses and the presence of underlying disease (Myerowitz et aI., 
1977). 
Candidaemia has increased in frequency primarily due to the widespread 
use of intravascular catheters, repeated injection by drug addicts, and long-term use 
of broad-spectrum antimicrobial or steroid therapy (Giunchi, 1958; Seelig, 1966; 
Hay, 1986; Crump and Collignon, 2000). Early studies by Hay (1986) identified 
drug addicts using contaminated lots of heroin or needles with Candidal 
endocarditis syndrome. Disseminated candido sis occurs mostly III 
immunocompromised patients, especially organ transplant recipients and 
neutropenic patients (Bodey and Luna, 1974). Thaler et al. (1988) found a distinct 
syndrome known as chronic disseminated candidosis almost exclusively in patients 
with acute leukemia. Currently, Candida infections are a major cause of septicemia 
in neonatal intensive care units, and are associated with high morbidity and 
mortality. The neonatal infections most commonly observed are those caused by C. 
albicans and C. parapsilosis, but in the last few years there has been an increase in 
cases caused by C. tropicalis (Leibovitz, 2002). Recently, Dixon et al. (2004) 
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described an adult patient with chronic mucocutaneous candidiasis who developed 
a disseminated infection with C. tropicalis. 
1.3 Factors predisposing to candidosis 
Although risk factors for invasive candidosis have been clearly identified 
(such as colonization, length of stay, use of parenteral nutrition, antibiotics, central 
lines, and abdominal surgery), there are few risk assessment strategies that clearly 
define or predict a population at high risk of getting this disease. Therefore, the 
severity and extent of Candida infection tends to increase with the number and 
severity of predisposing factors. There are certain diseases and disorders that have 
for years been especially associated with candido sis (Odds, 1988). Some of these 
factors are mentioned briefly below. 
1.3.1 Debilitating diseases and disorders 
Numerous investigators have reported that high blood and tissue glucose 
levels favoured the growth of Candida in diabetics (Kandhari et aI., 1969). 
Stenderup and Schonheyder (1984) state that oral and oesophageal candidosis are 
common conditions in AIDS patients, and vaginal candidosis is very common 
among women with AIDS. The incidence of thrush reaches approximately 15 % in 
patients with malignant diseases (Boggs et aI., 1961). Candida carriage is one of 
the common predisposing factors for cancer patients, especially those with 
leukaemia (Gentle et aI., 1984; Ghannoum et ai., 1985). 
1.3.2 Digressions from normal physiological status 
A number of studies have shown that oral infections in newborn infants 
within the first few days after birth are due to contamination with Candida from the 
birth canal of the mother (Taschdjian and Kozinn, 1957). Vaginal candido sis has 
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always been found to be greater in pregnant than in non-pregnant women (Odds, 
1988). 
1.3.3 Dietary factors 
Several studies have demonstrated that nutritional deficiencies, such as 
vitamin C deficiency, predispose to candidosis. Roger et al. (1983) showed in an 
animal model that vitamin C deficiency reduced the resistance of guinea pigs to 
renal candidosis. Other studies using two animal models showed that 
hypovitaminosis A increased, and hypervitaminosis A decreased the susceptibility 
of rats and mice to infection with C. albicans (Odds, 1988). Moreover, iron-
deficiency anaemia may be an important predisposing factor in some types of 
candidosis (Higgs and Wells, 1972). 
1.3.4 Mechanical factors 
Many case reports show that severely burned patients are particularly 
susceptible to colonization and deep-seated infection with Candida (Zanini et ai., 
1983). However, Holzheimer and Dralle (2002) showed that the mortality of bums 
patients with fungal infections dropped from 80-100 % to approximately 10 % 
through good bums management. Oral yeast infections are higher among denture 
wearers of various types than among non-wearers (Berdicevsky et ai., 1980; 
Mitchell et ai., 1982). 
1.3.5 Treatment with drugs 
Most studies indicate that treatment with antibacterial antibiotics is an 
important factor in candidosis, especially treatment with tetracycline (Odds, 1988), 
penicillin and erythromycin (Meads et ai., 1951; Heimdahl and Nord, 1982) and 
ampicillin (Fitzpatr and Topley, 1966). In addition, steroid therapy is known to be 
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a major factor predisposing to superficial candido sis (Gale, 1982) and systemic 
candido sis (Date et ai., 1983). Wied et al. (1966) noted a significant increase in 
vaginal Candida infections among users of hormonal contraceptives. 
1.3.6 Surgical procedures 
Invasive Candida infections are a significant cause of mortality and 
morbidity for patients undergoing solid organ transplantation, including liver and 
lung transplantation (Alexander, 2002; Zaas and Alexander, 2004). Bone marrow 
transplant recipients are at increased risk of a variety of infections from 
endogenous and exogenous sources (Kusne and Krystofiak, 2001) and a case of 
necrotizing fasciitis due to C. albicans following renal transplantation has been 
reported (Wai et ai., 2001). 
1.3.7 Implanted medical devices 
A variety of implanted devices are now known to be important risk factors 
for Candida infections (Table 1). They include indwelling catheters (central venous 
catheters and urinary catheters), joint prostheses, dialysis access devices 
(permanent haemodialysis and peritoneal dialysis), cardiovascular devices (heart 
valves, pacemakers, implantable cardioverter defibrillators and left ventricular 
assist devices), central nervous devices (ventriculoperitoneal shunts), penile 
implants and endotracheal tubes (Jones et ai., 2001; Kojic and Darouiche, 2004). 
The surgically implanted device that is most commonly infected is the 
central venous catheter, which is used to administer fluids and nutrients as well as 
cytotoxic drugs. Infection can arise at any time during the use of this type of 
catheter. According to the National Nosocomial Infections Surveillance data, 87% 
of primary bloodstream infections occur in patients with a central line (Mermel et 
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aI., 2001). The infusion fluid itself, or the catheter hub, can be contaminated but, 
more often, organisms are introduced from the patient's skin or from the hands of 
nursing staff. Sometimes the distal tip of the catheter is contaminated at the time of 
insertion; alternatively, organisms can migrate down the catheter wound 
(Goldmann and Pier, 1993; Sherertz, 2000). However, if Candida species 
colonizing the gastrointestinal tract as commensals are able to penetrate the 
intestinal mucosa and invade the bloodstream, circulating yeasts can 'seed' the 
catheter tip endogenously (Goldmann and Pier, 1993). This could be a common 
entry mechanism for cancer patients receiving chemotherapeutic regimens that 
cause serious damage to the intestinal mucosa (Kullberg and Filler, 2002). 
1.4 Chemotherapy of candidosis 
Fungi, like their human hosts, are eukaryotic organisms, and thus the 
number of potential targets for drug action is very limited. Although it is known 
that the most common pathogen among Candida species is C. albicans, in recent 
years there has been a shift in the spectrum of identifiable Candida infections 
(Nguyen et aI., 1996). In view of the significant morbidity and mortality associated 
with invasive fungal infections, it is particularly important to make the diagnosis as 
early as possible and to select the best available antifungal drug for treatment. 
Fortunately, the prevention and treatment of invasive fungal infections have been 
improved over the last two decades by the development of new antifungal agents. 
To date, four classes of antifungal agents have been approved for treating invasive 
fungal infections: (1) Polyenes (amphotericin Band amphotercin B liposomal 
formulations) which destabilize fungal cell membranes; (2) Nucleoside analogues 
(5-fluorocytosine) which interfere with DNA and RNA synthesis. 
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Table 1. Implantable devices in which Candida biofilms develop most 
frequently 
Infection Main Candida 
Device risk (%) species 
Central and peripheral venous 3-8 albicans, glabrata 
catheters parapsilosis 
Haemodial ysis and peritoneal 1-20 albicans, parapsilosis 
dialysis catheters 
Urinary catheters 10-30 albicans, glabrata 
Endotracheal tubes 10-25 albicans 
Intracardiac prosthetic devices 1-3 albicans, glabrata 
parapsilosis, tropicalis 
Breast implants 1-2 albicans 
Prosthetic joints 1-3 albicans 
parapsilosis, glabrata 
Neurosurgical shunts 6-15 albicans 
V oice prostheses 50-100 albicans, tropicalis 
Dentures 5-10 albicans, glabrata 
(Ramage et al., 2006) 
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(3) Azoles (ketoconazole, fluconzole, itraconazole, and newer azoles such as 
voriconazole, posaconazole, and ravuconazole) which interfere with sterol 
synthesis and compromise fungal cell membrane integrity; and (4) Echinocandins 
(caspofungin) which inhibit glucan synthesis leading to increased cell wall 
permeability and lysis (Abuhammour and Habte-Gaber, 2004). 
1.4.1 Polyenes 
The first clinically useful antifungal drugs were the polyenes (Fig. 1a), 
amphotericin B and nystatin, which became available in the 1950s (Hazen and 
Brown, 1950). They are amphoteric molecules with a hydrophobic polyene face 
and a hydrophilic surface containing multiple hydroxyl groups. Polyenes bind to 
ergosterol in the fungal membrane forming a channel in the membrane with the 
hydrophilic surface of the drug facing the interior of the channel. This mechanism 
permits leakage of intracellular components, leading to fungal death (Abuhammour 
and Habte-Gaber, 2004). These fungicidal drugs have the broadest spectrum of 
activity in the clinical field (Cowen et aI., 2000). 
1.4.2 Nucleoside analogues 
The antifungal activity of flucytosine (5-fluorocytosine; Fig. 1b) was 
discovered later and was reported in 1963 (Grunberg et aI., 1963) during the 
development of antineoplastic drugs. It is a fluorinated analogue of cytosine. 
Among the pyrimidine class of antifungal drugs, only 5-fluorocytosine is approved 
for the chemotherapy of systemic candidosis. It is a fungicidal drug, with a limited 
activity spectrum (Dismukes, 2000). It works as an antifungal agent through 
conversion to 5-fluorouracil within the target cells. This compound becomes 
incorporated into RNA, and inhibits DNA synthesis through effects on thymidylate 
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synthesis (Odds et aI., 2003). 5-Fluorocytosine is thought to enhance the antifungal 
activity of amphotericin B, especially in anatomical sites where amphotericin B 
penetration is poor (Denning and Stevens, 1990) and it is generally used III 
combination with this drug since the prevalence of primary resistance to 5-
fluorocytosine among Candida isolates is high. 
1.4.3 Azoles 
The continued search for new and less toxic antifungals led to the discovery 
of the azoles. The azole class was discovered in the late 1960s and clotrimazole and 
miconazole were introduced for clinical use in the early 1970s. Ketoconazole was 
released in the early 1980s, and was selected as the first available compound for the 
oral treatment of systemic fungal infections. Indeed, azole antifungals are divided 
into two categories, the imidazole group, which include clotrimazole, miconazole 
and ketoconazole, and the triazole group, which includes itraconazole, fluconazole, 
voriconazole and posaconazole. The main difference between them is that 
compounds in the latter group have three instead of two nitrogen atoms in the azole 
ring (Maertens, 2004). The azoles inhibit fungi by blocking ergosterol sythesis 
through inhibition of the enzyme lanosterol 14a-demethylase. Ergosterol depletion 
coupled with the accumulation of methylated sterol precursors results in inhibition 
of fungal cell growth, fungal cell death, or both (Torres et aI., 2005). 
Fluconazole (Fig. lc) is well tolerated with very low incidence of side 
effects and is the most effective agent for the treatment of oropharyngeal and 
vaginal candidiasis, as well as prophylaxis for fungal infections in neutropenic 
patients undergoing bone marrow transplantation and for oropharyngeal candidiasis 
in HN-infected persons (Andriole, 1999). 
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Recently, voriconazole (Fig. 1d), a novel triazole antifungal, has been 
approved for treatment of serious fungal infections caused by Aspergillus, 
Fusarium, Scedosporium, and resistant Candida species. Voriconazole has in vitro 
activity against yeasts and yeast-like fungi similar, or superior to, fluconazole, 
itraconazole and amphotericin B. Additionally, the drug possesses potent fungicidal 
activity against moulds including Aspergillus, Scedosporium, and Fusarium. 
Fungicidal activity is likely due to the high affinity of voriconazole for fungal 14-
a-demethylase. 
Posaconazole is a new second-generation triazole drug for the treatment and 
prevention of invasive fungal infections. It is structurally closely related to the old 
broad-spectrum itraconazole. In vitro, posaconazole is very active against Candida 
species and is more potent than itraconazole and fluconazole against virtually all of 
the Candida species and C. neoformans isolates tested (Pfaller et ai., 2001; Pfaller 
et ai., 2004). 
1.4.4 Echinocandins 
Most recently, a new antifungal drug was licensed which represented a new 
class of antifungal agents, the echinocandins. Echinocandins are fungal secondary 
metabolites comprising a cyclic hexapeptide core with a lipid side-chain that is 
responsible for antifungal activity. In the late 1990s, three echinocandin-class 
compounds were released, (the three-dimentional structure of all three molecules 
being similar): anidulafungin, caspofungin and micafungin (Odds et ai., 2003) and 
all entered clinical development (Vanden Bossche, 2002). 
Caspofungin (Cancidas) is the first licensed compound. It was isolated from 
the fungus Glarea lozoyensis (Maschmeyer and Glasmacher, 2005). The target for 
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this drug is a complex of proteins responsible for synthesis of cell-wall fJ-l,3 
glucan, which is not present in mammalian cells. The disruption of the cell wall 
results in osmotic stress, lysis, and then death of the microorganism. Caspofungin 
may be an effective alternative drug that is better tolerated than amphotericin B 
(Walsh et al., 2004). It was selected as the most successful treatment for a patient 
with oropharyngeal candidiasis caused by strains of C. albicans and C. glabrata 
resistant to azoles (Nevado et al., 2005). 
2 Virulence factors 
Generally, the organism most often responsible for Candida infections is C. 
albicans, and this is due to a number of virulence factors that contribute to 
pathogenesis. These factors include morphogenesis (the reversible transition 
between unicellular yeast cells and filamentous growth forms), adhesion (the host 
recognition biomolecules), and secreted aspartyl proteases and phospholipases 
(Calderone and Fonzi, 2001). Exactly and simply defined, a virulence factor is any 
attribute that a fungus possesses which increases its virulence in the host or 
escalates binding of the organism to host cells. 
2.1 Morphogenesis 
The yeast-to-hyphal transition has been shown to be an important virulence 
attribute that enables C. albicans to invade human tissues (Brown and Gow, 1999). 
Many fungal pathogens of humans are dimorphic and undergo reversible 
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Candida pseudohyphae range from relatively short to extended cells, and 
are microscopically distinguishable from true hyphae only by conspicuous 
constrictions of the pseudohyphae at septal junctions (Merson-Davies and Odds, 
1989). Morphogenesis can be activated by a wide range of factors and signals, 
many of which connect signalling pathways within fungal cells. (Gow et at., 2002). 
For example, hyphal growth is blocked by inactivation of the transcription factors 
Cph1p and Efg1p which belong to the mitogen-activated protein kinase (MAPK) 
cascade and Ras-cAMP pathways (Lo et ai., 1997). More recently, another protein 
kinase named CRK1 (in the Cdc2 subfamily of kinases) has also been shown to be 
essential for conversion of yeast to filamentous growth on serum-containing agar 
media (Chen et ai., 2000). 
2.2 Adhesion 
Microbial adherence to biomaterial surfaces or to host cells is seen as an 
essential early step and one of the most important determinants of pathogenesis. 
Candida species can adhere to the surfaces of medical devices, particularly 
catheters, and form biofilms which results in increased resistance to antifungal 
drugs compared with planktonic Candida cells, and an increase in Candidaemia 
related to catheter insertion (Hawser and Douglas, 1994b; Chandra et ai., 2001a). 
There is a correlation between the virulence of different Candida species and the 
ability to form biofilms (Hawser and Douglas, 1994b). 
Many studies have shown that several factors influence adhesion in vitro. 
For example, the composition of the growth medium can affect adhesion; yeasts 
grown in medium containing 500mM galactose or glucose are significantly more 
adherent to denture acrylic or to buccal epithelial cells than organisms grown in a 
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low concentration (50mM) of glucose (McCourtie and Douglas, 1981; McCourtie 
and Douglas, 1984). Increased adhesion appears to be due to enhanced production 
of a surface mannoprotein that binds to fucose-containing glycolipids in epithelial 
cell membranes (Cameron and Douglas, 1996). 
Recent adhesion studies have focused on the identification of genes that 
encode a host-recognition protein. The agglutinin-like sequence (ALS) gene family 
of C. albicans encodes large cell-surface glycoproteins that are implicated in the 
process of adhesion. ALS genes are also found in other Candida species that are 
isolated from cases of clinical disease. AlsIp and Als5p participate in adhesion to 
human buccal epithelial cells and fibronectin (Hoyer, 2001). The role of AlsIp is 
important for the adherence of the organism to the oral mucosa during the early 
stages of the infection (Kamai et aI., 2002). 
Another protein called hyphal wall protein 1 (Hwpl), is found on the 
surface of germ tubes and true hyphae, but not yeasts or pseudohyphae of C. 
albicans (Sundstrom et aI., 2002). Hwpl encodes an outer surface mannoprotein 
that is supposed to be oriented with its amino-terminal domain surface-exposed and 
the carboxyl terminus most probably covalently incorporated with cell wall /3-
glucan (Staab et aI., 1996). It is well known that oroesophageal candidiasis is 
caused by the combined action of fungal virulence factors and host inflammatory 
responses when protective immunity is absent. Hwpl is a substrate for mammalian 
transglutaminase and becomes cross-linked to transglutaminase-expressing surface 
squames of the oral mucosa. Therefore, Hwpl is a promising target for 
development of antifungal drugs for treatment of oroesophageal candidiasis 
(Sundstrom et al., 2002). 
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It well known that C. albicans binds to several extracellular matrix ligands, 
including fibronectin, laminin, fibrinogen and collagen (Hostetter, 1994). These 
binding activities are characteristic of the integrin family of mammalian cell 
receptors. Hostetter (1994) showed that monoclonal antibodies to the a-chain of 
integrin proteins bind to proteins of C. albicans; some of these reactive proteins 
were partially characterized. The author suggested that C. albicans expresses an 
integrin-like protein (Intlp). A putative integrin gene INTi from C. albicans has 
also been identified (Gale et aI., 1996) and it seems likely that INTi plays. 
important roles in adherence and filmentation of C. albicans (Gale et aI., 1998). 
2.3 Hydrolytic enzymes 
To assist in the invasion of host tissues, many pathogenic microbes possess 
constitutive and inducible hydrolytic enzymes that destroy, alter, or damage 
membrane integrity, leading to dysfunction or disruption of host cells. Pathogenic 
species of Candida produce a large variety of secreted hydrolases, among which 
the secreted aspartic proteinases (Sap) and phospholipases (PL) have been 
intensively investigated (Calderone and Ponzi, 2001; Haynes, 2001). 
2.3.1 Aspartic proteinases 
Medically important yeasts of the genus Candida have the ability to secrete 
extracellular aspartic proteinases (Saps), which are of particular interest as 
virulence factors. This characteristic is shared by C. albicans, C. dubliniesis, C. 
tropicalis and C. parapsilosis. The enzymes produced by these yeasts are all 
carboxyl proteinases capable of degrading human proteins such as albumin, 
hemoglobin, keratin, and secretory immunoglobulin A (Hube et aI., 1998). 
There are at least ten proteins that comprise the Sap family. 
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In vivo studies show that SAP genes 1, 2 and 3 are expressed by yeast cells 
only, whereas SAP 4, 5 and 6 expression has been detected in C. albicans 
undergoing a transition from yeast to hyphae at neutral pH (Schaller et ai., 1999). 
The expression of SAP 7 has never been detected under any growth conditions. 
SAP 8 transcripts have been detected in yeast cells grown at 25°C in a defined 
medium and SAP 9 is preferentially expressed in later growth phases (Monod et ai., 
1998). Like C. alb icans , C. tropicalis secretes in vitro Sap activity in a medium 
containing bovine serum albumin as the only source of nitrogen (Symersky et ai., 
1997). 
2.3.2 Phospholipases and lipases 
The role of extracellular phospholipase (PL) as a potential virulence factor 
has been investigated in several pathogenic fungi, including C. albicans, 
Cryptococcus neoformans, and Aspergillus fumigatus (Ghannoum, 2000). 
According to the different and specific ester bond cleaved, these enzymes have 
been classified into four PLs so far (A, B, C and D). Only PLB activity has been 
demonstrated in C. albicans. This is an 84-kDa glycoprotein that has both 
hydrolase (fatty acid release) and lysophospholipase trans acylase activities 
(Mukherjee and Ghannoum, 2002). PL activity has also been observed with C. 
glabrata, C. parasilosis, C. tropicalis, C. krusei and C. lusitaniae (Ghannoum, 
2000). Studies by Dagdeviren et ai. (2005) demonstrated a correlation between 
adherence-phospholipase and adherence-aspartic proteinase properties of C. 
parasilosis strains; PL production appeared to be an important virulence factor in 
bloodstream infections caused by C. parasilosis. In a more recent study, 61 isolates 
of Candida recovered from HIV and cancer patients were investigated for PL and 
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Sap activity. This was more obvious in C. albicans isolates, with 100% PL and 
94.1 % Sap activity. In contrast, non-C. albicans species showed only 29.6% PL 
and 70.3% Sap activity, indicating a relationship between other virulence 
determinants in these yeasts with colonization and disease (Kumar et a!., 2006). 
Secreted hydrolytic lipases and esterases are also thought to be important as 
virulence factors in bacteria and fungi. These enzymes are characterized by their 
ability to catalyse both the hydrolysis and synthesis of ester bonds of mono-, di-
and triacylglycerols or even phospholipids (Schaller et a!., 2005). Extracellular 
lipase activity of pathogenic Candida species was first detected by Werner (1966) 
who noted that the fungi could grow with different Tween detergents as sole 
sources of carbon. A secreted esterase was later characterized by Tsuboi et al. 
(1996). Subsequently, Fu et al. (1997) discovered by chance the first lipase gene of 
C. albicans, LIP1, while the authors were searching for phospholipases. Another 
nine new members of this lipase gene family (LIP2-LIP1O) were later cloned and 
characterized (Rube et a!., 2000). All ten lipase genes encode highly similar 
proteins with up to 80% identical amino acid sequences. Sequences similar to 
LIP1-LIP1O were also detected in other pathogenic Candida species such as C. 
parasilosis, C. krusei and C. tropicalis, but not in C. glabrata or S. cerevisiae (Fu 
et a!., 1997). 
3 Microbial biofilms 
Over the past century, microorganisms have primarily been characterised as 
planktonic, freely suspended cells and described on the basis of their growth 
properties in nutritionally rich culture media. Rediscovery of a microbiological 
phenomenon first described by Antonie Van Leeuwenhoek, that microorganisms 
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attach to and grow on exposed surfaces, led to studies which revealed that surface-
associated microorganisms (biofilms) exhibit a distinct phenotype with respect to 
gene transcription and growth rate. Biofilm formation involves specific 
mechanisms for initial attachment to a surface, development of a community 
structure and ecosystem, and detachment (Donlan, 2002). Earlier studies by 
Heukelekian and Heller (1940) demonstrated that bacterial growth and activity 
were substantially enhanced by the incorporation of a surface to which these 
organisms could attach. Also, Zobell (1943) found that the number of bacteria on 
surfaces was dramatically higher than in the surrounding medium (seawater). 
Moreover, Characklis (1973) studied microbial slimes in industrial water systems 
and showed that these microorganisms were not only very tenacious but also highly 
resistant to disinfectants such as chlorine. 
Costerton et al. (1978), based on observations of dental plaque and sessile 
communities in mountain streams, formulated a biofilm hypothesis that explained 
the mechanisms whereby microorganisms adhere to either biotic (living materials 
such as tissues and cells) and abiotic (nonliving materials) and the benefits derived 
from this ecologic niche. Later on, Carpentier and Cerf (1993) simplified the 
concept of a biofilm as a community of microbes embedded in an organic polymer 
matrix, adhering to a surface. Furthermore, Elder et al. (1995) and Mah and 
O'Toole (2001) described a biofilm in more co-operative terms as a functional 
consortium of microorganisms that is difficult to eradicate by conventional 
antimicrobial therapy and can cause indolent infections. It has become clear that 
biofilm-grown cells express properties distinct from planktonic cells, one of which 
is an increased resistance to antimicrobial agents. 
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Over the last two decades several definitions of a biofilm have been 
proposed by researchers. One which is widely quoted (Donlan and Costerton, 
2002) states that a biofilm is 'a microbially derived sessile community 
characterized by cells that are irreversibly attached to a substratum or interface or 
to each other, are embedded in a matrix of extracellular polymeric substances that 
they have produced, and exhibit an altered phenotype with respect to growth rate 
and gene transcription'. Underlying this definition are the three basic components 
of a biofilm: microbes, matrix, and surface. If one of these essentials is removed 
from the environment, the biofilm will not form. Clearly, this is an over 
simplification of a fairly complex process that does not take into account the type 
of microorganisms, the composition of the surface, or the influences of 
environmental factors (Micheal, 2000). 
3.1 Stages of biofilm development 
Palmer and White (1997) outlined the steps for the early stages of biofilm 
formation that included cell-surface and cell-cell interactions, followed by the 
development of the mature biofilm. Briefly, when microorganisms are transported 
to the surface by sedimentation, liquid flow, or active swimming, they first make 
weak and transient attachments. The next phase, irreversible attachment, depends 
on the properties of both biomaterial surface and the microbial cell surface. During 
irreversible attachment, a monolayer of single cells firmly adhered to a surface is 
produced. Next, microcolonies develop, finally forming the mature biofilm. 
Eventually, if the experimental conditions are no longer favourable, cells can 
detach from the biofilm and revert to a planktonic lifestyle (Fig. 2) (Wolfaardt et 
a!., 1994; Kierek-Pearscon and Karatan, 2005). 
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3.2 Biofilm architecture and structure 
During the transition from initial attachment to formation of a mature 
biofilm, the microbial cells undergo significant changes. This process of biofilm 
development results in the formation of a complex, three-dimensional architecture 
that usually includes mushroom-like structures, water channels, and pores 
(Lewandowski, 2000; Reisner et aI., 2003). Biofilm architecture can be visualized 
using a variety of microscopy methods such as transmission electron microscopy 
(TEM) , fluorescence microscopy, scanning electron microscopy (SEM), and 
confocal laser scanning microscopy (CLSM). In particular, CLSM which allows 
the visualization of fully hydrated samples, has revealed the complex three-
dimensional structure of biofilms (Costerton et aI., 1995). For instance, Lawrence 
et aI. (1991) used this method to study biofilms formed by P. aeruginosa, P. 
jluorescens, and Vibrio parahaemolyticus in flow chambers. They found that while 
each biofilm varied in depth, structure, and ratio of cellular to noncellular material, 
all of the biofilms developed water channels (Lawrence et aI., 1991). Many 
conditions such as surface and interface properties, the composition of the 
microbial community, and hydrodynamics, can affect biofilm structure and 
architecture, especially nutrient availability in the environment (Bowden and Li, 








Figure 2. Model of bioIIlm development 
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Individual planktonic cells can form cell-to-surface and cell-to-cell contacts 
resulting in the formation of microcolonies. Cells in the biofilm can return to a 
planktonic lifestyle to complete the cycle of biofilm development (O'Toole et a!., 
2000). 
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3.3 Biofilm matrix and its composition 
A characteristic feature of biofilms is the production of an extracellular 
matrix that envelops the attached cells. This is generally composed of water and 
microbial macromolecules and provides a complex group of micro environments 
surrounding the microorganisms (Sutherland, 2001a). In addition, the matrix 
contains a range of enzymic and regulatory activities. The matrix architecture is 
based upon a combination of intrinsic factors such as the genotype of the attached 
cells and a number of extrinsic factors, including fluctuations in nutrient and 
gaseous levels and fluid shear. Together, these intrinsic and extrinsic factors 
combine to produce a dynamic, heterogeneous microenvironment for the attached 
and enveloped cells (Allison, 2003). 
Much research during last two decades has focused on characterizing the 
matrix material of both Gram-negative and Gram-positive bacterial biofilms, such 
as P. aeruginosa biofilms (Harrison et al., 2005) and S. epidermidis biofilms 
(Sadovskaya et al., 2005). Microbial polymers such as exopolysaccharides, 
proteins, nucleic acids and various other components are invariably present. 
However, water is by far the main component of the biofilm matrix, accounting for 
up to 97% of the mass. The water may be bound within the capsules of the bacterial 
cells or can exist as a solvent whose physical properties are determined by the 
solutes dissolved in it (Sutherland, 2001a). In Gram-negative bacteria, some 
exopolysaccharides are neutral, whereas others are polyanionic because of the 
presence of uronic acids such as D-glucuronic, D-galacturonic, and D-mannuronic 
acids, or phosphate or sulphate residues (Sutherland, 2001b). In contrast to Gram-
negative bacteria, Gram-positive bacteria often produce polycationic extracellular 
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polymeric substances (Hussain et ai., 1993; Mack et ai., 1996). However, some 
polysaccharides carry hydrophobic groups which may be involved in hydrophobic 
interactions when adhering to hydrophobic interfaces (Neu et ai., 1992). 
Additionally, many matrix materials possess backbone structures that contain 
sequences of 1,3- or l,4-p-linked hexose residues that are likely to be more rigid in 
structure, and in some cases less soluble or even insoluble (Sutherland, 2001b). 
Moreover, in the presence of ions, the extracellular polymeric material shows 
increased viscosity or gelation (Loaec et ai., 1997). 
Generally, matrix polymer synthesis is dependent on the availability of 
nutrients such as carbon, nitrogen, potassium, or phosphate. In addition, slow 
bacterial growth will enhance extracellular polymeric substance production 
(Sutherland,2001b). 
3.4 Human infections involving biofilms 
Several of the common diseases associated with biofilm colonisation will 
be discussed in this and the next (3.5) section. These will include biofilms which 
attach to tissues in different organs of the human body and device-associated 
infections where the biofilm is attached to some sort of prosthesis placed within the 
body. 
3.4.1 Native valve endocarditis 
Native valve endocarditis is a condition that results from the interaction 
between the vascular endothelium, generally of the mitral, aortic, tricuspid, and 
pulmonic valves of the heart, and bacteria or fungi circulating in the bloodstream 
(Livomese and Korzeniowski, 1992). An early study by Tunkel and Mandell 
(1992) noted that of 2,300 cases of infective endocarditis, 56% were caused by 
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streptococci (including viridans streptococci, enterococci, pneumococci, and S. 
bovis), 25% by staphylococci, and the balance by Gram-negative bacteria and fungi 
including Candida and Aspergillus species. These organisms gain access to the 
bloodstream, primarily via the oropharynx, gastrointestinal tract, and genitourinary 
tract. Fungal endocarditis is a serious condition that affects particular groups of 
patients and is associated with considerable morbidity and mortality. The incidence 
of this disease has increased during the past 2 decades, and fungi now account for 
1 %-10% of organisms isolated in patients with infective endocarditis 
(Giamarellou, 2002). 
3.4.2 Cystic fibrosis 
Cystic fibrosis (CF), a chronic disease of the lower respiratory system and 
an autosomal inherited disease of Caucasians, is caused by dysfunction of the CF 
transmembrane conductance regulator protein. This disease is characterized by the 
production of copious amount of hyperviscous mucus, which covers the surface of 
the epithelial cells and impairs mechanical clearance mechanisms (Gibson et ai., 
2003). Chronic infections of biofilm-forming bacteria such P. aeruginosa are 
frequently found in the lungs of CF patients. These biofilm infections cause chronic 
endobronchiolitis in the lungs and they have been studied extensively. 
Characteristic features of these infections are their resistance to the innate and 
immune defence mechanisms and their resistance to antimicrobial agents (Hoiby et 
ai.,2001). 
3.4.3 Periodontitis 
Periodontal disease, infections involving the supporting tissues of teeth, 
range from mild inflammation of the gums (gingiva) to chronic destruction of 
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periodontal tissues. The channel between the tooth root and the gingiva, termed the 
subgingival crevice, is the primary site of periodontal infection (Lamont and 
Jenkinson, 1998). Moore et al. (1983) characterized the organisms isolated from 
patients with periodontal disease and found that Lactobacillus species, Actinomyces 
naeslundii, Fusobacterium nucleatum, Peptostreptococcus mzcros, and 
Haemophilus aphrophilus were all positively correlated with gingivitis. As the 
organisms develop biofilms in the subgingival crevice, they produce proteolytic 
enzymes that can damage tissue directly or interfere with the host defences. 
Collagenase and hyaluronidase are also present and are capable of degrading 
collagen (Marsh, 1995). 
3.5 Implant-associated infections 
Medical devices are responsible for a large proportion of nosocomial 
infections. Device-associated infections can cause major medical and economic 
sequelae. Moreover, the pathogenesis of device-related infection results from the 
complicated interaction of microorganism, device, and host factors. Microbial 
factors are probably the most important in the pathogenesis of infection, whereas 
device factors are the most amenable to modification with the objective of 
preventing infection (Bums, 2000; Darouiche, 2001; Donlan, 2001). Biofilms 
formed by bacteria on various medical devices have been studied extensively over 
the last 20 years. Until recently, less attention has been focused on the formation of 
fungal biofilms. However, Candida species are now recognised as important 
nosocomial pathogens, and an implanted device with a detectable biofilm is 
frequently associated with these infections (Table 1) (Douglas, 2003). 
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3.5.1 Central venous catheters 
Maki (1994) noted that central venous catheters pose a greater risk of 
device-related infection than does any other indwelling medical device, with 
infection rates of 3 to 5%. Colonization and biofilm formation may occur within 3 
days of catheterization (Anaissie et aI., 1995). Analysis of National Nosocomial 
Infections Surveillance data shows that 87% of primary bloodstream infections 
occur in patients with a central line (Mermel et aI., 2001). A separate study by 
Richards et aI. (2000) found that a total of 72 to 87% of bloodstream infections, 
including Candidaemia, are catheter related in intensive care unit patients. C. 
albicans accounts for up to 63% of all cases of Candidaemias, followed by C. 
glabrata or, in some hospitals, C. tropicalis (Fraser et aI., 1992). A recent study 
(Yapar et aI., 2006) has demonstrated a progressive increase in the frequency of 
nosocomial Candidaemia, especially among critically ill or immunocompromised 
patients. The results showed that C. albicans was the most common species 
(57.7%) and non-albicans species accounted for (42.3%) of all episodes. The most 
common non-albicans Candida species isolated was C. tropicalis (20.2%) followed 
by C. parapsilosis (12.5%). The most frequent risk factors associated with the 
Candidaemia were previous antibiotic treatment (76.9%), presence of a central 
venous catheter (71.2%) and total parenteral nutrition (55.8%). 
3.5.2 Joint prostheses 
In modem medicine, the most commonly implanted joint prostheses are hip 
and knee prostheses. The incidence of infection is low: 1 % in primary cases and up 
to 3% in secondary procedures. However, Candida accounts for less than 1 % of all 
cases of infections of joint prostheses (Stocks and Janssen, 2000). 
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3.5.3 Dialysis access 
The number of persons with a dialysis access continues to rise. Infection is 
the second most common cause of death in patients with end-stage renal disease. 
Additionally, infection is the most frequent cause of hospitalization and is the 
leading cause of morbidity and mortality in patients requiring dialysis (Cheung and 
Wong, 2001). Fungal infections of hemodialysis access sites are rare. However, 
current reports indicate that Candida accounts for 2.6 to 7% of peritoneal dialysis-
related infections (Lew and Kaveh, 2000; Vas and Oreopoulos, 2001). Moreover, 
non-albicans Candida species account for up to two-thirds of Candida isolates. C. 
parapsilosis seems to be the most prevalent non-C. albicans species. This 
infectious complication is associated with a high mortality and morbidity, including 
prolonged hospital stay and recourse to hemodialysis (Asim et a!., 1999; Prasad 
and Gupta, 2005). 
3.5.4 Central nervous system devices 
Most recently used ventriculoperitoneal shunts are made of silicone 
polymers. Obstruction and infection are the two most common complications 
occurring in patients with these devices. Candida is the causative agent in 1 % of 
such infections and the mortality rate is estimated to be 9% (Sanchezportocarrero et 
a!., 1994). 
3.5.5 Cardiovascular devices 
Two major groups of prosthetic heart valves are currently used: mechanical 
valves and bioprostheses (tissue valves). The rates of prosthetic valve endocarditis 
(PVE), or microbial infection of the valve and surrounding tissues of the heart, are 
similar for both types of valve (Braunwald, 1997). Fungi are responsible for 2 to 
10% of all cases of PVE, and Candida species account for up to 90 % of these 
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fungal infections (Melgar et aI., 1997). Furthermore, fungal PVE is associated with 
a higher mortility rate than bacterial PVE (Kojic and Darouiche, 2004). 
Infectious complications involving pacemakers have decreased in frequency 
as a result of improvements in surgical methods and device technology, but they 
remain in the range of 0.5 to 7 %. Candida species account for up to 4.5 % of these 
infections (Joly et aI., 1997; Wilhelm et aI., 1997). Pacemaker-related endocarditis 
represents about 10 % of pacemaker infections due to infection of the subcutaneous 
portion adjacent to the intravascular section, which seeds the intracardiac electrode 
(Joly et aI., 1997). Pacemaker endocarditis due to C. albicans, C. glabrata and C. 
tropicalis have all been reported (Cacoub et aI., 1998; Kurup et aI., 2000; Roger et 
al.,2000). 
3.5.6 Urinary catheters 
Indwelling urinary catheters are used frequently in older patient 
populations. For either short- or long-term catheters, the infection rate is about 5%. 
E. coli remains the most common infecting organism, but a wide variety of other 
organisms may be isolated, including Candida species as the second most common 
group. Urinary catheter biofilms are unique in that certain of the component 
organisms may alter the local pH through the production of urease, which 
hydrolyzes the urea of the urine to form free ammonia (Tunney et aI., 1999). 
Candida infections of the urinary tract are strongly associated with the presence of 
a urinary catheter. According to a recent National Nosocomial Infections 
Surveillance system report, C. albicans caused 21 % of catheter-associated urinary 
tract infections, in contrast to 13% of non-catheter-associated infections (Richards 
et aI., 1999). 
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4 Candida biofilms 
4.1 Candida infections and biofilms 
Candida species are now recognized as major agents of hospital-acquired 
infection. Their emergence as important nosocomial pathogens is related to specific 
risk factors associated with modem medical procedures, notably the use of 
immunosuppressive and cytotoxic drugs, powerful antibiotics that suppress the 
normal bacterial flora, and implanted devices of various kinds. Recent data from 
the US National Nosocomial Infections Surveillance System rank these organisms 
as the fourth most common cause of bloodstream infection, behind coagulase-
negative staphylococci, S. aureus and enterococci (Calderone, 2002). Candida 
species are also frequently identified as agents of nosocomial pneumonias and 
urinary tract infections. Almost invariably, an implanted device such as an 
intravascular or urinary catheter, or endotracheal tube, is associated with these 
infections and a biofilm can be detected on the surface of the device (Crump and 
Collignon, 2000; Maki and Tambyah, 2001). Other devices totally implanted into 
the body, such as prosthetic heart valves, cardiac pacemakers and joint 
replacements (e.g. hip or knee), are also liable to Candidal infection, usually at the 
time of surgical placement. 
Superficial Candida infections associated with implanted devices are much 
less serious, but are encountered frequently and can be difficult to manage. The 
commonest is probably denture stomatitis, which is a Candida infection of the oral 
mucosa that is promoted by a close-fitting upper denture (Budtz-Jorgensen, 1999). 
Silicone rubber voice prostheses which are fitted in laryngectomized patients can 
also become contaminated by polymicrobial biofilms containing Candida species 
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(Van der Mei et aI., 2000). Non-device-related infections, too, can involve 
biofilms; these include Candida endocarditis and Candida vaginitis (Donlan and 
Costerton, 2002). 
4.2 Model biofilm systems 
Various model systems have been used to characterise Candida biofilms. 
They include catheter disks, acrylic strips, microtitre plates, cylindrical cellulose 
filters, and the perfused biofilm fermenter (Baillie and Douglas, 1999b; Douglas, 
2003). Almost all of these model systems have been adapted from methods 
reported previously for bacteria. The simplest method, and the first to be described, 
involves growing adherent populations on the surfaces of small disks cut from 
catheters (Hawser and Douglas, 1994b; Hawser and Douglas, 1995b; Baillie and 
Douglas, 1999b). A similar model system has been used to study the formation of 
biofilms on strips of denture acrylic (Nikawa et aI., 1996; Chandra et aI., 2001b). 
For rapid processing of large numbers of samples, biofilms can be grown in 96-
well microtitre plates (Ramage et aI., 2001b). This method was devised for high-
throughput testing of biofilm susceptibility to antifungal agents. 
All of these procedures measure biofilm formation under static incubation 
conditions. In vivo, however, developing biofilms are often subjected to a liquid 
flow. Several flow systems have been described, including the cylindrical cellulose 
filter (Baillie and Douglas, 1998b; Baillie and Douglas, 1999a; Baillie and 
Douglas, 1999b) and the perfused biofilm fermenter (Baillie and Douglas, 1998a; 
Baillie and Douglas, 1999b). In the former system, biofilms are formed on filters 
which consist of cylindrical paper sleeves with a packed cellulose filling. With the 
perfused biofilm fermenter, a biofilm is established on the underside of a cellulose 
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membrane (0.22/lm) in the base of a fermenter, and the membrane is perfused with 
medium from the sterile side. These systems are more complex to operate than 
static ones, although several biofilms can be studied simultaneously, and with 
relative ease, using cylindrical cellulose filters. The perfused biofilm fermenter is 
the only model system that allows accurate control of biofilm growth rate. 
Recently, two different animal models of catheter-associated Candida 
infections have been described. Visualization of the resulting in vivo-formed 
biofilms indicated structural features similar to those of biofilms formed in vitro. 
Schinabeck et al. (2004) described a rabbit model of catheter-associated infection 
with C. alb icans , and also showed that antifungal lock therapy with liposomal 
amphotericin B was an effective treatment for biofilm infections using this model. 
The second in vivo system, developed by Andes et al. (2004) , used a rat central 
venous catheter model for C. albicans biofilm formation. 
4.3 Biofilm ultrastructure 
Visualisation of Candida biofilm structure has been achieved usmg 
different microscopic techniques, including fluorescence microscopy, scannmg 
electron microscopy, and confocal laser scanning microscopy. One distinguishing 
feature of C. albicans biofilms is the mixture of morphological forms usually 
present. Biofilm development on catheter disks was first examined by SEM, which 
showed that initial attachment of yeast cells was followed, after 3-6 hours, by 
germ-tube formation. Fully mature biofilms, produced after incubation for up to 48 
hours, consisted of a dense network of yeasts, hyphae, pseudohyphae, and 
extracellular polymeric material was visible on the surfaces of some of these 
morphological forms (Hawser and Douglas, 1994b). 
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The role of morphogenesis in overall biofilm structure was also investigated 
using SEM. Biofilms produced by wild-type strains of C. albicans were compared 
with those formed by two morphological mutants incapable of yeast and hyphal 
growth, respectively (Baillie and Douglas, 1999a). Wild-type biofilms on catheter 
disks consisted two distinct layers: a thin, basal region of densely packed yeast 
cells and an overlying thicker, but more open, hyphallayer. In contrast, the hypha-
negative mutant produced only the basal yeast layer, whereas the yeast-negative 
mutant formed a thicker, hyphal biofilm resembling the outer zone of wild-type 
structures. Baillie and Douglas (1999a) observed that biofilms of the yeast-negative 
mutant were more easily detached from catheter disks than the other strains, 
indicating that the basal yeast layer has an important function in anchoring the 
biofilm to the surface. 
Despite its excellent resolution properties, scanning electron microscopy 
has the disadvantage that all samples examined must be totally dehydrated 
(Douglas, 2003), since water of hydration is not compatible with the vacuum used 
with the electron beam. This dehydration process results in significant sample 
distortion and artifacts; the extracellular polymeric substances, which are 
approximately 95% water (Characklis and Marshall, 1990) will appear more as 
fibres than as a thick gelatinous matrix surrounding the cells. The development of 
the confocal laser scanning microscope in the 1980s provided researchers with the 
ability to examine biofilms in situ without the limitations associated with the 
scanning electron microscope, albeit at lower magnification (Donlan and Costerton, 
2002). CLSM allows the examination of fully hydrated, living biofilms if 
fluorescence is introduced to visualise the cells (Douglas, 2003). 
37 Introduction 
Recent CLSM studies suggest that biofilms of both C. albicans and C. 
dubliniensis have similar three-dimensional structures consisting of micro colonies 
surrounded by water channels (Chandra et ai., 2001a; Ramage et ai., 2001c; 
Ramage et ai., 2001a). Such studies have also confirmed the yeast-hyphal bilayer 
structure of C. albicans microcolonies when biofilms are grown on plastic surfaces 
(Fig. 3) (Kuhn et ai., 2002a). However, investigation of C. albicans biofilms using 
spectroscopic techniques such as Raman microscopy (Suci et ai., 2001) failed to 
reveal complex architectural features. 
4.3.1 Composition of matrix material 
The matrix material of Candida biofilms has received relatively little 
attention. Baillie and Douglas (2000) isolated the matrix of C. albicans biofilms 
and compared its composition with that of extracellular polymeric material 
obtained from culture supernatants of planktonically grown organisms. They found 
that both preparations contained carbohydrate, protein, phosphorus and 
hexosamine; however, the matrix had significantly less carbohydrate (41 %) and 
protein (5%). It also had a higher proportion of glucose 16% than mannose, and 
contained galactose, suggesting that it might possess components unique to 
biofilms (Baillie and Douglas, 2000). 
4.4 Drug resistance of biofilms 
Microbial biofilms are notoriously resistant to a variety of antimicrobial 
agents, including antibiotics, antiseptics and industrial biocides. For example, when 
bacteria exist in the biofilm form they are 10-1000 times more resistant to 
antibiotics than are planktonic cells (Donlan and Costerton, 2002). Corresponding 






Figure 3. Stages in the formation of C albicans bioftlm 
Stages in the fonnation of a C. albicans biofilm on a polyviny1chloride (PVC) 
catheter surface. (A) Catheter surface with an adsorbed conditioning film of host 
proteins (black dots). (B) Initial yeast (red) adhesion to the surface. (C) Fonnation 
of the basal layers of yeast microcolonies. (D) Completion of micro colony 
fonnation by addition of the upper, mainly hyphal layer and matrix material 
(yellow) that surrounds both yeast (red) and hyphae (green). Mature biofilms 
contain numerous micro colonies with interspersed water channels to allow 
circulation of nutrients. On other surfaces (e.g. cellulose fibres) microcolonies 
consisting entirely of yeast cells are produced (Douglas, 2003). 
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Douglas (1995b). They used a catheter disk assay to detennine drug concentrations 
that caused a 50% inhibition of metabolic activity. 
The biofilms were tested with five clinically important antifungal agents, 
namely amphotericin B, fluconazole, flucytosine, itraconazole, and ketoconazole. 
All of these agents were much less active against C. albicans biofilms on PVC 
disks than against planktonic cells. Subsequent studies indicated that C. albicans 
cells growing in biofilms were 100-fold more resistant to fluconazole and 20 to 30-
fold more resistant to amphotericin B compared to planktonic cells (Baillie and 
Douglas, 1998a; Chandra et aI., 2001a; Ramage et aI., 2001b). Biofilms of non-C. 
albicans species, such as C. tropicalis, C. parasilosis, C. glabrata, and C. krusei 
were also drug resistant (Hawser and Douglas, 1995b; Zhang et aI., 2006). 
Separate studies have demonstrated drug resistance for Candida biofilms 
grown on different surfaces such as cellulose (Baillie and Douglas, 1998b; Baillie 
and Douglas, 1999a), polystyrene (Ramage et aI., 2001b; Ramage et aI., 200le), 
silicone elastomer (Chandra et aI., 2001a), polyurethane (Lewis et aI., 2002), and 
denture acrylic (Chandra et aI., 2001b). Recently, however, it has been reported 
that some of the newer antifungal agents are active against Candida biofilms. 
Although biofilms of C. albicans and C. parapsilosis were clearly resistant to two 
new triazoles (voriconazole and ravuconazole), there appeared to be some 
antibiofilm activity with lipid fonnulations of amphotericin B and two 
echinocandins (caspofungin and micafungin) (Kuhn et aI., 2002b). The efficacy of 
caspofungin against C. albicans biofilms in vitro has now been confirmed by other 
workers (Bachmann et aI., 2002; Ramage et aI., 2002a). These intriguing recent 
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findings could lead to important developments in the treatment of fungal infections 
of implants. 
5 Mechanisms of biofilm drug resistance 
The mechanisms of biofilm resistance to antimicrobial agents are not fully 
understood. At least four possible explanations for increased resistance of biofilms 
have been proposed. These include: (l) phenotypic changes resulting from a 
decreased growth rate or nutrient limitation; (2) differential gene expression 
(induction of biofilm phenotype) including drug efflux pumps; (3) delayed or 
restricted penetration of drug through the biofilm matrix; and (4) the existence of a 
small number of 'persisters' cells. It is now thought likely that a combination of 
these mechanisms operate in both bacterial and fungal biofilms. 
5.1 Slow growth rate or nutrient limitation 
Phenotypic changes conferring drug resistance could be induced by a slow 
growth rate or by nutrient limitation within the biofilm. Both growth rate and 
nutrient limitation are known to affect the cell surface composition of 
microorganisms and hence perhaps their susceptibility to antimicrobial agents. 
Growth rate could therefore be an important modulator of drug activity in biofilms. 
Using a method of cell culture designed to study the effect of growth rate 
separately from other biofilm processes, Evans et al. (1990a) found that the slowest 
growing E. coli cells in biofilm culture were the most resistant to the drug, 
cetrimide. However, biofilm and planktonic cells were equally susceptible to the 
drug when exposed at growth rates higher than 0.3 generation per hour (Evans et 
aI., 1990a). Another study by the same group showed that drug susceptibility 
increased for both S. epidermidis biofilm and planktonic cultures with increases in 
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growth rate. The dependence of susceptibility upon growth rate was greatest for 
slow growing cells and it was concluded that the faster the rate of cell growth, the 
more rapid the rate of inactivation by ciprofloxacin (Duguid et ai., 1992). 
The effect of growth rate on Candida biofilm resistance to amphotericin B 
has been investigated using the approach taken by Evans et al. (1990b), in which 
biofilms, resuspended biofilm cells, and daughter cells were separately tested for 
drug susceptibility after growth at different rates in a perfused biofilm fermentor. 
The results were then compared with those obtained for planktonic cells grown at 
identical rates in a chemostat. The results showed that biofilms were resistant to the 
drug at all growth rates tested whereas planktonic cells were resistant only at low 
growth rates (Baillie and Douglas, 1998a). Interestingly, very similar results have 
been reported for biofilm and planktonic cells of a mucoid strain of P. aeruginosa 
tested by the same protocol for susceptibility to the quinolone ciprofloxacin (Evans 
et ai., 1991). 
A separate study using the cylindrical cellulose filter model system (Baillie 
and Douglas, 1998b) demonstrated that glucose-limited and iron-limited biofilms 
of C. albicans grown at the same low rate were equally resistant to amphotericin B. 
However, daughter cells from iron-limited biofilms were significantly more 
susceptible to the drug than those from glucose-limited biofilms. An acute 
disseminated infection produced by the release of such cells from an implant 
biofilm might therefore respond rapidly to amphotericin B but the biofilm would be 
unaffected. 
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5.2 Differential gene expression (induction of biofilm phenotype) 
A second possible explanation for biofilm drug resistance is that when 
microorganisms attach to a surface and form a biofilm there is an upregulation of 
genes which affect antimicrobial susceptibility. Altered gene expression by 
organisms within the biofilm can result in a phenotype with reduced susceptibility 
to an antimicrobial agent. 
The multiple antibiotic resistance (mar) operon is a global regulator 
controlling the expression of various genes in E. coli which constitute the mar 
regulon. Upregulation of mar leads to a multi-drug resistant phenotype, which 
includes resistance towards structurally unrelated antibiotics, organic solvents and 
the disinfectant pine oil. Maira-Litran et al. (2000a) used E. coli mar O(II)-lacZ 
fusion strains to monitor mar expression under various growth conditions including 
batch, continuous and biofilm culture. From this study they found that LacZ 
expression by the mar O(II)-lacZ fusion was generally low within the total biofilm 
population and equivalent to that of stationary phase cultures grown in batch 
culture, suggesting that its induction within biofilms cannot explain the elevated 
levels of antibiotic resistance observed (Maira-Litran et al., 2000a). The same 
researchers (Maira-Litran et al., 2000b) subsequently used mar- and acrAB-deleted 
strains to determine if the resistance of E. coli biofilms to ciprofioxacin was 
affected by loss of these loci. They demonstrated no differences between the wild-
type and mar-deleted isolates, and showed that isolates constitutive for mar 
displayed reduced susceptibility to ciprofioxacin at low concentration (O.004mg/l) 
but not at a higher concentration (O.lmgll). From these results the authors 
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concluded that antimicrobial agent resistance in E. coli biofilms is not mediated by 
the upregulation of the mar or acrAB operons (Maira-Litran et aI., 2000b). 
Work has now began to focus on the identification of genes that are 
activated or repressed in Candida biofilms compared with planktonic cells, and 
which might contribute to a multidrug-resistant phenotype. For example, 
upregulation of genes coding for multi drug efflux pumps would result in a 
multidrug-resistant phenotype. C. albicans possesses two different types of efflux 
pump: ATP-binding cassette (ABC) transporters and major facilitators, which are 
encoded by CDR and MDR genes, respectively. A recent study demonstrated that 
genes encoding both types of efflux pump are upregulated during biofilm formation 
and development. However, mutants carrying single or double deletion mutations 
in some of these genes were highly susceptible to fluconazole when growing 
planktonically but still retained the resistant phenotype during biofilm growth 
(Ramage et aI., 2002b). 
Subsequent studies by Mukherjee et aI. (2003) determined the antifungal 
susceptibilities of biofilms developed by C. albicans mutants carrying single, 
double, or triple deletion mutations of the CDR and MDRI genes. These results 
showed that at an early phase of biofilm development these mutants were more 
susceptible to fluconazole than the wild-type strain. Interestingly, at later time 
points (12 and 48 h), all the strains became resistant to fluconazole. These 
observations indicate a lack of involvement of efflux pumps in resistance at late 
stages of biofilm formation and suggest that multicomponent, phase-specific 
mechanisms are effective in antifungal resistance of Candida biofilms (Mukherjee 
et aI., 2003). 
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Andes et al. (2004) investigated differential gene expression in planktonic 
cells of C. albicans and in vivo biofilm-associated cells grown in a rat model 
system by using quantitative RT-PCR. The authors found that there was no 
difference in expression of the azole target enzyme gene ERGll, or MDRl, 
between planktonic and biofilm-associated cells. However, mRNAs from both of 
the ATP-binding cassette pumps, CDRl and CDR2 were significantly increased in 
the biofilm state. Interestingly, CDR2 was more noticeably affected, with a nearly 
lO-fold increase in expression (Andes et aI., 2004). 
5.3 Restricted or delayed penetration of drug through the biofilm matrix 
The production of matrix material, or glycocalyx, is one of the 
distinguishing characteristics of biofilms. Undoubtedly, one of the most important 
functions of the matrix is to provide the structural complexity and mechanical 
stability of the biofilm. A number of other functions have been ascribed to the 
biofilm matrix. Among these, protection of the enveloped cells from antimicrobial 
treatments is one of the most important (Allison, 2003). Since the matrix structure 
and integrity is heavily influenced by changes in the surrounding environment, it 
might exclude or limit the access of antimicrobial agents to microorganisms deep 
in biofilm (Sutherland, 2001a). However, most studies with bacterial biofilms 
indicate that the matrix material does not form a major barrier to drug diffusion, 
although for certain compounds penetration can be delayed (Mah and O'Toole, 
2001). 
5.3.1 Studies with bacteria 
A number of studies have shown an apparent failure of certain antimicrobial 
agents to penetrate the biofilm. For example, chlorine, a commonly used 
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disinfectant, did not reach more than 20% of the bulk media's concentration within 
a mixed K. pneumoniae and P. aeruginosa biofilm, as measured by a chlorine-
detecting micro electrode (De Beer et ai., 1994). In fact, the penetration profile was 
suggestive of a substrate being consumed within the matrix material. Similarly, 
Suci and co-workers (1994) used infrared spectroscopy to show that the rate of 
transport of the antibiotic ciprofloxacin to a colonized surface was reduced 
compared with transport to a sterile surface; what normally required 40s for 
penetration to a sterile surface required 21 min for a biofilm-containing surface. 
The authors suggested that the ciprofloxacin was binding and reacting with the 
biofilm components (Suci et ai., 1994). 
Studies by other researchers have taken different approaches. Hoyle et ai. 
(1992) examined the penetration of the antibiotic piperacillin through a P. 
aeruginosa biofilm grown on one side of a dialysis membrane. Their results were 
consistent with a role for P. aeruginosa biofilm matrix as a physical rather than an 
enzymatic diffusion barrier to this antibiotic. Ca2+ treatment of biofilms, which 
alters the structure of the mucoid exopolysaccharide, eliminated the diffusion of 
piperacillin, consistent with the behaviour of the exopolysaccharide as a molecular 
sieve. In a separate investigation, S. epidermidis biofilms were established on a 
dialysis membrane in a model similar to that of Hoyle and colleagues (Dunne et ai., 
1993). It was found that the antibiotics rifampicin and vancomycin diffused across 
the membrane, indicating that these drugs could efficiently penetrate S. epidermidis 
biofilms. These results suggested that inhibition of diffusion cannot always explain 
resistance to antimicrobial compounds (Dunne et ai., 1993). Moreover, these 
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observations also provided evidence that bactericidal levels of both rifampicin and 
vancomycin can be attained at the surface of an infected implant. 
Anderl and colleagues (2000) investigated the penetration of two 
antibiotics, ampicillin and ciprofioxacin, through biofilms of Klebsiella 
pneumoniae developed on microporous membranes resting on agar plates with or 
without antibiotics. The study showed that ampicillin was unable to penetrate the 
wild-type biofilm, and that the production of the ampicillin-degrading enzyme ~­
lactamase was responsible for this phenomenon. However, ~-lactamase-deficient K. 
pneumoniae biofilms in which ampicillin was shown to penetrate completely were 
still resistant to ampicillin treatment. Moreover, ciprofioxacin was able to penetrate 
the wild-type K. pneumoniae biofilms, but, as was the case with ampicillin, was 
unable to kill the biofilm bacteria (Anderl et al., 2000). These results indicate that 
other mechanisms contribute to the resistance of biofilm cells. 
It well known that cells of mucoid and non-mucoid P. aeruginosa ill 
biofilms are at least one-thousandfold less sensitive to the antibiotics tobramycin 
and cefsulodin than are cells of the same bacteria in planktonic suspension. Nichols 
and co-workers (1989) constructed a mathematical model in order to estimate time-
courses of penetration of tobramycin and cefsulodin into biofilms and 
microcolonies of mucoid and non-mucoid P. aeruginosa. They demonstrated that 
the longest time-period for tobramycin concentration at the base of a biofilm 
100/lm deep to rise to 90 % of the concentration outside the biofilm would be 2.4 
hour. However, the calculations predicted that the cefsulodin concentration at the 
base of a biofilm 100/lm deep would rise to 90% of the external concentration in 
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only 29s when fi-Iactamase was synthesized at the basal level (Nichols et ai., 
1989). 
Hatch and Schiller (1998) demonstrated that a 2% suspensIOn of P. 
aeruginosa alginate prepared from two clinical P. aeruginosa isolates can 
completely block the diffusion of gentamicin, tobramycin, and polymyxin B, 
showing how alginate production can help protect P. aeruginosa growing within 
alginate microcolonies in patients with cystic fibrosis from the effects of 
aminoglycoside. This aminoglycoside diffusion barrier was degraded with a 
semipurified preparation of alginate lyase (Hatch and Schiller, 1998). The authors 
suggested that the blocking activity of the alginate might be due to its ability to 
form viscous gels as well as to its ionic charge, and that when the mucoid polymer 
is degraded, the aminoglycoside-blocking activity is effectively reduced. This 
supports the theory that degradation of mucoid polymers within the lungs of cystic 
fibrosis patients may make the infecting pathogen more susceptible to 
aminoglycoside chemotherapy (Hatch and Schiller, 1998). 
In summary, many researchers have proposed that biofilm drug resistance is 
due to the glycocalyx which creates a diffusion barrier to antimicrobial agents 
(Brown et ai., 1995; Chen and Stewart, 1996; Liu et ai., 1998). Early studies 
showed that diffusion through a biofilm may be affected by charge (ionic) 
interactions between the matrix material and the antimicrobial agent, by an increase 
in the distance the agent must diffuse, by molecular sieving (size exclusion), and by 
the viscosity of the matrix material. Moreover, some researchers suggest that the 
polyanionic nature of the glycocalyx creates a barrier (charge interactions) to the 
diffusion of cationic antimicrobial agents (Chester et ai., 1972; Costerton et ai., 
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1981). For example, the negatively charged biofilm matrix delays some drugs such 
as aminoglycosides, which carry a positive charge. Walters et al. (2003) 
investigated the penetration of tobramycin through P. aeruginosa biofilms and 
found that it was completely retarded for the first 12 hours of a 36-hour assay, 
whereas ciprofloxacin, a fluoroquinolone, diffused across completely within the 
first 12 hours. However, at 36 hours approximately 40% of the antibiotic 
tobramycin had diffused across the biofilm. They concluded that once the binding 
capability of the matrix is exceeded, free diffusion could ensue (Walters et aI., 
2003). 
5.3.2 Studies with Candida 
To investigate whether the matrix plays a role in the antifungal resistance of 
Candida biofilms, Baillie and Douglas (2000) compared the susceptibility of C. 
albicans biofilms grown statically (which have minimal matrix material) with those 
of biofilms incubated with gentle shaking (which produce much more matrix 
material). The results of the study showed that the extent of matrix formation in 
Candida biofilms grown with or without shaking did not significantly affect 
biofilm susceptibility to any of the clinically important antifungal agents tested, 
including amphotericin B, flucytosine, and fluconazole (Baillie and Douglas, 
2000). However, other investigations with biofilms developed under flow 
conditions suggested that matrix material might play a minor role in biofilm 
resistance, since resuspended cells (which presumably had lost most of their matrix 
material) were 20% less resistant to amphotericin B than intact C. albicans biofilms 
(Baillie and Douglas, 1998a; Baillie and Douglas, 1998b). These findings with 
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resuspended biofilm cells were subsequently confirmed elsewhere (Ramage et aI., 
2002b). 
Mixed species fungal-bacterial biofilms consisting of C. albicans and S. 
epidermidis have been investigated by Adam and collaborators (2002). Drug 
susceptibility studies suggested that fungal cells can modulate the action of 
antibiotics, and that bacteria can affect antifungal activity in these mixed fungal-
bacterial biofilms, possibily as a result of increased viscosity of the matrix. Overall, 
these results seem to indicate that the matrix material plays a partial role in fungal 
biofilm resistance, but other factors are also likely to be involved. 
S.4 'Persister' cells 
One the newest hypotheses for the reduced susceptibility of biofilms to 
antimicrobials is the formation of a special class of protected subpopulation cells 
termed 'persisters' (Spoering and Lewis, 2001). Little is known about persisters, no 
doubt because of the technical difficulties of working with a small fraction of cells 
(usually 10-6_10-4 of the population) expressing a temporary phenotype of uncertain 
functional significance (Lewis, 2001). 
Brooun et al. (2000) studied a dose-response killing of P. aeruginosa 
biofilms by the quinolones, ofloxacin and ciprofloxacin. The results proved that the 
majority of cells were effectively killed by low, clinically achievable 
concentrations of drug akin to the concentrations which are lethal to planktonic 
cultures. These experiments indicated that the presence of a small fraction of 
persister cells was primarily responsible for the very high level of resistance of the 
biofilms (Brooun et aI., 2000). It has been suggested that persisters, and biofilms 
that contain them, display tolerance, which means that cells do not grow in the 
50 Introduction 
presence of antimicrobial agents; however, they do not die either. This capability to 
avoid being killed is one of the defining features of persisters (Keren et aI., 2004; 
Cogan, 2006). 
Because the study of persister cells in bacterial biofilms is in its infancy, it 
is not known whether the same phenomenon occurs in Candida biofilms. A recent 
publication by LaFleur et al. (2006) reported that biofilms formed by C. albicans 
exhibited a strikingly biphasic killing pattern in response to two antifungal agents. 
The results indicated that a subpopulation of highly tolerant cells existed. 
Interestingly, surviving C. albicans persisters were only observed in biofilms and 
not in planktonic exponentially growing, or stationary, populations. The authors 
concluded that C. albicans persisters are not mutants, but phenotypic variants of 
the wild type which switch on "persister" genes in response to the biofilm mode of 
growth (LaFleur et aI., 2006). Another recent study by Khot and co-workers (2006) 
demonstrated that C. albicans biofilms cultured in a tubular flow cell system 
harboured a subpopulation of yeast cells that were significantly more resistant to 
amphotericin B than planktonic populations. This subpopulation of yeast cells 
formed a basal layer that was tenaciously attached to the surface of the tubing 
(Khot et aI., 2006). 
6 Mixed species fungal-bacterial biofilms 
Bacteria are often found with Candida species in polymicrobial biofilms in 
vivo, and it is likely that extensive interspecies interactions take place in these 
adherent populations. In vitro, several model systems have been used to investigate 
mixed species fungal-bacterial biofilms, including catheter disks, polycarbonate 
membrane filters, and denture acrylic disks. Adam et al. (2002) used a simple 
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catheter disk model system to study the development in vitro of mixed-species 
biofilms of C. albicans and Staphylococcus epidermidis, the commonest agent of 
bacterial catheter-related infection. Two strains of S. epidermidis were used: a 
slime-producing wild type and a slime-negative mutant. Interestingly, in mixed 
fungal-bacterial biofilms, both staphylococcal strains showed extensive interactions 
with both yeasts and hyphae under scanning electron microscopy. Similar 
observations have been made with biofilms consisting of C. albicans and oral 
streptococci (Streptococcus gordonii and Streptococcus salivarius) on denture 
acrylic (Jenkinson and Douglas, 2002). 
Recently O'May and co-workers (2005) designed a complex in vitro 
fermenter system to replicate the biofilm that forms within gastric feeding tubes. 
This chemostat fermenter was inoculated with the most common strains found in 
clinical gastric feeding tube samples such as Lactobacillus sharpeae, Lactobacillus 
paracasei, E. coli, K. pneumoniae, S. aureus, C. albicans and C. famata. In this 
model, the mixed-species biofilms formed on the chemostat tubing, and were 
composed of both yeast and bacterial cells. Surprisingly, acid suppression therapy 
was found to change community structure in favour of Candida (O'May et al., 
2005). 
Over the last decade, two opportunistic pathogens, P. aeruginosa and C. 
albicans, have been shown to be significantly involved in many device-associated 
nosocomial infections. Recent in-vitro studies have shown antagonistic interactions 
between these organisms (Hogan and Kolter, 2002; Hogan et al., 2004). P. 
aeruginosa formed a dense biofilm on C. albicans hyphae, and killed the fungus. 
By contrast, the bacteria were unable to bind to, or kill, yeast-form C. albicans. 
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Hyphal death occurred only after the beginning biofilm formation. To examine the 
possible role of virulence genes in these interactions, three classes of P. aeruginosa 
mutants were tested for their ability to kill fungal cells. The results indicated that 
several virulence factors, including pili and secreted molecules such as 
phospholipase C, were acting in concert to kill Candida hyphae (Hogan and Kolter, 
2002). The authors suggested that many microbial virulence factors, normally 
considered in the context of human infection, might also be involved in bacterial-
fungal interactions. Subsequently, Hogan et al. (2004) identified P. aeruginosa 
mutants incapable of inhibiting C. albicans filamentation. During these studies they 
found that 3-oxo-C12 homoserine lactone, a cell-cell signalling molecule produced 
by P. aeruginosa, was sufficient to inhibit C. albicans filamentation without 
affecting fungal growth rates (Hogan et al., 2004). 
In the oral cavity, Candida or other yeast species always co-exist with 
commensal bacteria within a biofilm matrix. In vitro, Larnfon et al. (2005) used 
denture acrylic (polymethylmethacrylate) disks to co-culture fungal-bacterial 
biofilms derived from denture plaque from denture stomatitis patients. They found 
that Actinomyces, Lactobacillus, Streptococcus and Candida species grew readily 
in the biofilm mode in vitro and suggested that the system could be used to assess 
the susceptibility of Candida species within these biofilms to antifungal agents 
(Larnfon et al., 2005). Similar studies have been performed by Shapiro et al. (2002) 
to examine the efficacy of different mouth-rinses containing chlorhexidine, 
hexetidine, octenidine, Triclosan and aminefluoride against mixed-species fungal-
bacterial biofilms. 
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In a recent investigation, Thein and colleagues (2006) evaluated the effect 
of varying concentrations of eight different aerobic and anaerobic oral commensal 
bacterial species such as Actinomyces israelii, Lactobacillus acidophilus, 
Prevotella nigrescens, Porphyromonas gingivalis, P. aeruginosa, E. coli, 
Streptococcus mutans, and Streptococcus intermedius on in vitro C. albicans 
biofilm formation. Polystyrene plastic surfaces were used as a substrate for biofilm 
development. They found that co-culture with different concentrations of bacteria 
had variable effects on Candida biofilm formation. Moreover, co-culture with the 
highest concentrations of bacteria resulted in a consistent reduction in the yeast 
count in Candidal biofilms. The data demonstrated the quantitative and qualitative 
nature of the bacteria modulating C. albicans biofilm formation in mixed-species 
environments such as the oral cavity (Thein et al., 2006). 
7 Aims and objectives of research 
In recent years, the use of medical implants such as catheters, prosthetic 
heart valves and joint replacements has increased dramatically. These devices can 
be colonised by microorganisms that form an adherent biofilm consisting of a 
mono- or multilayer of cells embedded within a matrix of extracellular polymric 
material. They are phenotypically different from planktonic or suspended cells; 
notably, they resist host defences and display a significantly decreased 
susceptibility to antimicrobial agents. Fungal implant infections are less common 
than bacterial ones but tend to be more serious and are an increasing problem. They 
are most often caused by the pathogenic Candida species, particularly C. albicans. 
Some of these infections involve mixed species biofilms of C. albicans with, for 
example S. epidermidis. C. albicans biofilms, like their bacterial counterparts, are 
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inherently less susceptible to antimicrobial agents than planktonic cells but the 
mechanism of this drug resistance is unknown. The aim of this project was to 
explore the possible role of the extracellular matrix material as a barrier to drug 
penetration in both single species Candida biofilms and in mixed species bacterial-
fungal biofilms. 
Specific objectives included the following: 
1) Determination of the penetration of antifungal agents through both single 
species Candida biofilms and mixed species bacterial-fungal biofilms using 
a novel filter disk assay. 
2) Comparison of the drug susceptibility of biofilms grown statically and 
under conditions of continuous flow using the modified Robbins device. 
3) Isolation and analysis of matrix material extracted from biofilms formed by 
different Candida species. 
4) Enzymic detachment of biofilms formed by different Candida species using 
a range of commercially available enzymes of known specificity. 
Materials and Methods 
MATERIALS AND METHODS 
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1 Origin and maintenance of organisms 
Three strains of C. albicans were used in this study. Strains GDH 2346 
(NCYC 1467) and GDH 2023 (NCYC 1468) were originally isolated from 
patients with denture stomatitis at Glasgow Dental Hospital. Strain GRI 682 
(NCYC 1473) was obtained from a routine cervical smear taken from an 
asymptomatic woman at Glasgow Royal Infirmary. 
C. glabrata AAHB 12, C. parapsilosis AAHB 4479 and C. tropicalis 
AAHB 73 were isolated from patients with line infections at Crosshouse Hospital, 
Kilmarnock, Scotland. C. krusei was obtained from a clinical specimen and came 
from the Regional Mycology Reference Laboratory, Glasgow, Scotland. 
Two strains of S. epidermidis (RP62A and M7) were used in this study. 
Both were kindly supplied by Professor C. G. Gemmell, Glasgow Royal 
Infirmary. Strain RP62A (ATCC 35984) is known to be a slime producer; strain 
M7 is a slime-negative mutant obtained after chemical mutagenesis of S. 
epidermidis RP62A with mitomycin C (Schumacher-Perdreau et aI., 1994). The 
growth rate, initial adherence, cell-wall composition, surface characteristics and 
antimicrobial susceptibility profile of strain M7 are indistinguishable from those 
of the wild type (Schumacher-Perdreau et aI., 1994). 
Candida isolates were maintained on slopes of Sabouraud dextrose agar 
(SDA; Difco; Appendix 1.2) and S. epidermidis strains on Tryptic soy agar (TSB; 
Difco) at 4°C, and subcultured monthly. Every two months, the cultures were 
replaced by new ones freshly grown from freeze-dried stocks. Both freeze-dried 
fungi and bacteria were stored in small, evacuated glass ampoules kept at -20°C. 
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2 Growth media and culture conditions 
Two media were used in this study. Yeast nitrogen base (YNB) was used 
for the growth of Candida species while Tryptic soy broth (TSB) was employed 
for S. epidermidis. In some experiments, mixed species biofilms containing both 
Candida and S. epidermidis were also grown in TSB. 
2.1 Yeast nitrogen base medium (YNB; Difeo; Appendix 1.1) 
Yeast nitrogen base (6.7g per litre) was supplemented with 9.0g of glucose 
to give a final concentration of 50 mM glucose as the carbon source (McCourtie 
and Douglas, 1981). This medium had a final pH of 5.4 and was autoclaved at 10 
p.s.i. for 1Omin. Batches of medium (50ml, in 250ml Erlenmeyer flasks) were 
inoculated with Candida isolates from fresh culture slopes and incubated at 37°C 
for 24h in an orbital shaker operating between 60-90 rpm. All Candida strains and 
species, with the exception of the C. tropicalis isolate, grew exclusively in the 
budding-yeast phase under these conditions. Overnight cultures were harvested by 
centrifugation at 3000 rpm for 5 min and washed twice with sterile 0.15 M 
phosphate-buffered saline (PBS; pH 7.2, Ca2+ and Mg2+ free) then resuspended in 
PBS before use in biofilm experiments. All washed cell suspensions were adjusted 
to an optical density of 0.8 at 520 nm or 0.2 at 600 nm (for penetration assays). 
2.2 Tryptic soy broth (TSB; Difeo; Appendix 1.3) 
As a result of preliminary experiments with a range of media, Tryptic soy 
broth (TSB) was selected as the liquid medium best able to support the growth of 
both fungi and bacteria. Isolates of C. albicans GDH 2346 and S. epidermidis 
(RP62A and M7) grew at similar rates in this medium (Adam et aI., 2002). The 
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medium was autoclaved at 121°C for 15 min. Batches of medium (50 ml, in 250-
ml Erlenmeyer flasks) were inoculated from fresh culture slopes and incubated at 
37°C for 24h on a shaking platform operating at 60-90 rpm. Cells were harvested, 
washed twice in sterile PBS and finally resuspended in PBS to an optical density 
of 0.8 at 520 nm or 0.2 at 600 nm (for penetration assays). For development of 
mixed species biofilms, equal volumes from the standardized suspensions of each 
organism were mixed immediately before use. 
3 Penetration of biofilms by antifungal agents 
Several model systems have been developed to study the biofilm mode of 
growth. In this study, the penetration of antifungal drugs through Candida, S. 
epidermidis and mixed fungal-bacterial biofilms was investigated by adapting a 
novel filter disk assay described by Anderl et al. (2000) for bacterial biofilms. 
3.1 Antifungal agents 
Four clinically important antifungal agents were used in this study. 
Flucytosine (5-fluorocytosine) and amphotericin B were obtained from Sigma. 
Fluconazole and voriconazole were kindly donated by Pfizer Ltd. All drug 
solutions were prepared immediately before use. Flucytosine and fluconazole 
were dissolved in sterile distilled water and then added to molten culture medium 
at 50°C via a minis art sterile filtration unit (Sartorius AG, Goettingen, Germany) 
to create antifungal-supplemented agar for biofilm experiments. Voriconazole and 
amphotericin B were dissolved in dimethyl sulfoxide (DMSO) and filtered into 
the warm growth medium. The medium was buffered to pH 7 with 0.165 M 
morpholinopropanesulfonic acid (MOPS) buffer (Sigma). High drug 
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concentrations were used in the antifungal-supplemented agar. They were selected 
on the basis of their ability to give large zones (Fig. 4) of growth inhibition in 
control assays for drug penetration outlined below. The concentrations used were 
as follows: flucytosine, 6 ~g/ml (30 times the MIC for planktonic C. albicans 
GDH 2346); fluconazole, 24 ~g/ml (60 times the MIC); voriconazole, 10 ~g/m1 
(10 times the MIC); and amphotericin B, 78 ~g/ml (60 times the MIC). 
Figure 4. Measurement of drug penetration by zone-of-inhibition bioassay. 
YNB agar containing 200mM glucose was seeded with 150~l of a standardized 
suspension of C. albicans GDH 2346 to determine zone of growth inhibition 
(arrows) around disks containing antifungal agents. 
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3.2 Biofilm formation on membrane filters 
Biofilms were grown on membrane filters resting on agar culture medium 
in petri dishes. Polycarbonate membrane filters (diameter, 25 mm; pore size, 
0.2/lm; Whatman) were sterilized by exposure to ultraviolet radiation for 15min 
on both sides prior to inoculation, and placed on the surface of YNB agar 
containing 50 mM glucose for Candida species or TSB agar for S. epidermidis 
and mixed species biofilms. A standardized cell suspension (50 Ill) was applied to 
the surface of each sterile membrane. All plates were incubated at 37°C for 24 h. 
The membrane-supported biofilms were then transferred to fresh agar (YNB agar 
with 50 mM glucose or TSB agar) for a further 24 h, giving a total incubation 
time of 48 h for biofilm formation. Smaller, polycarbonate membrane filters 
(diameter, 13 mm; pore size, 0.2 /lm; Whatman) were sterilized by exposure to 
ultraviolet radiation for 15 min on both sides, and were then carefully placed on 
top of the 48-h biofilms. Paper concentration disks (diameter, 6 mm; Becton 
Dickinson) were also sterilized by exposure to ultraviolet radiation for 15 min per 
side, and then moistened with growth medium (normally 29 Ill) prior to placement 
on top of the 13-mm-diameter membranes. Because of an occasional variation in 
disk thickness, a slightly higher or lower volume of medium was sometimes 
required to saturate the disks. Wetting the disks helped prevent the capillary 
action of the antifungal medium through the biofilms. Biofilms sandwiched 
between the membranes and moistened disks were transferred to antifungal agent-
containing agar culture medium (Fig. 5). All plates were incubated for specified 
exposure times, namely, 60, 90, 120, 180,240, or 360 min. 
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The amount of antifungal agent which had penetrated each biofilm and 
which had reached the concentration disk was determined by using the disk in a 
standard drug diffusion assay. Plates of YNB agar supplemented with 200 mM 
glucose were seeded with 150 Jll of a standardized suspension of planktonic C. 
albicans GDH 2346 (used here as an indicator organism, and adjusted to an 
optical density of 1.0 at 520nm). After the appropriate exposure time, 
concentration disks were removed from the biofilm 'sandwiches' and placed on 
the seeded plates, which were then incubated at 37°C for 24 h. The zones of 
growth inhibition (Fig. 4) were measured (in mm) at four points around each disk 
and the mean value calculated. This value was then used to determine the 
concentration of active antifungal agent in the disk by reference to a standard 
curve prepared using drug solutions of different concentrations but fixed volumes. 
All drug penetration assays were carried out in duplicate on at least two 
separate occasions. In control assays, concentration disks were placed on the two-
membrane system to which no cells had been added, i.e., the unit without the 
biofilm. The drug concentration that penetrated the biofilms (C) was divided by 
the drug concentration determined for the controls (Co) to provide a normalized 
penetration curve (Ander! et al., 2000). 
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/ 
Figure 5. The experimental system used to determine the penetration of 
antifungal agents through bioitlm. 
(A) A 25mm-diameter microporous polycarbonate membrane 
(B) Biofilm 
(C) A 13mm-diameter microporous polycarbonate membrane 
(D) A concentration disk 
(E) Antifungal agent-containing agar 
E 
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3.3 Preparation of standard curves for drug penetration assays 
3.3.1 Flucytosine (S-fluorocytosine) 
A standard curve of flucytosine concentration plotted against diameter of 
zone of growth inhibition was prepared using flucytosine solutions (in water) of 2, 
4, 6, 8, 10, and 20 Ilg/ml (Table 2). Overnight cultures of C. albicans GDH 2346 
were harvested by centrifugation at 3000 rpm for 5 min, washed twice in sterile 
0.15 M PBS (pH 7.2) and then resuspended in PBS to an optical density of 1.0 at 
520 nm. YNB agar supplemented with 200 mM glucose was seeded with 150 III 
of this standardized suspension (used here as an indicator organism) to measure 
the zones of inhibited growth. Blank paper concentration disks were moistened 
with a fixed volume (24 Ill) of drug solution before being transferred to the pre-
seeded plates. All plates were incubated at 37°C for 24 h. A total of 9 disks was 
used for each drug concentration (Table 2). Mean values for the diameter of the 
zone of growth inhibition were calculated, and plotted against the flucytosine 
concentration used, to produce a standard curve. Thereafter, test zones of growth 
inhibition were compared to the standard curve to determine the concentration of 
flucytosine in experimental disks (Fig. 6). 
3.3.2 Fluconazole 
A standard curve of fluconazole concentration against diameter of zone of 
growth inhibition was prepared as described for flucytosine except that 
fluconazole solutions (in water) of 8, 10, 12, 14, 18, 20, and 25 Ilg/ml were used 
(Table 3; Fig. 7). A total of 5 disks was used for each drug concentration (Table 
3). 
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Table 2. Zone of growth inhibition due to flu cytosine on plates seeded with C. 
albicans GDH 2346 a 
Diameter of zone (mm) of growth inhibition produced 
by flucytosine at a concentration (pg!ml) of 
Disk b 2 4 6 8 10 20 c 
1 2.0 4.0 6.0 6.50 7.0 11.0 
2 2.0 4.50 6.0 6.50 7.50 9.50 
3 2.0 4.50 7.0 7.0 7.0 10.50 
4 3.0 4.50 7.0 6.0 8.0 9.50 
5 2.0 4.0 6.0 7.0 7.50 9.50 
6 3.0 4.50 6.0 6.50 7.0 9.0 
7 3.0 4.50 7.0 6.0 7.0 9.0 
8 2.0 4.50 7.0 6.50 7.0 9.50 
9 2.50 4.0 8.0 6.50 7.50 9.0 
Total 21.50 39.0 60.0 58.50 65.50 86.50 
Meand 2.39 4.33 6.67 6.50 7.28 9.61 
a Growth medium (YNB supplemented with 200 mM glucose) was seeded with 
150 III of a standardized suspension of C. albicans. 
b Blank paper concentration disks (9 for each drug concentration) were moistened 
with a fixed volume (24111) of drug solution. 
C Different concentrations (Ilg/ml) of flucytosine were used to draw the standard 
curve. 
d Data are means from three independent experiments done in duplicate. 
















1 10 100 
Drug concentration (lJg/ml) 
Figure 6. Standard curve for flucytosine in drug penetration assay 
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Table 3. Zone of growth inhibition due to fluconazole on plates seeded with 
C. albicans GDH 2346 a 







Mean d 0.0 
Diameter of zone (mm) of growth inhibition produced 
by fluconazole at a concentration (flglml) of 
10 12 14 18 20 25 c 
0.0 0.0 2.50 3.75 5.25 7.50 
0.0 0.0 2.50 3.25 5.50 7.50 
0.0 0.0 2.50 3.75 5.50 7.25 
0.0 0.0 2.50 3.25 5.75 7.75 
0.0 0.0 2.50 4.00 5.50 7.25 
0.0 0.0 12.50 18.00 27.50 37.25 
0.0 0.0 2.50 3.60 5.50 7.45 
a Growth medium (YNB supplemented with 200mM glucose) was seeded with 
150111 of a standardized suspension of C. albicans. 
b Blank paper concentration disks (5 for each drug concentration) were moistened 
with a fixed volume (27111) of drug solution. 
C Different concentrations (l1g/ml) of fluconazole were used to draw the standard 
curve. 
d Data are means from two independent experiments done in duplicate. 
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Drug concentration (J.lg/ml) 
Figure 7. Standard curve for fluconazole in drug penetration assay 
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3.3.3 Amphotericin B 
A standard curve of amphotericin B concentration against diameter of 
zone of growth inhibition was prepared as described for flucytosine except that 
amphotericin B solutions (in dimethyl sulfoxide) of 20,30,40, 50, 60, 70, and 80 
/lg/ml were used (Table 4; Fig. 8). 
3.3.4 V oriconazole 
A standard curve of voriconazole concentration against diameter of zone 
of growth inhibition was prepared as described for flucytosine except that 
voriconazole solutions (in dimethyl sulfoxide) of 2, 5, 10, 15, and 20 /lg/ml were 
used (Table 5; Fig. 9). 
3.4 Viable counts of biofilm cells exposed to antifungal agents 
After biofilm formation on 25-mm-diameter membrane filters, biofilms 
were capped with sterile, 13-mm-diameter filters, transferred to antifungal agent-
containing agar, and incubated at 37°C for 6 h (the maximum exposure period in 
drug penetration assays) or 24 h. The longer time period was chosen to check 
whether prolonged drug exposure might increase biofilm susceptibility. After 
incubation, biofilm cells were scraped gently from the membranes using a sterile 
scalpel and resuspended in 10 ml of PBS. Serial dilutions (10-1 to 10-6) of each 
biofilm cell suspension were then prepared. Triplicate samples (0.1 ml) of the 10-
4, 10-5 and 10-6 dilutions were spread on YNB agar containing 200 mM glucose, 
and the plates were incubated at 37°C for 24 h. In control assays, the membranes 
were transferred to growth medium containing no antifungal agent. 
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Table 4. Zone of growth inhibition due to amphotericin B on plates seeded 
with C. albicans GDH 2346 a 





Mean d 1.63 
Diameter of zone (mm) of growth inhibition produced 
by amphotericin B at a concentration (,..g!ml) of 
30 40 50 60 70 
2.50 3.0 3.87 4.0 5.0 5.0 
2.75 3.0 4.0 4.13 4.88 5.0 
2.63 3.13 3.38 4.0 4.75 4.88 
7.88 9.13 11.25 12.13 14.63 14.88 
2.63 3.04 3.75 4.04 4.88 4.96 
a Growth medium (YNB supplemented with 200mM glucose) was seeded with 
150/11 of a standardized suspension of C. albicans. 
b Blank paper concentration disks (3 for each drug concentration) were moistened 
with a fixed volume (33/11) of drug solution. 
C Different concentrations (/1g/ml) of amphotericin B were used to draw the 
standard curve. 
d Data are means from two independent experiments done in duplicate. 

















Drug concentration (lJglml) 
Figure 8. Standard curve for amphotericin B in drug penetration assay 
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Table 5. Zone of growth inhibition due to voriconazole on plates seeded with 
C. albicans GDH 2346 a 





Mean d 5.42 
Diameter of zone (mm) of growth inhibition produced 
by voriconazole at a concentration (flg/ml) of 
5 10 15 20 c 
9.50 12.25 13.00 15.00 
9.25 12.25 13.00 15.00 
9.00 12.25 13.75 14.75 
27.75 36.75 39.75 44.75 
9.25 12.25 13.25 14.92 
a Growth medium (YNB supplemented with 200mM glucose) was seeded with 
150111 of a standardized suspension of C. albicans. 
b Blank paper concentration disks (3 for each drug concentration) were moistened 
with a fixed volume (30111) of drug solution. 
C Different concentrations (Ilg/ml) of voriconazole were used to draw standard 
curve. 
d Data are means from two independent experiments done in duplicate. 
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Drug concentration (lJg/ml) 
Figure 9. Standard curve for voriconazole in drug penetration assay 
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4 Drug susceptibility of biofilms formed under static and flow 
conditions 
4.1 Biofilm formation under static conditions on catheter disks 
Biofilms grown statically were formed on the surfaces of small disks 
(diameter, 0.8cm) cut from polyvinyl chloride (PVC) Faucher tubes (French 
gauge 36; Vygon, Cirencester, UK) using a punch (Fig. 10). Disks were sterilized 
by exposure to ultraviolet radiation for 30 min on both sides and then placed in 
the wells of 24-well Nunclon tissue culture plates (Coming Incorporated 3524, 
USA). Standardized cell suspensions (80 Ill) were applied to the surface of each 
sterile disk. Initially, incubation lasted for 1 h at 37°C (adhesion period). 
Thereafter, each disk was gently dipped into a well containing 3ml of sterile PBS 
to remove any non-adherent cells. The disks were transferred to wells of new 
tissue culture plates each containing 1 ml of YNB supplemented with 50 mM 
glucose, or TSB medium. They were then incubated statically at 37°C for 48 h, 
submerged in growth medium, for biofilm formation. 
4.2 Biofilm formation under flow conditions using the modified Robbins 
device (l\1RD) 
Several model systems have been developed to study the biofilm mode of 
growth under conditions of continuous flow. The modified Robbins device (MRD, 
Fig. 11 a and b) is one of the most widely used and well-known systems (Lappin-
Scott et aI., 1993). It provides quantifiable samples of biofilms growing on 
submerged surfaces in aqueous systems. 
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Figure 10. Punch device used to prepare small disks (diameter, 0.8cm) from 
PVC Faucher tubes for biofIlm formation under static and flow conditions. 
Arrow cutting edge of punch. 
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Figure 11 
(a) The modified Robbins device (MRD) 
(b) The experimental system used in this study to provide a continuous flow 
of cell suspension and culture medium for biomm formation 
(A) 5-litre Erlenmeyer flask with YNB or TSB culture medium. 
(B) 250-ml Erlenmeyer flask containing cell suspension. 
(C) Peristaltic pump to adjust flow rate. 
(D) Modified Robbins device (MRD). 
(E) Translucent silicone tubing connected to waste flask. 
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4.2.1 MRD model system 
The MRD is an artificial multiport sampling catheter, constructed of an 
acrylic block (41.5 cm long, 20 mm high and 26 mm across) with a rectangular 
lumen (2 mm deep by 10 mm wide). There are 25 evenly spaced sampling ports, 
11 mm in diameter, with polypropylene connectors at either end for attaching the 
tubing from the culture vessel (Lappin-Scott et aI., 1993). The sample studs, also 
made of acrylic, are 26 mm in length and are inserted into the sample ports; this is 
assisted by rubber O-rings which effectively seal the ports to prevent leakage. 
Each O-ring is positioned in a narrow groove, 21 mm from the top of the stud. 
The bottom surface of the sample stud has a lcm rim designed to hold a sterile 
disk of the material being studied (Fig. 12). The sampling studs can be removed 
and replaced aseptically. To establish a biofilm on the surface of disks in the 
MRD, a reservoir containing a standardized suspension of the test organism(s) 
was connected to a peristaltic pump and the MRD via silicone tubing. The entire 
apparatus was incubated at 37°C. Cell suspension was pumped through the MRD 
at a flow rate of 60 ml h-1 for 1 h to allow cells to adhere to each of the 25 catheter 
disks attached to the sample studs. Upon leaving the MRD, the cell suspension 
was collected in an effluent container. Fresh growth medium (either YNB with 50 
mM glucose, or TSB) was then continuously pumped through the MRD at the 
same flow rate for 48 h. After this time, biofilms formed on the catheter disks 
could be retrieved by removing the sample studs from the MRD (Fig. 11 a and b). 
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Figure 12. Sampling studs containing sterile catheter disks are inserted into 
MRD model system for biofIlm formation under continuous flow. 
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4.2.2 Cleaning and maintenance of the MRD 
The MRD was completely dismantled and thoroughly cleaned between 
each assay. After the completion of each experiment, the MRD was sterilized with 
0.05 % hibitane, which was pumped through the MRD for 1 h at a flow rate of 60 
mllh. This was followed by a 1-h wash with sterile distilled water, pumped 
through at a rate of 200 mllh to remove any traces of hibitane. The device was 
occasionally soaked in bleach (Virkon) for a short time to remove any build-up of 
attached biofilm along the lumen. Afterwards, it was washed thoroughly by 
running tap water through it for an extended period of time. The MRD was stored 
at ambient temperature on a flat, clean surface, away from direct sun light. 
4.3 Susceptibility of biofilms to antifungal agents 
The susceptibilities of biofilms grown statically or III the MRD to 
amphotericin B and fluconazole were tested by treatment with YNB or TSB 
growth medium containing these antifungal agents. Drug solutions were prepared 
immediately prior to use. Stock solutions of the drug in DMSO (amphotericin B; 
1.95 mg / 50ml) or water (fluconazole; 0.6 mg/50ml) were sterilized by filtration 
(filter pore size, 0.2I1m; Sartorius minisart), and then diluted in warm growth 
medium buffered to pH 7 with 0.165 M morpholinepropanesulphonic acid 
(MOPS) buffer (Sigma). After incubation of biofilms on catheter disks for 48 h at 
37°C, the disks were transferred to fresh 24-well tissue culture plates. Buffered 
growth medium (lml) containing amphotericin B (6.5 or 39 I1g/ml) or fluconazole 
(12 I1g/ml) was added to each well and the plates were incubated at 37°C for 5 h 
or 24 h. Following exposure to antifungal agents, the biofilms were washed gently 
in 5 ml of PBS and transferred to fresh tissue culture plates. Thereafter, biofilm 
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activity was assessed quantitatively by tetrazolium salt (XTT; Sigma) reduction 
assays. The effect of an antimicrobial agent was measured in terms of XTT 
reduction by biofilms as compared with values obtained for control biofilms 
incubated under identical conditions in the absence of the drug. 
4.4 Quantitative analysis of biofilm growth by the XTT assay 
XTT is converted to a coloured formazan product (brown colour) in the 
presence of metabolic activity (Fig. 13). The primary mechanisms of XTT-to-
formazan conversion are the mitochondrial succinoxidase and cytochrome P450 
systems, as well as flavoprotein oxidase (Kuhn et aI., 2003). However, addition of 
the electron coupling agent menadione (Vit.K3; 2-Methyl-1,4-naphthoquinone; 
Sigma) is essential in the XTT assay. 
A stock solution of XTT (2.5 mg/ml) was prepared in prewarmed (37°C) 
PBS containing 1 % of glucose, 1 ml of XTT solution was added to each well of a 
new tissue culture plates which containing disks with 48-h mature biofilms grown 
on the surface of PVC catheter. Menadione solution (1mM in acetone; 4 Ill; 
Sigma) an electron-coupling agent was also added to each well. All plates were 
incubated at 37°C for 5 h, in dark conditions. After incubation, the XTT solution 
in each well was transferred to a microfuge tube and clarified at 13,000 rpm for 3 
min. The supernatant was then transferred to a spectrophotometer cuvette and 
formazan production measured at 492 nm (Mosmann, 1983; Tellier et aI., 1992; 
Meshulam et aI., 1995; Hawser, 1996; Baillie and Douglas, 1999b). 
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Figure 13. Colorimetric tetrazolium assays (XTT) were used to measure 
bioiIlm growth and for drug susceptibility testing. XTT is converted to a 
coloured formazan product (brown colour) after incubation for 5h at 37°C 
(B). The blank is colourless (A). 
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5 Isolation of extracellular polymeric substances (EPS) 
5.1 Biofilm formation 
Biofilms were formed on sections (4 cm long) of PVC Faucher tubes (French 
gauge 36; Vygon, Cirencester, UK) that had been cut into three equal concave 
strips. These were sterilized by exposure to ultraviolet radiation for 15 min on 
each side. Standardized cell suspension (400 Ill) was applied to the surface of each 
one and the strips were incubated for 1 h at 37°C. Non-adherent cells were 
removed by gently dipping each strip into a wide-neck conical flask containing 10 
ml of sterile PBS. The strips were then transferred to 250-ml, wide-neck 
Erlenmeyer flasks, (six strips per flask) containing yeast nitrogen base (50 ml) 
supplemented with 50mM glucose. Flasks were incubated at 37°C for 48 h on an 
orbital shaker operating at low shaking speeds between 20-50 rpm. This allowed 
biofilm formation with increased synthesis of extracellular matrix material 
(Hawser et ai., 1998a). 
5.2 Isolation of biofilm EPS 
Extracellular polymeric material from Candida biofilms was prepared by a 
modification of the method of Baillie and Douglas (2000). Biofilm EPS was 
physically extracted, without adding any chemical extractants. Catheter strips 
containing mature biofilms were transferred to universal bottles (six strips per 
bottle), each containing 10 ml of distilled water. The bottles were sonicated in a 
water bath at room temperature for 5 min and vortexed vigorously for 1 min to 
disrupt the biofilms. Cell suspensions were then pooled and the extracellular 
material was removed from yeast cells by centrifugation at 4,000g for 15 min at 
room temperature. The supernatants were concentrated to one-tenth of the original 
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volume using an Amicon DC2 hollow-fibre concentration system with a 3.0 K 
filter (Millipore Ltd, Watford, UK). The concentrated solutions which contained 
low molecular-weight metabolites were dialysed through a dialysis membrane 
(3.5 kDa cut-off; Pierce, Cheshire, U.K) at 4°C for 3 days against five changes (5 
litres each) of distilled water and then retentates (crude EPS) were freeze-dried. 
6 Chemical analysis of EPS 
After lyophilization, the total weight of extracted EPS was determined. 
EPS preparations were then analysed quantitatively for total carbohydrate, 
protein, phosphorus, uronic acid, hexosamine and glucose using procedures 
described below. Full details of these procedures, together with standard curves, 
are given in Appendix 4 and 5. 
6.1 Estimation of total carbohydrate 
Total carbohydrate, including both neutral and charged polysaccharides, 
was determined using the phenol-sulphuric acid method. This utilizes phenol as 
the specific organic colour-developing agent. Glucose was used as a standard 
(Dubois et aI., 1956). 
6.2 Estimation of protein 
The Lowry method, with a protein standard of bovine serum albumin 
(BSA, fraction V; Sigma) was used. It is based on the reaction of peptide bonds 
with copper in alkaline solution (Biuret reaction) followed by reduction of 
phosphomolybdic and phosphotungstic acids by the Folin-Ciocalteau phenol 
reagent (Lowry et aI., 1951). 
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6.3 Estimation of phosphorus 
All methods currently used to determine phosphorus in biological material 
on a micro scale are photometric and based on the same principle. Organically 
combined phosphorus in the sample is first converted to inorganic phosphate by 
digestion with acid. The phosphate formed then reacts with ammonium molybdate 
to give phosphomolybdate. The concentrations of this compound were measured 
spectrophotometrically, according to Chen et aI., (1956) with potassium 
phosphate (KH2P04) solution as a standard. 
6.4 Estimation of uronic acid 
The reaction of uronic acids with carbazole is the most satisfactory method 
of estimating uronic acids. The procedure established by Bitter and Muir (1962) 
using borate in concentrated sulphuric acid was adopted here. There is an 
approximately two-fold increase in sensitivity as compared with the original 
method described by Dische (1947) for glucuronolactone. In addition, the 
absorbance is a linear function of concentration between 4 - 40 Ilglml, maximum 
colour develops immediately, and there is greater reproducibility and reduction of 
interference by chloride ion and oxidants. Glucuronic acid (Sigma) was used as a 
standard. 
6.5 Estimation of total hexosamine 
Total hexosamine was determined by using Ehrlich's reagent, according to 
the method of Blumenkrantz and Asboehansen (1976), with glucosamine as a 
standard. This procedure yields a chromogen of equal intensity with equal 
concentrations of glucosamine and galactosamine. 
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6.6 Glucose determination 
Prior to glucose analysis, EPS samples from C. albicans GDH 2346 (0.5 
ml of 2 mg/ml solution of EPS) and from C. tropicalis AAHB 73 (0.25ml of 5.9 
mg/ml solution of EPS) were hydrolysed in 1.0 M HCl for 5 h in sealed ampoules 
at 100°C, and then neutralized with 0.5 M NaOH. Glucose was determined by an 
enzymatic method, using a glucose assay kit (Sigma-Aldrich, USA) with a 
standard of D-glucose. 
Enzymatic methods are based on the oxidation of glucose to gluconic acid 
and hydrogen peroxide by glucose oxidase. The hydrogen peroxide formed reacts 
with O-dianisidine in the presence of peroxidase to form a coloured product. 
Oxidized O-dianisidine then reacts with sulphuric acid to form a more stable 
coloured product. 
7 Enzymatic treatment of Candida biofilms 
Eight enzymes were tested for their ability to cause the detachment of 
Candida biofilms from plastic surfaces. All enzyme solutions were prepared and 
buffered immediately before use. The following enzymes were used (i) proteinase 
K (in 0.2 M disodium hydrogen phosphate - 0.2 M sodium dihydrogen phosphate 
buffer, pH 7.5) extracted from Tritirachium album; (ii) protease type XIV (in 0.2 
M disodium hydrogen phosphate - 0.2 M sodium dihydrogen phosphate buffer, 
pH 7.5) from Streptomyces griseus; (iii) deoxyribonuclease (DNase I) type IV (in 
0.1 M citric acid - 0.2 M disodium hydrogen phosphate buffer, pH 5.0) from 
bovine pancreas; (iv) ~-N-acetylglucosaminidase (in 0.1 M citric acid - 0.2 M 
disodium hydrogen phosphate buffer, pH 5.0) from Canavalia ensiformis (Jack 
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bean); (v) chitinase (in 0.1 M citric acid - 0.2 M dis odium hydrogen phosphate 
buffer, pH 6.0) from Streptomyces griseus; (vi) lipase type VII (in 0.2 M 
disodium hydrogen phosphate - 0.2 M sodium dihydrogen phosphate buffer, pH 
7.2) from Candida rugosa; (vii) phospholipase A2 (in 0.2 M Tris maleate - 0.2 M 
sodium hydroxide, pH 8.0) from bovine pancreas; and (viii) lyticase (in 0.2 M 
dis odium hydrogen phosphate - 0.2 M sodium dihydrogen phosphate buffer, pH 
7.5) from Arthrobacter luteus. All enzymes were purchased from Sigma. 
7.1 Detachment assay 
To investigate whether these enzymes could cause the removal of Candida 
biofilms from plastic surfaces, a detachment assay based on that reported by 
Kaplan et al. (2004) for S. epidennidis biofilms was used. For detachment 
experiments, Candida species were grown in YNB containing 50mM glucose at 
37°C in an orbital shaker at 60 rmp. Cells were harvested after 24 h and washed 
twice in 0.15 M PBS, pH 7.2. All washed cell suspensions were standardized in 
growth medium to an optical density of 0.8 at 520nm. Candida biofilms were 
formed in 96-well polystyrene microtitre plates (model 3596; Corning). The wells 
of 96-well polystyrene microtitre plates were filled with standardized cell 
suspensions (100 Ill), and the plates were incubated statically for 48 h at 37°C for 
biofilm formation. 
To assay biofilm detachment, mature biofilm cells were exposed to 
different test enzymes. Following incubation of biofilms in 96-well polystyrene 
microtitre plates for 48 h at 37°C, the growth medium was removed from each 
well and replaced by an equal volume (100111) of test enzyme. Enzyme treatments 
were carried out for 2 h at 25°C (for chitinase, deoxyribonuclease, lyticase and ~-
85 Materials and Methods 
N-acetylglucosaminidase) or 37°C (for lipase type VII, phospholipase A2, protease 
type XIV and proteinase K) according to the temperature optimum for the enzyme 
and at a final enzyme concentration of 50 ~g/ml. Following incubation, biofilm 
cells were stained with Gram-staining reagent (2 g of crystal violet, 0.8 g of 
ammonium oxalate, and 20 ml of ethanol per 100 ml), then washed twice gently 
with 200~1 of distilled water and left to dry. Thereafter, the amount of biofilm was 
quantitated by measuring the optical densities of the wells using a Bio-Rad 
Benchmark microplate reader set to 570 nm. 
7.2 Studies with lyticase 
Further experiments were carried out to investigate whether lyticase was 
acting solely on biofilm matrix material, or whether some cell lysis also occurred. 
The wells of a 24-well polystyrene microtitre plate (model 3524; Coming) were 
filled with 400 ~l of standardized cell suspension, and the plates were incubated 
for 48 h at 3rC for biofilm formation, the same conditions as those used in the 
detachment assay. Following incubation, the growth medium was removed from 
each well and replaced by an equal volume (400 ~l) of lyticase in 50 mM tris-HCI 
buffer (pH 7.2), at a final enzyme concentration of 50 ~g/ml. In control 
experiments, growth medium was removed from each well and replaced by an 
equal volume of 50 mM tris-HCI buffer without lyticase. Both test and control 
samples were incubated for 2 h at 25°C, the same conditions as those used in the 
detachment assay. After incubation with lyticase, the 50 mM tris-HCI buffer was 
discarded from control samples, and the cells were resuspended in 50 mM tris-
HCI buffer (pH 7.2) containing 10 mM MgCh and 1 M sorbitol. The optical 
densities of suspensions were adjusted to 0.8 - 1.0 at 520 nm and 600 nm. The 
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volume of buffer used was noted. For the test samples, the lyticase solution was 
discarded from the wells, and the cells were resuspended in 50 mM tris-HCI-
MgCh-sorbitol buffer using the same volume as that used for the control 
suspensions. At this stage, the optical densities were recorded at 520 and 600 nm 
for both control and test samples (zero time). Thereafter, further readings for 
control and test samples were taken at 15 and 30 min during incubation at room 
temperature. All biofilm and control assays were carried out in triplicate. 
8 Scanning electron microscopy (SEM) of biofilms 
Biofilm development in all the model systems utilised in this study was 
observed using scanning electron microscopy. 
8.1 Air-drying procedure 
Biofilms formed on polycarbonate membranes and catheter disks were fixed 
with 2.5% (v/v) glutaraldehyde in PBS (pH 7.2) for 1 h at room temperature. They 
were then treated with 1 % (w/v) osmium tetroxide for 1 h, washed three times in 3 
ml of distilled water, treated with 1% (w/v) uranyl acetate for 1 h, and finally 
washed twice in 3 ml of distilled water. Dehydration of the samples was 
accomplished by immersion in a series of ethanol solutions (30%, 50%, 70%, 
90% absolute ethanol, and dried absolute ethanol) for 10 minutes each. All 
samples were air dried in a desiccator for 48 h then mounted on aluminium stubs 
before being gold coated with a polaron coater, and viewed under a Philips 500 
scanning electron microscope (Hawser and Douglas, 1994a). 
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8.2 Freeze-drying procedure 
The drying procedure selected markedly affects the extent to which the 
biofilm structure, particularly the matrix of extracellular polymeric material, is 
retained. Freeze-drying is an effective technique for matrix preservation. Samples 
were fixed with 2.5% (v/v) glutaraldehyde in O.lM cacodylate buffer (pH 7.0), 
washed gently in distilled water three times and then plunged into a liquid 
propane-isopentane mixture (2:1, v/v) at -196°C before freeze-drying under 
vacuum (10-6 Torr). Disks were mounted on aluminium stubs and coated with 
gold before being viewed using a Philips 500 scanning electron microscope 




1 Penetration of antifungal agents through biofilms using a novel 
filter disk assay 
In this part of the project a novel, filter disk assay devised by (Anderl et aI., 
2000) was adapted to investigate the penetration of antifungal agents through single 
and mixed species biofilms containing Candida. The technique involves the 
formation of a 48-h-old colony biofilm on a polycarbonate membrane filter and the 
capping of this biofilm with a second, smaller membrane filter and then a wetted 
paper disk of the type used in zone-of-inhibition bioassays. The assembly, which 
represents a primitive diffusion cell, is transferred to agar medium containing the 
antifungal agent. During subsequent incubation, the drug diffuses out of the agar 
and through the biofilm sandwich to the moistened paper disk. The drug 
concentration in the disk can finally be determined by measuring the zone of 
growth inhibition that it produces on medium seeded with an indicator strain of C. 
albicans in standard bioassays (Anderl et aI., 2000). 
1.1 Penetration of flucytosine through biofilms of different strains of C. 
albicans 
1.1.1 Susceptibility of C. albicans to flu cytosine 
The minimum inhibitory concentration (MIC) of flucytosine for planktonic 
C. albicans GDH 2346 was 0.2j.lglml (Hawser and Douglas, 1995a). In the 
experiments presented here, using biofilms of C. albicans, 30 times the MIC of 
flucytosine (6j.lg/ml) was used. Planktonic cells were rapidly killed by the drug at 
this concentration. 
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1.1.2 Flucytosine penetration through c. albicans GDH 2346 biofilms 
The rate of penetration of flucytosine through C. albicans GDH 2346 
biofilms was initially low (Fig. 14). The drug concentration (C) at the distal edge of 
the biofilm (i.e., distal with respect to the agar) was 55 % of the control value (Co) 
after 180 min. Within 240 min, the flucytosine concentration had reached 70% of 
the control value. 
1.1.3 Flucytosine penetration through C. albicans GDH 2023 biofilms 
Drug penetration after 60 min was 29 % of the control value. After 120 min 
the rate of drug penetration increased slightly and had reached approximately 45% 
of the control value after 180 min. Within 240 min, the flucytosine concentration 
had reached 65 % of the control value (Fig. 15). 
1.1.4 Flucytosine penetration through c. albicans GRI 682 biofilms 
The rate of diffusion of flucytosine through C. albicans GRI 682 biofilms 
was relatively rapid overall. Within 60 min, the drug concentration at the distal 
edge of biofilm was 25 % of the control value. After 180 min it had reached 50%, 
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Figure 14. Penetration of flucytosine through biofilms of C. albicans GDH 
2346, grown on polycarbonate membranes on YNB agar containing 50mM 















0 60 120 180 240 300 360 
Tirre(nin) 
Figure 15. Penetration of flucytosine through biofilms of C. albicans GDH 
2023, grown on polycarbonate membranes on YNB agar containing SOmM 
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Figure 16. Penetration of flucytosine through biofilms of C. albicans GRI 682, 
grown on polycarbonate membranes on YNB agar containing 50mM glucose. 
Error bars indicate the standard errors of the means. 
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1.1.5 Comparison of flucytosine penetration through biofilms of different C. 
albicans strains 
Flucytosine penetration of biofilms of three C. albicans strains was similar, 
but initially was lower with strain GDH 2346. The drug concentration at the distal 
edge of the biofilms was approximately 50 % of the control value after 180 min. 
After 240 min it had reached 63 to 78 % of the control value (Fig. 17). Drug 
penetration rates levelled off or fell slightly between 240 min and 360 min. 
1.2 Penetration of flucytosine through biofilms of other Candida species 
1.2.1 Flucytosine penetration through C. glabrata AAHB 12 biofilms 
The rate of penetration of flucytosine through C. glabrata AAHB 12 
biofilms was initially rapid, reaching 50 % of the control value after 60 min. A 
decrease to a stable level of 30 % (Fig. 18) followed the initial speedy penetration. 
1.2.2 Flucytosine penetration through C. krusei (Glasgow) biofilms 
The drug rapidly penetrated through C. krusei biofilms. Within 60 min, the 
flucytosine concentration at the distal edge was 52 % of the control concentration. 
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Figure 17. Penetration of flucytosine through biof"Ilms of C. albicans GDH 
2346 (.A.), c. albicans GDH 2023 (_), and C. albicans GRI 682 (e ) grown on 
polycarbonate membranes on YNB agar containing 50mM glucose. Error bars 
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Figure 18. Penetration of flucytosine through biofilms of C. glabrata AAHB 12, 
grown on polycarbonate membranes on YNB agar containing 50mM glucose. 
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Figure 19. Penetration of flucytosine through biofilms of C. krusei grown on 
polycarbonate membranes on YNB agar containing 50mM glucose. Error bars 
indicate the standard errors of the means. 
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1.2.3 Flucytosine penetration through C. parapsilosis AAHB 479 biofilms 
Flucytosine diffusion through C. parapsilosis biofilms was 0% after 60 and 
90 min. Slow penetration then ensued and the drug concentration at the distal edge 
of the biofilm was 25% of the control by 360 min (Fig. 20). 
1.2.4 Flucytosine penetration through C. tropicalis AAHB 73 biofilms 
The rate of penetration of flucytosine through biofilms of C. tropicalis was 
very low (10.4 % of the control value after 180 min). The drug concentration 
reached a maximum (15 % of the control) after 360 min (Fig. 21). 
1.2.5 Comparison of flucytosine penetration through non-C. albicans 
Candida biofilms 
The penetration of flucytosine through biofilms of different Candida 
species is compared in Fig. 22. Initially, there was rapid diffusion of the drug 
(approximately 50 % of the control value after 60 min) through both C. glabrata 
and C. krusei biofilms, followed by a decrease to a stable level of around 30%. In 
contrast, flucytosine penetrated slowly through C. parapsilosis biofilms, reaching a 
maximum of 25 % by 360 min. However, the slowest drug diffusion was detected 
with C. tropicalis biofilms (15 % after 360 min; Fig. 22). 
When compared with flucytosine penetration through C. albicans biofilms 
(Fig. 17), penetration through C. krusei and C. glabrata biofilms was initially 
faster, while that through C. parapsilosis and C. tropicalis biofilms was much 
slower. However, after 360 min, drug penetration through all of these non-Co 
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Figure 20. Penetration of flucytosine through biofilms of C. parapsilosis AAHB 
479, grown on polycarbonate membranes on YNB agar containing SOmM 
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Figure 21. Penetration of flucytosine through biofilms of C. tropicalis AAHB 
73, grown on polycarbonate membranes on YNB agar containing SOmM 
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Figure 22. Penetration of flucytosine through biofIlms of C. parapsiiosis ( A ), 
C. krusei (_), C. giabrata (+), c. tropicalis (e) grown on polycarbonate 
membranes on YNB agar containing 50mM glucose. Error bars indicate the 
standard errors of the means. The mean Co after 6h was 22.7f.1g of 
flucytosine/ml. 
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1.2.6 Flucytosine degradation 
Enzymatic degradation of flucytosine by C. glabrata and C. krusei was 
investigated qualitatively and did not occur. This was demonstrated by removing 
membrane-supported biofilms from antifungal agent-containing plates and 
spreading a sensitive strain (strain GDH 2346) of C. albicans on to the plates. 
These indicator organisms were unable to grow on any part of the plate, including 
the area that had been under the biofilm (results not shown). 
1.3 Penetration of fluconazole through biofilms of different strains of C. 
albicans 
1.3.1 Susceptibility of C. albicans to fluconazole 
The MIC of fluconazole for C. albicans GDH 2346 is OAIlg/ml (Hawser 
and Douglas, 1995a). In the work presented here, biofilms were challenged with 60 
times the MIC of fluconazole (24Ilg/ml). The drug rapidly killed planktonic cells of 
C. albicans at this concentration. 
1.3.2 Fluconazole penetration through C. albicans GDH 2346 biofilms 
Fluconazole diffused through biofilms of C. albicans GDH 2346 very 
quickly (Fig. 23). The drug concentration at the distal edge of the biofilm was 85-
90 % of the control value after 60-90 min. There was then a slight decrease and a 
levelling off at 80 % of the control value after 360 min (Fig. 23). 
1.3.3 Fluconazole penetration through C. albicans GDH 2023 biofilms 
Penetration of C. albicans GDH 2023 biofilms by fluconazole was also 
very rapid. The fluconazole concentration at the distal edge of the biofilm was 93 % 
of the control value after 60 min. Later, there was a slight decrease and levelling 
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Figure 23. Penetration of fluconazole through biofilms of C. albicans GDH 
2346, grown on polycarbonate membranes on YNB agar containing SOmM 
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Figure 24. Penetration of fluconazole through biofilm of C. albicans GDH 
2023, grown on polycarbonate membranes on YNB agar containing 50mM 
glucose. Error bars indicate the standard errors of the means. 
104 Results 
1.3.4 Fluconazole penetration through C. albicans GRI 682 biofilms 
Fluconazole penetration of biofilms of this third strain of C. albicans was 
also extremely rapid. Within 60 min, the drug concentration at the distal edge of 
biofilm was 95 % of the control. Subsequently, the rate of penetration of 
fluconazole decreased and levelled off at a CICo value of 0.77 (Fig. 25). 
1.3.5 Comparison of fluconazole penetration through biofilms of different C. 
albicans strains 
Fluconazole penetration was similar and rapid for three C. albicans strains 
reaching approximately 90 % of the control value after 60 min, then decreasing and 
stabilising at 70 % of the control value after 360 min (Fig. 26). Interestingly, 
diffusion was much more rapid with fluconazole than with flucytosine, but the final 
levels of drug penetration were similar after 360 min (Figs. 17 and 26). However, 
this represents a higher drug concentration with fluconazole. 
1.4 Penetration of fluconazole through biofilms of other Candida species 
1.4.1 Fluconazole penetration through C. glabrata AAHB 12 biofilms 
The rate of penetration of fluconazole through C. glabrata AAHB 12 
biofilms was rapid (80-85 % of that for the control after 60-90 min). There was 
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Figure 25. Penetration of fluconazole through biofilms of C. albicans GRI 682, 
grown on polycarbonate membranes on YNB agar containing 50mM glucose. 
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Figure 26. Penetration of fluconazole through biofIlms of C. albicans GDH 
2346 (A), c. albicans GDH 2023 (_), and C. albicans GRI 682 (e) grown on 
polycarbonate membranes on YNB agar containing 50mM glucose. Error bars 
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Figure 27. Penetration of fluconazole through biofilms of C. glahrata AAHB 12 
grown on polycarbonate membranes on YNB agar containing 50mM glucose. 
Error bars indicate the standard errors of the means. 
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1.4.2 Fluconazole penetration through C. krusei (Glasgow) 12 biofilms 
The drug also diffused through C. krusei biofilms rapidly. Within 60 min, 
the fluconazole concentration at the distal edge of biofilm was approximately 80% 
of the control concentration. This was followed by a decrease to a stable level of 70 
% of the control after 360 min (Fig. 28). 
1.4.3 Fluconazole penetration through C. parapsilosis AAHB 479 biofilms 
Fluconazole diffusion through biofilms of C. parapsilosis was zero after 60 
min. However, there was a sharp rise to 75 % of the control value after 90 min. 
This was followed by a levelling off to 65 % after 360 min (Fig. 29). 
1.4.4 Fluconazole penetration through C. tropicalis AAHB 73 biofilms 
The diffusion of fluconazole through biofilms of C. tropicalis was very 
slow, with 0 % penetration after 90 min. After 120 min, the drug concentration at 
the distal edge of biofilms was 65 % of the control value. A stable level of 58 % of 
the control was attained after 180 min (Fig. 30). 
1.4.5 Comparison of fluconazole penetration through biofilms of other 
Candida species 
When non-Co albicans Candida species were used, there was rapid 
fluconazole penetration through biofilms of either C. glabrata or C. krusei, 
followed by a decrease to approximately 70 % of the control value (Fig. 31). Drug 
penetration through C. parapsilosis biofilms was zero after 60 min but rose rapidly 
to 75 % of the control value and then levelled off at 65 %. As noted for flucytosine 
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Figure 28. Penetration of fluconazole through biofilms of C. krusei grown on 
polycarbonate membranes on YNB agar containing SOmM glucose. Error bars 
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Figure 29. Penetration of fluconazole through biofilms of C. parapsilosis 
AAHB 479, grown on polycarbonate membranes on YNB agar containing 
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Figure 30. Penetration of fluconazole through biofilms of C. tropicalis AAHB 
73, grown on polycarbonate membranes on YNB agar containing SOmM 
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Figure 31. Penetration of fluconazole through biofIlms of C. glabrata (. ), c. 
krusei (_ ), c. parapsilosis ( . ), and C. tropicalis (. ) grown on polycarbonate 
membranes on YNB agar containing 50mM glucose. Error bars indicate the 
standard errors of the means. The mean Co after 6h was 26.6 Ilg of 
fluconazole/mI. 
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For all non-Co albicans specIes, the overall level of penetration of 
fluconazole (55% to 85 %; Fig. 31) was higher than that of flucytosine (15 % to 50 
%; Fig. 22). 
When compared with fluconazole penetration through C. albicans biofilms 
(Fig. 26), penetration through C. krusei and C. glabrata biofilms was slightly 
slower, which that through C. parapsilosis and C. tropicalis biofilms was 
considerably slower. However, after 360 min, drug penetration through all of these 
non-Co albicans Candida biofilms was only slightly lower than that through any of 
the C. albicans strains tested. 
1.5 Penetration of flucytosine through single- and mixed-species biofilms of 
C. albicans and S. epidermidis 
1.5.1 Flucytosine penetration through single-species biofilms of C. albicans 
and S. epidermidis 
Flucytosine diffused through biofilms of C. albicans GDH 2346 fairly 
slowly, as described above (Fig. 14). In these experiments, however, the C. 
albicans biofilms, like the mixed-species biofilms, were grown on tryptic soy agar 
(TSA) rather than YNB agar. The drug concentration at the distal edge of biofilm 
was 40 % of the control value after 240 min. Within 360 min, the flucytosine 
concentration had reached a maximum of 45-50 % of the control value (Fig. 32). 
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Figure 32. Penetration of flu cytosine through biofilms of C. albicans GDH 
2346, grown on polycarbonate membranes on tryptic soy agar. Error bars 
indicate the standard errors of the means. 
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By contrast, flucytosine penetration through S. epidermidis RP62A biofilms 
was very slow and poor. There was zero penetration after 180 min and only 12 % 
after 240 min. Subsequently, there was a levelling off to 10 % of the control value 
(Fig. 33) after 360 min. 
The diffusion of flucytosine through S. epidennidis M7 biofilms was also 
slow, but slightly faster than with wild-type biofilms. Drug diffusion started after 
120 min and the concentration at the distal edge of the biofilms was 14 % of the 
control value by 180 min. Within 360 min, the drug concentration decreased to a 
stable level of approximately 12 % (Fig. 34). 
1.5.2 Flucytosine penetration through mixed-species biofilms of C. albicans 
and S. epidermidis 
The concentration of flucytosine at the distal edge of mixed-species 
Candida-RP62A biofilms was only 11 % of the control value after 240 min. There 
was then a slight decrease and a levelling off at 9 % of the control value after 360 
min (Fig. 35). However, diffusion through Candida-M7 biofilms by flucytosine 
was slightly more rapid. The drug concentration at the distal edge of the biofilm 
was approximately 13 % of the control value after 180 min. Later, there was a 
slight decrease and levelling off at 11 % of the control value after 360 min (Fig. 36). 
A composite graph, with results for all single and mixed-species biofilms shows the 
poor penetration by flucytosine overall; it also illustrates the finding that diffusion 
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Figure 33. Penetration of flu cytosine through biofilms of S. epidermidis 
RP62A, grown on polycarbonate membranes on tryptic soy agar. Error bars 
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Figure 34. Penetration of flucytosine through biofilms of S. epidermidis M7, 
grown on polycarbonate membranes on tryptic soy agar. Error bars indicate 
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Figure 35. Penetration of flucytosine through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis RP62A, grown on polycarbonate 
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Figure 36. Penetration of flucytosine through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis M7, grown on polycarbonate 
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Figure 37. Penetration offlucytosine through single and mixed species biof"Ilms 
of C. albicans GDH 2346 (.A.), S. epidermidis RP62A (e), S. epidermidis M7 (_), 
c. albicans GDH 2346 and S. epidermidis RP62A (0), and C. albicans GDH 
2346 and S. epidermidis M7 (D) grown on polycarbonate membranes on tryptic 
soy agar. Error bars indicate the standard errors of the means. The mean Co 
after 6h was 24.2 Jlg of flucytosine/ml. 
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1.6 Penetration of fluconazole through single- and mixed-species biofilms of 
C. albicans and S. epidermidis 
1.6.1 Fluconazole penetration through single-species biofilms 
Penetration of fluconazole through biofilms of C. albicans was rapid and 
extensive, as before. In these experiments, however, the C. albicans biofilms, like 
the mixed-species biofilms, were grown on TSA rather than YNB agar. The drug 
concentration at the distal edge of the biofilm was 90 % of the control value after 
90 min. After 360 min, the fluconazole concentration had dropped slightly to 75 % 
of that of the control (Fig. 38). 
There was much slower and poorer penetration of fluconazole through 
biofilms of S. epidermidis RP62A (wild-type strain). The fluconazole concentration 
reached a maximum of 55 % of the control value after 180 min. It then decreased 
slightly to a stable level of approximately 50 % after 240-360 min (Fig. 39). 
The rate of drug penetration through biofilms of the slime-negative mutant 
S. epidermidis M7 was also slower and poorer than that through C. albicans 
biofilms. The fluconazole concentration reached a maximum of 55 % of the control 
value after 180 min, then levelled off to 50 %, in a manner almost identical to that 
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Figure 38. Penetration of fluconazole through biofilms of C. albicans GDH 
2346, grown on polycarbonate membranes on tryptic soy agar. Error bars 
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Figure 39. Penetration of fluconazole through biofilms of S. epidermidis 
RP62A, grown on polycarbonate membranes on tryptic soy agar. Error bars 
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Figure 40. Penetration of fluconazole through biofilms of S. epidermidis M7, 
grown on polycarbonate membranes on tryptic soy agar. Error bars indicate 
the standard errors of the means. 
125 Results 
1.6.2 Fluconazole penetration through mixed-species biofilms of C. albicans 
and S. epidermidis 
With mixed fungal-bacterial biofilms, there was also relatively slow and 
poor penetration of fluconazole. The drug concentration at the distal edge of the 
biofilm reached 49 % of the control value after 360 min for Candida-RP62A 
biofilms (Fig. 41). However, with biofilms containing the slim-negative mutant, S. 
epidermidis M7, diffusion was more rapid and the drug concentration reached 50 % 
after 240 min (Fig. 42). A composite graph, with results for all single- and mixed-
species biofilms is presented in Fig. 43. Fluconazole penetrated mixed-species 
biofilms to a greater extent than any other antifungal agent tested. 
1.7 Penetration of amphotericin B through single- and mixed-species 
biofilms of C. albicans and S. epidermidis 
1.7.1 Susceptibility of C. albicans to amphotericin B 
The MIC of amphotericin B for planktonic C. albicans GDH 2346 is 1.3 
Ilg/ml (Hawser and Douglas, 1995a). In the work presented here, biofilms of C. 
albicans were challenged with 60 times the MIC of amphotericin B (78 Ilg/ml). 
The drug rapidly kills planktonic cells at this concentration. 
1.7.2 Amphotericin B penetration through single-species biofilms of C. 
albicans and S. epidermidis 
Despite its low solubility in water, amphotericin B diffused rapidly through 
biofilms of C. albicans GDH 2346. In these experiments the C. albicans biofilms, 
like the mixed-species biofilms, were grown on tryptic soy agar (TSA) rather than 
YNB agar. The drug concentration at the distal edge of the biofilm was 65 % of 
the control value after 60 min. There was then a slight decrease and a levelling off 













0 60 120 180 240 300 360 
Time (min) 
Figure 41. Penetration of fluconazole through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis RP62A, grown on polycarbonate 
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Figure 42. Penetration of fluconazole through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis M7, grown on polycarbonate 
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Figure 43. Penetration of fluconazole through single and mixed-species 
biofIlms of C. albicans GDH 2346 (.), S. epidermidis RP62A (e ), S. 
epidermidis M7 (_ ), c. albicans GDH 2346 and S. epidermidis RP62A (0), and 
C. albicans GDH 2346 and S. epidermidis M7 (D) grown on polycarbonate 
membranes on tryptic soy agar. Error bars indicate the standard errors of the 
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Figure 44. Penetration of amphotericin B through biofilms of C. albicans GDH 
2346, grown on polycarbonate membranes on tryptic soy agar. Error bars 
indicate the standard errors of the means. 
130 Results 
The diffusion of amphotericin B through S. epidermidis biofilms was 
slower and less extensive. In this instance, penetration was faster through biofilms 
containing the wild-type strain RP62A than through those containing the slime-
negative mutant M7. Within 120 min, the drug concentration at the distal edge of S. 
epidermidis RP62A (wild-type strain) biofilms was 32 % of the control value. This 
was followed by a decrease to a stable level of roughly 27 % of the control value 
after 360 min (Fig. 45). 
By contrast, the rate of drug diffusion through biofilms of the slime-
negative mutant was slower than that through wild-type biofilms. The drug 
concentration at the distal edge of the biofilm was 21 % of the control value after 
180 min. The amphotericin B concentration reached a maximum of 31 % of the 
control value after 360 min (Fig. 46). 
1.7.3 Amphotericin B penetration through mixed-species biofilms of C. 
albicans and S. epidermidis 
With mixed fungal-bacterial biofilms, amphotericin B penetration was also 
slow and poor, although in this instance diffusion was faster through biofilms 
containing S. epidermidis RP62A than through those containing S. epidermidis M7. 
The drug concentration at the distal edge for Candida-RP62A biofilms was 23 % of 
the control value after 180 min; it then increased to 30 % after 360 min (Fig. 47). 
However, with biofilms containing the slime-negative mutant, S. epidermidis M7, 
penetration was slower and the drug concentration reached 16 % after 240 min. 
After 360 min, the rate of concentration reached a maximum of 18 % of the control 
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Figure 45. Penetration of amphotericin B through biofilms of S. epidermidis 
RP62A, grown on polycarbonate membranes on tryptic soy agar. Error bars 
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Figure 46. Penetration of amphotericin B through biofilms of S. epidermidis 
M7, grown on polycarbonate membranes on tryptic soy agar. Error bars 
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Figure 47. Penetration of amphotericin B through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis RP62A, grown on polycarbonate 
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Figure 48. Penetration of amphotericin B through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis M7, grown on polycarbonate 
membranes on tryptic soy agar. Error bars indicate the standard errors of the 
means. 
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A composite graph, with results for all single and mixed-species biofilms is 
presented in Fig. 49. Surprisingly, the Co of amphotericin B (Fig. 49), like that of 
flucytosine (Fig. 22), was higher than the drug concentration in the agar. The 
reason for this is not clear. However, it is conceivable that during the drug 
penetration assay some drugs bind to the disk cellulose (thus effectively reducing 
their concentration in solution) but then are released during the zone-of-inhibition 
assay. 
1.8 Penetration of voriconazole through single- and mixed-species biofilms 
of C. albicans and S. epidermidis 
1.8.1 Susceptibility of C. albicans to voriconazole 
The MIC of the newer azole, voriconazole, for planktonic C. albicans is 1.0 
Ilg/ml (Lozano-Chiu et at., 1999). In the experiments presented here biofilms of C. 
albicans were challenged with 10 times the MIC (lOllg/ml) of the drug. 
Voriconazole rapidly killed planktonic cells at this concentration. 
1.8.2 Voriconazole penetration through single-species biofilms of C. albicans 
and S. epidermidis 
In these experiments, the C. albicans biofilms, like the mixed-species 
biofilms, were grown on TSA rather than YNB agar. Voriconazole penetrated 
rapidly through biofilms of C. albicans GDH 2346. The drug concentration at the 
distal edge of the biofilm was 56 % of that of the control value after 60 min. The 
voriconazole concentration reached a maximum of 59 % of the control value after 
90 min. It then decreased and levelled off at 23 % of the control value after 360 
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Figure 49. Penetration of amphotericin B through single- and mixed-species 
biof"Ilms of C. albicans GDH 2346 (.A.), S. epidermidis RP62A (e ), S. 
epidermidis M7 (_), c. albicans GDH 2346 and S. epidermidis RP62A (0), and 
C. albicans GDH 2346 and S. epidermidis M7 (0) grown on polycarbonate 
membranes on tryptic soy agar. Error bars indicate the standard errors of the 
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Figure 50. Penetration of voriconazole through biofilms of C. albicans GDH 
2346, grown on polycarbonate membranes on tryptic soy agar. Error bars 
indicate the standard errors of the means. 
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There was much slower and poorer penetration of voriconazole through S. 
epidermidis biofilms. Drug diffusion through biofilms of the wild-type strain was 
approximately 18 % of the control value after 180 min. Drug penetration rates fell 
slightly between 180 min and 360 min (Fig. 51). Similarly, with biofilms 
containing the slime-negative mutant, S. epidermidis M7, diffusion was 17 % of the 
control value after 180 min. The concentration of drug at the distal edge of the 
biofilm was 15 % of the control by 360 min (Fig. 52). 
1.8.3 Voriconazole penetration through mixed-species biofilms of C.albicans 
and S. epidermidis 
With mixed fungal-bacterial biofilms there was also slower and poorer 
penetration of voriconazole. Drug diffusion to the distal edge of the biofilm 
reached 17 % of the control value after 180 min, then decreased slightly to level off 
at 12 % of the control value after 360 min for Candida-RP62A biofilms (Fig. 53). 
However, with biofilms containing the slime-negative mutant, S. epidermidis M7, 
diffusion was faster and the drug concentration reached 25 % of the control value 
after 120 min. After 360 min, the drug concentration had fallen to 12 % of the 
control value (Fig. 54). 
A composite graph, with the results for all single and mixed-species 
biofilms, shows that the diffusion of voriconazole, like that of flucytosine, was 
more rapid with mixed-species biofilms containing S. epidermidis M7 than with 
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Figure 51. Penetration of voriconazole through biofilms of S. epidermidis 
RP62A, grown on polycarbonate membranes on tryptic soy agar. Error bars 
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Figure 52. Penetration of voriconazole through biofilms of S. epidermidis M7, 
grown on polycarbonate membranes on tryptic soy agar. Error bars indicate 
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Figure 53. Penetration of voriconazole through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis RP62A, grown on polycarbonate 
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Figure 54. Penetration of voriconazole through mixed-species biofilms of C. 
albicans GDH 2346 and S. epidermidis M7, grown on polycarbonate 
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Figure 55. Penetration of voriconazole through single- and mixed-species 
biotIlms of C. albicans GDH 2346 (A), S. epidermidis RP62A (e ), S. 
epidermidis M7 (_ ), c. albicans GDH 2346 and S. epidermidis RP62A (0), and 
C. albicans GDH 2346 and S. epidermidis M7 (0 ) grown on polycarbonate 
membranes on tryptic soy agar. Error bars indicate the standard errors of the 




1.9 Effect of antifungal agents on the viability of biofilms cells 
To assess the effects of antifungal agents on biofilm cells, biofilms 
sandwiched between the two membranes, as in the drug penetration assay, were 
exposed to antifungal-containing agar at 37°C for 6 h (the time period during which 
drug penetration was determined) or 24 h. Antifungal agents (flucytosine or 
fluconazole) were present at concentrations identical to those used in the drug 
penetration assay. After incubation, the numbers of viable biofilm cells were 
determined by a standard procedure of serial dilution followed by plating. In no 
case did drug penetration result in complete killing of biofilm cells (Table 6). 
Biofilms of C. glabrata AAHB 12 were wholly unaffected by fluconazole 
after 6h. However, many strains of this species are known to be resistant to 
fluconazole even when grown in planktonic culture (Cox and Perfect, 1993). The 
results with fluconazole overall were not unexpected, despite the high 
concentration used, since this drug is generally considered to be fungistatic only. 
However, a recent study (Moosa et ai., 2004) has demonstrated that fluconazole 
can be fungicidal under certain conditions. 
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Table 6. Viability of 48-h biofilm cells of Candida species after exposure to 
flucytosine or fluconazole for 6 or 24 h a 
Viability (%) 
Organism Flucytosine (6 flglml) Fluconazole (24 flglml) 
6h 24h 6h 24h 
C. albicans 34.0 ± 2.3 28.9 ± 0.5 64.1 ± 1.7 81.0 ± 1.5 
GDH2346 
C. albicans 45.6 ± 1.5 29.9 ± 1.6 73.0 ± 2.0 62.1 ± 1.4 
GDH2023 
C. albicans 38.2 ± 2.2 29.4 ± 0.9 67.6 ± 1.6 78.7 ± 2.9 
GRI682 
C. glabrata 15.8 ± 1.2 24.2 ±0.6 101.7 ± 1.1 81.1 ± 1.5 
AAHB12 
C. krusei 71.3 ± 1.3 66.9 ± 0.5 74.4 ± 0.6 47.8 ± 1.2 
(Glasgow) 
C. parapsilosis 74.9 ±0.7 62.1 ± 1.5 67.4 ± 3.0 51.1 ± 1.2 
AAHB 479 
C. tropicalis 65.0 ± 1.8 40.5 ± 1.4 49.6 ±0.9 37.7 ± 2.1 
AAHB 73 
a Viability is expressed as a percentage of that of control cells incubated under 
identical conditions in the absence of antifungal agent. The results are means ± 
standard errors of the means of triplicate determinations. Biofilms were grown on 
membrane filters on YNB agar containing 50mM glucose. 
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1.10 Scanning electron microscopy (SEM) of biofilms grown on 
polycarbonate filter disks 
Biofilms formed by different Candida species on filter disks were fixed and 
prepared for SEM by a dehydration procedure that involved air drying (Baillie and 
Douglas, 1999b); biofilm matrix material is not preserved using this protocol. 
Examination of biofilms by SEM showed that, after 48 h, those formed by C. 
albicans GDH 2346 consisted of a dense network of yeasts, germ tubes, 
pseudohyphae and hyphae (Fig. 56). However, C. glabrata AAHB 12 biofilm 
contained mainly small round-to-oval, budding yeast cells. Occasionally, 
pseudohyphae were present (Fig. 57). Biofilms of C. krusei, on the other hand, 
contained large numbers of pseudohyphae with fewer yeast cells, creating a cross-
matchsticks appearance (Fig. 58). Biofilms of C. parapsilosis consisted of yeast 
cells, many of which were elongated, together with relatively short pseudohyphae 
(Fig. 59). 
Biofilms of C. tropicalis AAHB 73 had a very slimy appearance, suggestive 
of an extensive matrix, and were poorly penetrated by both flucytosine and 
fluconazole. Examination of these biofilms by SEM showed that they consisted of 
a dense network of yeasts and filaments (pseudohyphae with possibly some 
hyphae). Many of the filaments appeared to lie parallel to each other in the form of 
bundles (Fig. 60). The procedure used for sample preparation allows clear 
visualization of biofilm cells but normally fails to preserve the biofilm matrix. 
However, fairly extensive matrix material could still be seen adhering to and 
linking some of the cells, a finding consistent with the slimy appearance of C. 
tropicalis biofilms. 
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Figure 56. Scanning electron micrograph of biofilm formation by C. albicans 
GDH 2346 on polycarbonate membrane filters after air-drying of samples. 
Biofilms consisted of a dense network of yeasts, germ tubes, pseudohyphae 
and hyphae (arrows). Scale bar, 20J.lm. 
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Figure 57. Scanning electron micrograph of biofilm formation by C. glabrata 
AAHB 12 on polycarbonate membrane filters after air-drying of samples. 
Biofilms consisted of round to oval, budding yeast cells with occasional 
pseudohyphae (arrows). Scale bar, 10J.lm. 
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Figure 58. Scanning electron micrograph of biofilm formation by C. krusei on 
polycarbonate membrane filters after air-drying of samples. Biofilms 
consisted of large numbers of pseudohyphae (arrows) with fewer yeast cells. 
Bar,lOpm. 
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Figure 59. Scanning electron micrograph of biofilm formation by C. 
parapsilosis AAHB 479 on polycarbonate membrane filters after air-drying of 
samples. Biofilms consisted of yeast cells, many of which were elongated, and 
pseudohyphae (arrows). Bar, 10 flm. 
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Figure 60. Scanning electron micrograph of biofilm formation by C. tropicalis 
AAHB 73 on polycarbonate membrane filters after air-drying of samples. 
Biofilms consisted of a dense network of yeast and filaments. Many of the 
filaments appeared to lie parallel to each other in the form of bundles. Matrix 
material is visible, indicated by arrows. Bar, 10 J.lm. 
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Previous work (Adam et aI., 2002) demonstrated that both strains of S. 
epidermidis used in this study formed thick biofilms on catheter disks. However, 
the wild-type strain RP62A, unlike the M7 mutant, produced abundant matrix 
material, or slime. This was not readily visible with the preparative techniques used 
here. SEM revealed that biofilms of mixed fungal-bacterial biofilms of C. albicans 
and S. epidermidis RP62A formed on filter disks contained clumps and clusters of 
smaller bacterial cells, some of which were attached to yeasts (Fig. 61). A similar 
examination of mixed fungal-bacterial biofilms of C. albicans GDH 2346 and S. 
epidermidis M7 grown on polycarbonate membranes also revealed multiple 
interactions between bacterial and fungal cells. Staphylococci were clearly adherent 
to both morphological forms of the fungus (Fig. 62). 
Although some hyphae were produced in mixed species biofilms with S. 
epidermidis M7 (Fig. 62) they appeared to be absent from mixed species biofilms 
with S. epidermidis RP62A (Fig. 61). It is therefore possible that the wild-type 
strain of S. epidermidis produces a famesol-like compound which inhibits hyphal 
production by C. albicans. A similar finding has been reported recently for mixed 
species biofilms containing C. albicans and P. aeruginosa (Hogan and Kolter, 
2002; Hogan et aI., 2004). 
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Figure 61. Scanning electron micrograph of mixed-species biofilm formation 
by C. albicans GDH 2346 and S. epidermidis RP62A on polycarbonate filters 
after air-drying of samples. Clumps and clusters of smaller bacterial cells 
(arrows) can be seen attached to yeasts. Bar, 10 flm. 
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Figure 62. Scanning electron micrograph of mixed-species biofilm formation 
by C. albicans GDH 2346 and S. epidermidis M7 on polycarbonate filters after 
air-drying of samples. Multiple, physical interactions between bacterial and 
fungal cells are evident (arrows). Bar,lO flm. 
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2 Drug susceptibility of biofilms grown statically and under 
conditions of continuous flow 
2.1 Comparison of biofilms grown statically and under conditions of 
continuous flow 
Two Candida species were assayed for biofilm formation under both static 
and continuous-flow conditions after incubation for 48 h in YNB medium 
containing 50 mM glucose. The organisms used were C. albicans GDH 2346 and 
C. tropicalis AAHB 73. Both of these isolates came originally from active 
infections; C. tropicalis AAHB 73 was from a line infection (Hawser and Douglas, 
1994a). 
2.1.1 Biofilms grown statically 
The model system used for static biofilm culture involved growing adherent 
populations on the upper surface of disks cut from catheter material (Hawser and 
Douglas, 1994a; Hawser and Douglas, 1994c; Baillie and Douglas, 1999b). This 
model has been well characterised and is known to produce reproducible biofilm 
populations. In this investigation, biofilms were grown statically on the surfaces of 
small disks (diameter, 0.8 cm) cut from polyvinyl chloride (PVC) Faucher tubes 
using a punch (Fig. 10). The disks were placed, concave side up, in wells of 24-
well Nunclon tissue culture plates. This simple model system was originally 
adapted from one used to evaluate the effects of antibiotics on biofilms of 
Escherichia coli and other Gram-negative bacteria (Prosser et aI., 1987). Scanning 
electron micrographs of biofilms formed by C. albicans GDH 2346 after 
incubation for 48 h, revealed a complex mixture of yeasts and hyphae (Fig. 63). 
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These observations confirmed prevIOUS studies undertaken with this system 
(Hawser and Douglas, 1994a). 
2.1.2 Biofilms grown under flow conditions 
The Robbins device, which provides quantifiable samples of biofilm 
growing on submerged surfaces in aqueous systems, is one of the best-known and 
most widely used systems for biofilm formation under continuous flow (Costerton 
et aI., 1987). The device was later modified by McCoy et aI. (1981) and was called 
the modified Robbins device (MRD) (Fig. 11a). There are 25 evenly spaced 
sampling ports, each of which is fitted with a stud. At the bottom of each stud a 
disk of catheter material can be fitted. Biofilms are established on the surfaces of 
the disks (Fig. 12), exposed to a liquid flow in the chamber of the MRD. Initial 
biofilm inoculation is done by pumping a standardised cell suspension of the test 
organism through the device at flow rate of 60 m1Ih for 1 h at 37°C, followed by 
sterile YNB or TSB medium at the same flow rate (Fig. 11 b). Incubation of 
catheter disks under conditions of continuous flow for 48 h increased the 
production of extracellular matrix material associated with the biofilm. The amount 
of extracellular matrix was monitored by SEM. Samples were prepared by a freeze-
drying protocol which permits better preservation of the matrix than air-drying. A 
flow rate of 60 mllh increased the synthesis of matrix material, as compared with 
that found in biofilms incubated statically. Biofilms grown under these conditions 
in the MRD possessed an extensive coating of matrix material (Fig. 64). 
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Figure 63. Scanning electron micrograph of a biofilm formed by C. albicans 
GDH 2346 on a PVC catheter disk after incubation for 48h under static 
conditions in YNB medium containing 50mM glucose. The biofilms consisted 
of a mixture of yeasts, germ tubes, hyphae and pseudohyphae (arrows). Bar, 
20 J.1m. 
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Figure 64. Scanning electron micrograph of biofilm formation by C. albicans 
GDH 2346 on the surface of PVC catheter disks processed by freeze-drying to 
preserve the biofilm matrix. Biofilms were incubated for 48h under flow 
conditions (MRD) in medium containing 50mM glucose. The biofilms 
consisted of a mixture of yeasts and hyphae (arrows) with extensive matrix 
material. Bar, 20 JIm. 
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2.2 Possible mechanisms of resistance to antifungal agents 
Candida biofilms, like those of other microorganisms, are drug resistant. 
They are resistant to the action of a range of important antifungal agents in current 
clinical use (Hawser and Douglas, 1995). The mechanisms by which Candida 
biofilms resist the action of antimicrobial agents are poorly understood. However, 
recent investigations indicate that at least four possible mechanisms of drug 
resistance are possible. Firstly, resistance could be due to the drug exclusion by the 
biofilm matrix material. Secondly, phenotypic changes conferring drug resistance 
could be induced by a slow growth rate, or by nutrient limitation within the 
biofilm. The third possibility is that attachment to a surface causes the switching on 
or off of genes which coincidentally affect antimicrobial susceptibility (Brown and 
Gilbert, 1993). In the present study, the aim was to investigate the first possibility. 
This was done by increasing the amount of extracellular matrix in biofilm cultures 
using the MRD continuous-flow system. Drug susceptibility profiles of biofilms 
incubated under flow conditions were then compared with those of biofilms 
incubated statically. The effect of an antifungal agent was measured in terms of the 
percentage inhibition of XTT-formazan formation by biofilms compared with 
values obtained for control biofilm cells incubated in the absence of the agent. 
2.3 Effect of amphotericin B on biofilms of C. albicans GDH 2346 grown 
under static and flow conditions 
The susceptibility of mature, 48-h C. albicans biofilms to antifungal agents 
was assessed colorimetrically by measuring the ability of biofilm cells to reduce 
the tetrazolium salt, XTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium 
bromide) to a formazan product after exposure to a drug. The assay (Baillie and 
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Douglas, 1999b) was modified from that described by Mosmann (1983) . 
Amphotericin B, one of the commonest antifungal agents used clinically, was 
added to buffered growth medium at different concentrations (5 and 30 times the 
MIC). Biofilm cells of C. albicans grown under static and flow conditions were 
exposed to this buffered medium containing amphotericin B at 37°C for 5 or 24 h. 
After incubation, metabolic activity of the biofilms, as measured by XTT 
reduction, was compared with that of control biofilms incubated in the absence of 
the drug (Table 7). C. albicans biofilms grown under flow conditions were highly 
resistant to amphotericin B at a concentration of 5 times the MIC; exposure for 24 
h had no effect on metabolic activity. At an even higher drug concentration (30 
times the MIC), with a shorter exposure time (5h), the biofilms were rather less 
resistant. However, for both drug treatments, biofilms formed under flow 
conditions were significantly more resistant that those grown statically (Table 7). 
Large clumps of biofilm were observed on the surfaces of catheter disks removed 
from the MRD during these experiments. Scanning electron microscopy showed 
that more matrix material was present in these biofilms than in those grown 
statically (Fig. 64). These findings suggest that the more extensive matrix of these 
biofilms could contribute to their enhanced resistance to amphotericin B. 
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Table 7. Metabolic activity of C. albicans GDH 2346 biofilms after treatment 
with amphotericin B for 5 h or 24 h 
XTT formazan formation a 
Drug treatment Static conditions b 
5 x MIC (24h) 1.194 ± 0.025 
30 x MIC (5h) 0.944 ± 0.003 
% of control 
60.7±1.3 
39.6±O.1 
Flow conditions b 
% of control 
2.948 ± 0.035 99.4 ± 1.2 
1.615 ± 0.218 54.6 ± 7.4 
a The data are means ± SEM of two independent experiments carried out in 
quadruplicate. 
b T-test showed statistically significant differences at P < 0.001 for biofilms grown 
under flow conditions as compared with those grown statically. 
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2.4 SEM of C. albicans GDH 2346 biofilms grown under static or flow 
conditions on PVC catheter disks 
Scanning electron microscopy showed that biofilms formed by C. albicans 
GDH 2346 incubated statically on PVC catheter disks comprised a dense network 
of yeasts, germ tubes, hyphae, and pseudohyphae (Fig. 63). By contrast, incubation 
of catheter disks under conditions of continuous flow at 60 mllh produced biofilms 
consisting of a mixture of yeasts and hyphae, as before, but the cells were 
surrounded by extensive matrix material (Fig. 64). 
2.5 Effect of amphotericin B and fluconazole on biofilms of C. tropicalis 
AAHB 73 grown under static and flow conditions 
The strain of C. tropicalis used in this study was a clinical isolate from a 
line infection and had a very slimy appearance on solid medium. Some of this 
slime, or matrix material, could be seen when biofilm preparations were observed 
under the scanning electron microscope (Fig. 65). The effect of antifungal agents 
on biofilm activity with this organism was assessed only with biofilms grown 
under static conditions since growth under flow conditions resulted in blockage of 
the MRD (see below). Following incubation for 48 h at 37°C, biofilms on catheter 
disks were further incubated with buffered growth medium containing the test 
antifungal agents at a concentration 30 times the MIC for a further 5 or 24 h at 
37°C (Table 8). The metabolic activity of C. tropicalis biofilms was then measured 
using the XTT assay. C. tropicalis biofilms were highly resistant to the action of 
both drugs at both exposure times (5 and 24h), despite the high drug concentration 
used (30 times the MIC; Table 8). SEM revealed that a large amount of matrix 
material, which seemed to envelope the cells, was present even under these static 
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Figure 6S. Scanning electron micrograph of biofilm formation by C. tropicalis 
AAHB 73 on the surface of PVC catheter disks processed by freeze-drying to 
preserve the biofilm matrix. Biofilms were incubated for 48h under static 
conditions in YNB medium containing SOmM glucose. Extensive matrix 
material is visible (arrows). Bar, 10 J.1m. 
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Table 8. Effect of amphotericin B and fluconazole on biofilms of C. tropicalis 
AAHB 73 after exposure for 5 h or 24 h 
XTT formazan formation a 
Antifungal agent b Static conditions C Flow conditions d 
% of control 
Amphotericin B (Sh) 1.981 ± 0.044 109.7 ± 2.4 ND 
Amphotericin B (24h) 1.916 ± 0.063 104.7 ± 3.4 ND 
Fluconazole (Sh) 1.923 ± 0.084 106.S ±4.7 ND 
Fluconazole (24h) 1.862 ± 0.060 101.8 ± 3.3 ND 
a The data are means ± SEM of two independent experiments carried out in 
quadruplicate. 
b The concentrations of the two drugs used in this assay were equivalent (30 x 
MIC). 
C There was no significant difference (P > O.OS) between values for drug - treated 
biofilms and those for the controls. 
d ND, not determined. 
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growth conditions with this organism (Fig. 65). These observations again suggest 
that the drug resistance of Candida biofilms may be partly accounted for by drug 
exclusion by the biofilm matrix. 
Attempts to grow biofilms of C. tropicalis AAHB 73 for 48h under flow 
conditions in the MRD were unsuccessful. Although biofilms of the organism 
appeared to develop quickly, the silicone tubing that connected the medium to the 
MRD (Fig. lIb) rapidly became blocked by fungal growth. Consequently, it was 
not possible to produce 48-h biofilms under conditions of continuous flow with this 
organism, and therefore no assays of biofilm drug susceptibility could be carried 
out for these conditions. 
2.6 SEM of C. tropicalis AAHB 73 biofilms grown under static conditions on 
PVC catheter disks 
Scanning electron microscopy showed that C. tropicalis biofilms grown 
statically on PVC catheter disks consisted of yeasts with some pseudohyphae. 
Extensive matrix material was visible at both lower and higher magnification and 
many of the microorganisms were almost hidden by the enveloping matrix (Fig. 
65). At high magnification, a large amount of extracellular polymeric material was 
visible on the surface of the filaments (Fig. 66). 
2.7 Effect of amphotericin B and fluconazole on mixed fungal-bacterial 
biofilms grown under static and flow conditions 
The catheter disk model system (Hawser and Douglas, 1994c; Baillie and 
Douglas, 1999b) was used to follow the development of biofilms containing C. 
albicans and S. epidermidis statically, while the MRD was used to provide 
conditions of continuous flow. Two strains of S. epidermidis were used in this 
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Figure 66. Scanning electron micrograph of biofilm formation by C. tropicalis 
AAHB 73 on the surface of PVC catheter disks processed by freeze-drying to 
preserve the biofilm matrix. Biofilms were incubated for 48h under static 
conditions in YNB medium containing 50mM glucose. Arrows indicate 
substantial amounts of extracellular polymeric material on the surfaces of 
filaments at high magnification. Bar, 2f.lm. 
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study: a slime-producing wild type (RP62A) and a slime-negative mutant (M7) 
obtained after chemical mutagenesis of S. epidermidis RP62A with mitomycin C 
(Schumacher-Perdreau et aI., 1994). The growth rate, initial adherence, cell-wall 
composition, surface characteristics and antimicrobial susceptibility profile of 
strain M7 are indistinguishable from those of the wild type (Schumacher-Perdreau 
et aI., 1994). The effects of the antifungal agents amphotericin B and fluconazole 
on mixed-species biofilms containing C. albicans and either the wild-type or 
mutant strain of S. epidermidis were examined. 
2.7.1 Effect of amphotericin B and fluconazole on mixed-species biofilms of 
C. albicans GDH 2346 and S. epidermidis RP62A 
After growth for 48 h, mixed-species biofilms containing C. albicans plus 
the slime-producing S. epidermidis RP62A were treated with amphotericin B and 
fluconazole by the procedure of Adam et aI. (2002). Briefly, the biofilms were 
incubated for a further 5 or 24 h at 37°C in buffered growth medium containing 
fluconazole (12 Ilg/ml), or amphotericin B (39 Ilg/ml) at concentrations 30 times 
the MIC. Biofilm activity was assessed by the XTT reduction assay, after transfer 
of the disks to new wells. The effect of antifungal agents was measured in terms of 
XTT reduction by biofilms as compared with values obtained for control biofilms 
incubated in an identical fashion in the absence of the agents. 
C. albicans biofilms were shown from previous studies to be highly 
resistant to the action of amphotericin B and fluconazole, when compared with 
planktonic cells of the same strain (Hawser and Douglas, 1994c). Mixed-species 
biofilms of C. albicans and S. epidermidis RP62A grown statically or under 
continuous flow conditions were also highly resistant to the action of both drugs 
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(Table 9). At exposure times of 5 and 24 h the drugs had no effect on the metabolic 
activity of mixed-species biofilms, despite the high drug concentration used (30 
times the MIC). Moreover, biofilms produced statically were just as resistant as 
those grown under flow conditions. These results contrast with those obtained for 
single-species C. albicans biofilms treated with amphotericin B where biofilms 
grown statically were more susceptible to the drug (Table 7). They suggest that the 
slime produced by S. epidennidis RP62A might partially protect C. albicans from 
amphotericin B in these statically grown, mixed-species biofilms. 
2.7.2 Effect of amphotericin B and fluconazole on mixed-species biofilms of 
C. albicans GDH 2346 and S. epidermidis M7 
Mixed-species biofilms of C. albicans and S. epidennidis M7 (the slime-
negative mutant) on catheter disks grown statically or under conditions of 
continuous flow were also exposed to buffered medium containing fluconazole (12 
Ilg/ml) or amphotericin B (39 Ilg/ml) for 5 or 24 h at 37°C. The metabolic activity 
of mature mixed-species biofilms was then determined colorimetric ally by the XTT 
reduction assay. The metabolic activity of drug-treated biofilms was determined as 
a percentage of that of control biofilms incubated under identical conditions in the 
absence of the antimicrobial agents. Mixed-species biofilms containing the slime-
negative mutant, M7, grown under flow conditions were highly resistant to 
amphotericin B and fluconazole at both exposure times (5 and 24 h), despite the 
high drug concentration used (30 times the MIC; Table 10). They were, however, 
slightly less resistant than biofilms containing the slime-producing S. epidennidis 
RP62A treated in the same way (Table 9). 
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Table 9. Metabolic activity of mixed-species biofilms of C. albicans GDH 2346 
and S. epidermidis RP62A after treatment with antifungal agents for 5 h or 24 
h 
XTT formazan formation a 
Antifungal agentb Static conditions C Flow conditions C 
% of control OD492 % of control 
Amphotericin B (Sh) 2.86 ± 0.03 98.9 ± 1.0 2.31 ± 0.16 lOS.8 ± 7.3 
Amphotericin B (24h) 2.87 ± O.OS 99.8 ± 1.7 2.97 ±0.06 93.2 ± 1.9 
Fluconazole (Sh) 2.76 ±0.06 9S.S ±2.1 2.18 ± 0.06 100.1 ±2.8 
Fluconazole (24h) 2.9S ±0.02 102.4 ±0.7 3.04±0.06 9S.3 ± 1.9 
a The data are means ± SEM of two independent experiments carried out in 
quadruplicate. 
b The concentrations of the two drugs used in this assay were equivalent (30 x 
MIC). 
C T-test showed no statistically significant differences (P> O.OS) between biofilms 
grown under static and flow conditions after treatment with antifungal drugs. 
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Table 10. Metabolic activity of mixed-species biofilms of C. albicans GDH 2346 
and S. epidermidis M7 after treatment with antifungal agents for 5 h or 24 h 
XTT formazan formation a 
Antifungal agent b Static conditions C Flow conditions C 
% of control % of control 
Amphotericin B (5h) 2.05 ± 0.03 88.7 ± 1.3 2.73 ± 0.01 99.0 ± 0.4 
Amphotericin B (24h) 1.69 ± 0.09 71.8 ± 3.8 2.94 ± 0.09 91.9 ± 2.8 
Fluconazole (5h) 1.53 ± 0.07 66.4 ± 3.0 2.58 ± 0.11 93.5 ± 3.9 
Fluconazole (24h) 1.59 ± 0.11 67.2 ± 4.6 2.92 ± 0.04 91.5 ± 1.3 
a The data are means ± SEM of two independent experiments carried out in 
quadruplicate. 
b The concentrations of the two drugs used in this assay were equivalent (30 x 
MIC) 
C T-test showed statistically significant differences (P < 0.01) between biofilms 
grown under static and flow conditions after drug treatment. 
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For both drug treatments, mixed-species biofilms containing M7 and developed 
under static conditions were significantly more susceptible than those grown under 
conditions of continuous flow. The difference was particularly marked for biofilms 
treated with fluconazole (Table 10). These findings suggest that under flow 
conditions enhanced production of matrix material by either C. albicans, or M7, or 
both organisms, might afford some protection against antifungal agents. 
2.8 SEM of mixed-species biofilms grown under static or flow conditions on 
PVC catheter disks 
Examination of mixed-species fungal-bacterial biofilms by SEM showed 
that, after 48 h, both staphylococcal strains formed extensive interactions with C. 
albicans; these interactions were more easily seen with the slime-negative mutant, 
using a preparative procedure that does not preserve the biofilm matrix. 
Examination of mixed-species biofilms containing the wild-type strain RP62A of S. 
epidermidis processed by the air-drying technique revealed clumps of smaller 
bacterial cells adherent to yeasts and hyphae. The matrix material was not visible 
(Fig. 67). The freeze-drying method of sample preparation, which does preserve 
some of the matrix material, allowed similar interactions to be visualised with 
biofilms containing the mutant M7 (Fig. 68). Clumps of staphylococci attached to 
either yeasts or hyphae could again be seen. In addition, a similar examination of 
mixed-species biofilms by SEM at low magnification revealed the presence of open 
channels between microcolonies in the biofilm structure. However, it is possible 
that these channels are an artefact of the sample preparation procedure rather than 
genuine features of the biofilm. Large numbers of hyphae are also visible at this 
low magnification (Fig. 69). 
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Figure 67. Scanning electron micrograph of mixed-species biofilm formation 
by C. albicans GDH 2346 and S. epidermidis RP62A on the surface of PVC 
catheter disks after air-drying of samples. Biofilms were incubated for 48h 
under flow conditions (MRD) in tryptic soy broth. Clumps of smaller bacterial 
cells (arrows) can be seen adherent to yeasts and hyphae. Matrix material is 
not visible. Bar, 10 J.lm. 
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Figure 68. Scanning electron micrograph of mixed-species biofilm formation 
by C. albicans GDH 2346 and S. epidermidis M7 on the surface of PVC 
catheter disks processed by freeze-drying to preserve the biofilm matrix. 
Biofilms were incubated for 48h in tryptic soy broth under flow conditions in 
the MRD. The biofilms consisted of clumps and clusters of smaller bacterial 
cells (arrows) attached to yeasts or hyphae. Fairly extensive matrix material is 
visible. Bar, 20 flm. 
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Figure 69. Scanning electron micrograph of mixed-species biofilm formation 
by C. albicans GDH 2346 and S. epidermidis M7 on the surface of PVC 
catheter disks after freeze-drying of samples. Biofilms were incubated for 48h 
under flow conditions CMRD) in tryptic soy broth. Open channels (arrows) are 
visible in the biofilm structure at low magnification. Scale bar = 200J.lm. 
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3 Isolation and analysis of extracellular polymeric substances 
(EPS) from biofilms of C. albicans and C. tropicalis 
3.1 Extraction of EPS 
To study the composition of EPS, an extraction method is required to 
separate cells from the matrix material. Various methods have been described for 
the isolation and analysis of EPS. However, no universal method has yet been 
adopted because the compromise between EPS yield and minimum cell lysis is 
difficult to establish (Azeredo et aI., 2003). In this study, EPS was extracted from 
biofilms formed on sections cut from PVC catheter tubing during incubation with 
gentle shaking at 37°C for 48 h. Quantification of EPS is highly dependent upon 
the extraction method used. Two main extraction methods have been developed for 
quantitative analysis, the most common of which is physical extraction. In this 
work, a physical extraction process modified from the method of Baillie and 
Douglas (2000) was used. It involved sonication, vortexing and centrifugation of 
biofilms formed on sections of catheter tubing. EPS was prepared from biofilms of 
two different Candida species, C. albicans GDH 2346 and C. tropicalis AAHB 73. 
3.1.1 Quantitative extraction of EPS from C. albicans GDH 2346 biofilms 
Following the extraction process, and after lyophilization, the total quantity 
of extracted EPS was weighed using a sensitive, 5-figure balance. Two separate 
extraction procedures were carried out with C. albicans biofilms to provide 
sufficient material for chemical analysis. Very similar quantities of EPS were 
obtained for the two preparations (10.7 and 9.40 mg; Table 11). 
176 Results 
Table 11. EPS extracted from different Candida biofilms a 
Total EPS (mg) 







a EPS was physically extracted, without adding any chemical extractant. 
b Each preparation was freeze-dried and then dissolved in distilled water (Iml) for 
biochemical analysis. 
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3.1.2 Quantitative extraction of EPS from C. tropicalis AAHB 73 biofilms 
The same extraction procedure was used for C. tropicalis biofilms. Again, 
two extractions were carried out to provide sufficient material for chemical 
analysis. However, the yield of EPS from biofilms of C. tropicalis was much 
higher than that from biofilms of C. albicans (16.5 and 23.6 mg; Table 11). This 
strain of C. tropicalis was isolated from a line infection and had a very slimy 
appearance on solid medium, suggestive of the production of copious amounts of 
extracellular polymers. 
3.2 Composition of the biofilm matrix material from different Candida 
species 
In general, extracellular polymeric substances consist of metabolic products 
that accumulate on the microorganism's surface (Morgan et a!., 1990). They play 
an important role in protecting the cells against host defences and harsh external 
environments such as those containing antimicrobial agents. They may also 
function in nutrition to extend the cells' carbon and energy reserves during 
starvation. Bacterial EPS is mainly composed of carbohydrate and protein plus 
smaller amounts of uronic acid, lipid and DNA (Liu and Fang, 2002). Preliminary 
results with C. albicans EPS (Baillie and Douglas, 2000) suggest that it has a 
similar composition overall. 
3.2.1 Composition of EPS extracted from C. albicans GDH 2346 biofilms 
To analyse the chemical composition of matrix material, biofilms were 
subjected to a physical extraction process, and two separate EPS preparations were 
obtained under identical conditions, as described above. The EPS preparations 
were analysed for carbohydrate, glucose, protein, hexosamine, phosphorus and 
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uronic acid by colorimetric or enzyme methods. EPS consisted largely of 
carbohydrate (39.6 %, including 32.2 % glucose), together with small amounts of 
protein (5.0 %), hexosamine (3.3 %), phosphorus (0.5 %), and uronic acid (0.1 %; 
Table 12). 
These results are similar to those obtained previously by Baillie and 
Douglas (2000) for the same C. albicans strain, except for the glucose content. The 
glucose content determined in this study (32.2 %) was higher than that reported by 
Baillie and Douglas (15.9 %). This may reflect the fact that the carbon source used 
here was glucose, whereas galactose was used in the earlier study. 
3.2.2 Composition ofEPS extracted from C. tropicalis AAHB 73 biofilms 
Table 13 shows the chemical composition of EPS extracted from C. 
tropicalis biofilms; no such data for C. tropicalis biofilms have been reported 
elsewhere so far. The EPS consisted largely of hexosamine (27.4 %), together with 
smaller amounts of carbohydrate (3.3 %, including 0.5 % glucose), protein (3.3 %) 
and phosphorus (0.2 %; Table 13). The C. tropicalis EPS also contained slightly 
more uronic acid (1.6 %) than that from C.albicans. The major difference between 
the two preparations, however, was that in C. tropicalis hexosamine appeared to 
replace glucose as the main identifiable sugar component. Interestingly, 
hexosamine (glucosamine) is also a major component of the matrix material of 
slime-producing S. epidermidis RP62A. 
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Table 12. Analysis of EPS extracted from C. albicans GDH 2346 biofilms 
Component Percentage composition of biofilm EPS a 
Carbohydrate 39.6 ± 0.3 
Glucose 32.2 ± 1.5 
Hexosamine 3.3 ± 0.6 
Phosphorus 0.5 ±O.O 
Protein 5.0 ± 0.1 
Uronic acid 0.1 ± 0.0 
a The data are means ± SEM for two independent experiments ( with two different 
preparations of EPS) carried out in duplicate or triplicate. 
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Percentage composition of biofilm EPS a 
3.30 ± 0.0 
0.50 ±O.O 
27.40 ± 0.2 
0.20 ±O.O 
3.30 ± 0.0 
1.60 ± 0.0 
a The data are means ± SEM for two independent experiments (with two different 
preparations of EPS) carried out in duplicate or triplicate. 
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4 Enzymatic detachment of Candida species biofilms 
At present, coagulase-negative staphylococci, mostly Staphylococcus 
epidermidis, are the most prominent organisms responsible for infections 
associated with implanted biomaterials such as intravascular catheters, prosthetic 
joints, and prosthetic cardiac valves (Kloos and Bannerman, 1994). S. epidermidis 
grows on medical devices as an adherent biofilm consisting of cells embedded in 
an amorphous, sticky matrix, which is composed of exopolysaccharides (Mack et 
aI., 1996). Recently, Kaplan et al. (2004) identified an enzyme, produced by 
Actinobacillus actinomycetemcomitans, that rapidly and efficiently removed S. 
epidermidis biofilms from plastic surfaces. This enzyme, named dispersin B, is an 
N-acetylglucosaminidase that apparently degrades a polymer of B (1 ~6)-linked N-
acetylglucosamine residues, which is a major component of the biofilm matrix of S. 
epidermidis. 
In the study described here, the enzymatic detachment assay devised by 
Kaplan et al. (2004) was used to investigate whether Candida biofilms could also 
be detached from plastic surfaces. A range of commercially available enzymes of 
known specificity was tested in an attempt to further characterise the biofilm 
matrix material. Both C. albicans and C. tropicalis were used in these experiments. 
4.1 Detachment of C. albicans GDH 2346 biofilms by different test enzymes 
To assess possible biofilm detachment or degradation of matrix material 
caused by different test enzymes, biofilms of C. albicans GDH 2346 were grown in 
the wells of a 96-well polystyrene microtitre plate. Following incubation, the wells 
were washed to remove loosely adherent cells and the remaining fungal cells 
attached to the bottoms of the wells were stained with crystal violet (Gram-staining 
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reagent). Adherent biofilm cells were indicated by the presence of dark-staining 
material on the bottoms of the wells (Fig. 70). The amount of biofilm could be 
quantified by measuring the OD of the wells at 570 nm with a microtitre plate 
reader. To assay biofilm detachment or degradation, wells containing mature 
biofilms were treated with different test enzymes at 37°C or 25°C (according to the 
temperature optimum) for 2 h at a final enzyme concentration of 50flg/ml. 
Treatment with lipase type VII, phospholipase A2, or protease type XIV failed to 
affect biofilms, which were similar in appearance to untreated biofilms (Table 14). 
However, treatment with proteinase K, DNase I, chitinase or ~-N­
acetylglucosaminidase resulted in a significant decrease in OD reading suggesting 
that the enzyme activity removed matrix material and caused some biofilm 
detachment from the surfaces of the wells. Interestingly, lyticase, which hydrolyses 
poly (~-1, 3-glucose), such as yeast cell-wall glucan, had by far the greatest effect 
on biofilms, causing an 85% reduction in optical density (P < 0.001). These results 
suggest that ~-1, 3-linked glucan might also be an important component of biofilm 
matrix material in C. albicans. 
4.2 Detachment of C. tropicalis AAHB 73 biofilms by different test enzymes 
C. tropicalis biofilms were grown in the wells of a 96-well polystyrene 
microtitre plate by the same procedure as that used for C. albicans. The biofilms 
were then treated with different test enzymes as before (final concentration, 50 
flg/ml) for 2 h at 37°C or 25°C according to the temperature optimum for the 
enzyme. After incubation, biofilm cells remaining attached to the bottom of the 
wells were stained with crystal violet (Fig. 71). 
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Figure 70. C. albicans GDH 2346 biof"tlm formation in the wells of 96-well 
polystyrene microtitre plates C. albicans GDH 2346 biofllms were grown in 
triplicate in 3 horizontal rows of wells, and then washed with PBS and stained 
with crystal violet. Two hours prior to washing, test enzyme was added to 
horizontal rows of wells labelled B. An equivalent volume of buffer was added 
to horizontal rows of wells labelled A (control wells). 
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Table 14. Detachment of C. albicans GDH 2346 biofilms after exposure to 
different test enzymes a 
Enzyme b ODs7o % of control 
Lipase type VII 0.144 ± 0.008 >100.0 c 
Phospholipase A2 0.161 ± 0.006 >100.0 c 
Protease type XIV 0.144 ± 0.007 >100.0 c 
Proteinase K 0.098 ± 0.004 69.2 ± 2.8 d 
Chitinase 0.131 ± 0.008 77.2 ±4.7 d 
DNase I 0.113 ± 0.007 70.8 ± 4.4 d 
Lyticase 0.025 ± 0.002 15.4 ± 1.2 e 
~-N-Acetylglucosaminidase 0.120 ± 0.004 79.3 ± 2.6d 
a The data are means ± SEM of two independent experiments each carried out with 
36 replicates for every enzyme tested. 
b All enzyme treatments were carried out for 2h at 37°C or 25°C with a final 
enzyme concentration of 50llg/ml. 
C Value not significantly different (P > 0.05) from that for the control. 
d Value significantly different at P ~ 0.05 from that for the control. 
e Value significantly different at P < 0.001 from that for the control. 
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Figure 71. C. tropicalis AAHB 73 biotilm formation in the wells of 96-well 
polystyrene microtitre plates C. tropicalis AAHB 73 biotilms were grown in 
triplicate in 3 horizontal rows of wells, and then washed with PBS and stained 
with crystal violet. Two hours prior to washing, test enzyme was added to 
horizontal rows of wells labelled B. An equivalent volume of buffer was added 
to horizontal rows of wells labelled A (control wells). 
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Treatment of biofilms with DNase I had no effect (Table 15) and the biofilms had 
an appearance similar to that of the untreated controls. Phospholipase A2, protease 
type XIV, proteinase K and ~-N-acetylglucosaminidase also failed to produce a 
statistically significant decrease in OD reading. Treatment with lipase type VII and 
chitinase, on the other hand, did result in a significant decrease in OD reading (P :S 
0.05) suggesting that these enzymes caused some biofilm detachment from the 
surface of the wells. Again, the greatest effect was with lyticase, which caused a 
reduction in optical density of over 53% (P < 0.001; Table 15). However, lyticase 
had less effect with C. tropicalis biofilms than with C. albicans biofilms (Table 14) 
whose matrix material contains substantially more glucose (Table 12). 
5 Further studies on the effect of lyticase on Candida biofilms 
The cell wall of yeasts and other fungi is a rigid structure essential for the 
survival of fungal cells. Because of its absence in mammalian cells, the cell wall is 
an attractive target for antimicrobial agents. Early studies (Yu et ai., 1967; 
Chattawa et ai., 1968) on the cell walls of C. albicans and S. cerevisiae established 
that the walls are qualitatively similar, being composed mainly of p-glucans, 
mannoproteins (previously called mannans) and a small amount of chitin. In 
general, p-glucans account for 60 % of the cell-wall dry mass, mannoproteins 40 % 
and chitin approximately 2 % (Klis et ai., 2002). Enzymes capable of degrading the 
yeast cell wall have been isolated from the culture supernatants of several 
microorganisms. In general, yeast lytic activity can be attributed to a P-1,3-
glucanase, although lytic P-1,6-glucanases have been characterised (Scott and 
Schekman, 1980). Lyticase is ap-1,3-glucanase produced by Arthrobacter luteus. 
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Table 15. Detachment of C. tropicalis AAHB 73 biofilms after exposure to 
different test enzymes a 
Enzyme b ODs7o % of control 
Lipase type VII 0.229 ± 0.006 73.9 ± 1.9 d 
Phospholipase A2 0.259 ± 0.007 92.2 ± 2.5 c 
Protease type XIV 0.244 ± 0.015 88.3 ± 5.4 c 
Proteinase K 0.255 ± 0.016 93.1 ± 5.8 c 
Chitinase 0.206 ± 0.010 71.3 ± 3.5 d 
DNase I 0.279 ± 0.006 100.0 ± 2.2 c 
Lyticase 0.147 ± 0.007 46.2 ± 2.2 e 
~-N - Acetylglucosaminidase 0.298 ± 0.008 94.9 ± 2.6 c 
a The data are means ± SEM of two independent experiments each carried out with 
36 replicates for every enzyme tested. 
b All enzyme treatments were carried out for 2h at 37°C or 25°C with a final 
enzyme concentration of 50!lg/ml. 
C Value not significantly different (P > 0.05) from that for the control. 
d Value significantly different at P :::; 0.05 from that for the control. 
e Value significantly different at P < 0.001 from that for the control. 
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It is frequently used in the preparation of yeast spheroplasts because it hydrolyses 
,B-l,3-glucan which is the main structural component of the yeast cell wall. 
In this investigation, previous studies (Section 4) showed that lyticase was 
the enzyme which caused most biofilm detachment from microtitre plates. This 
suggested that lyticase was capable of degrading one or more components of the 
biofilm matrix. However, it is also possible that lyticase treatment resulted in some 
lysis of biofilm cells. The following experiments were designed to investigate this 
possibility. 
5.1 Effect of lyticase on C. albicans GDH 2346 biofilm cells 
To assess the effect of lyticase enzyme on biofilm cells, biofilms were 
grown for 48 h in a 24-well microtitre plate and then treated with lyticase (final 
concentration 50 f.lg/ml) at 25°C for 2 h. The concentration of the enzyme used in 
this assay was identical to that used previously in the detachment assay. 
After incubation, the enzyme solution was removed and the biofilms were 
resuspended in 1M sorbitol buffer. Optical density readings at 520nm and 600nm 
were then taken after 0, 15 and 30 min. There was no decrease in optical density 
reading during this 30 min period for the lyticase-treated biofilm cells (Table 16). 
However, the optical density of these cell suspensions was only half that of cell 
suspensions from control biofilms that had not been exposed to the enzyme. This 
suggests some degree of cell lysis in the lyticase-treated biofilms although it is also 
possible that some of the reduction in optical density was due to degradation of 
matrix material. 
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0.35 ± 0.02 
0.37 ± 0.02 
0.37 ± 0.02 




0.32 ± 0.02 
0.34 ± 0.02 
0.34 ± 0.01 
% of control C 
48.5 ± 2.4 
49.1 ± 2.4 
52.7 ± 2.2 
a The data are means ± SEM of two independent experiments carried out in 
triplicate. After lyticase treatment, biofilm cells were resuspended in sorbitol buffer 
and the optical density of each suspension monitored after 0, 15 and 30 min. 
b The final concentration of lyticase used was 50 !lg/ml. 
C Optical density readings for lyticase-treated biofilm cells expressed as a 
percentage of those for control (untreated) cells. The differences between enzyme-
treated cells and control cells were statistically significant (P < 0.001). 
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5.2 Effect of lyticase on C. tropicalis AAHB 73 biofilm cells 
Biofilms were grown for 48 h on polystyrene surfaces in the wells of a 24-
well microtitre plate and then treated with the enzyme at a final concentration of 50 
/lglml at 25°C for 2 h. After removal of the enzyme solution the biofilm cells were 
resuspended in sorbitol buffer and optical density readings taken after 0, 15 and 30 
min. As with C. albicans biofilms, there was no decrease in optical density over the 
30-min period (Table 17). Moreover, with these biofilms, the optical density 
readings for the cell suspensions treated with lyticase were actually higher than 
those of the control suspensions. 
These results suggest that lysis of C. tropicalis cells does not occur during 
the lyticase treatment, even though C. tropicalis is known to be sensitive to the 
enzyme (Kamiryo et aI., 1982). 
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a The data are means ± SEM of two independent experiments carried out in 
triplicate. After lyticase treatment, biofilm cells were resuspended in sorbitol buffer 
and the optical density of each suspension monitored after 0, 15 and 30 min. 
b The final concentration of lyticase used was 50 Ilg/ml. 
C Optical density readings for lyticase-treated biofilm cells expressed as a 




1 Penetration of Candida biofilms by antifungal agents 
The mechanisms that protect microorganisms in biofilms from 
antibiotics, biocides and antibodies are still being elucidated. Currently, four 
mechanisms are under study: (i) slow penetration of the antimicrobial agent into 
the biofilm, (ii) an altered chemical microenvironment within the biofilm leading 
to zones of slow or no growth, (iii) adaptive responses to environmental stress, 
and (iv) the existence of persister cells that are protected from all types of 
antimicrobial insult (Stewart, 2003). Almost all of this work is being done with 
bacterial biofilms. At present, no single mechanism seems to account for the 
exceptional resistance of biofilm cells to a wide variety of antimicrobial agents. 
Instead, it is likely that two or more mechanisms operate together. Mathematical 
modelling suggests that multiple mechanisms of biofilm reduced susceptibility 
are manifested even in biofilms of the same species and that the particular 
resistance mechanism depends on the biofilm age, antimicrobial agent, and 
biofilm thickness (Dodds et aI., 2000). 
All four resistance mechanisms mentioned above appear to depend 
critically on the multicellular nature of biofilms. For example, when an 
antimicrobial agent fails to penetrate a biofilm, it is because the drug is reactively 
neutralized as it diffuses into a cell cluster. This process may involve enzymatic 
degradation of the drug or drug binding to charged extracellular polymers, but it 
is effective only when microorganisms are aggregated and exert their collective 
neutralizing activity (Stewart, 2003). Imipenem induces high levels of j3-
lactamase production in Pseudomonas aeruginosa biofilms. Treatment with 
piperacillin also induces j3-lactamase production in these biofilms but to a lesser 
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degree. The combination of ,B-Iactamase production with other protective 
properties of the biofilm mode of growth could be a major reason for the 
persistence of this sessile bacterium in chronic infections (Giwercman et aI., 
1991). 
In this study, the penetration of antifungal agents through single- and 
mixed-species biofilms formed by fungal pathogens in the genus Candida was 
investigated. The results demonstrated that fluconazole permeated all single-
species Candida biofilms more rapidly than flucytosine. The rates of diffusion of 
either drug through biofilms of three strains of C. albicans were similar. On the 
other hand, the rates of drug diffusion through biofilms of C. glabrata and C. 
krusei were faster than those through biofilms of C. parapsilosis and C. 
tropicalis. In all cases, the drug concentration reached at the distal edge of the 
biofilm was very high. However, drug penetration failed to produce complete 
killing of biofilm cells even when the incubation period was extended from 6 to 
24 h. These results indicate that poor drug penetration is not a major resistance 
mechanism for Candida biofilms. 
This conclusion is in agreement with previous studies on P. aerguinosa 
and K. pneumoniae biofilms by Stewart et al. (2001) who also found poor 
biofilm killing despite effective physical penetration of antimicrobial agents into 
the biofilm (Stewart et ai., 2001). Similarly, Zheng and Stewart (2002) showed 
that rifampin penetrated uniformly through biofilms formed by Staphylococcus 
epidermidis but failed to effectively kill the bacteria (Zheng and Stewart, 2002). 
All of these results indicate that biofilms are protected by mechanisms other than 
simple physical shielding by the matrix material. The results are also consistent 
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with earlier studies by Darouiche et al. (1994) who concluded that the failure of 
glycopeptide antibiotics to eradicate prosthesis-related infection was not due to 
poor penetration of drugs into the biofilm but might be due to a diminished 
antimicrobial effect on bacteria in the biofilm environment. 
The biofilms showing the lowest levels of drug penetration, particularly 
with fIucytosine, were those formed by C. parapsilosis and C. tropicalis. The 
strain of C. tropicalis used in these experiments, a clinical isolate, appeared to 
produce large amounts of matrix material, some of which could be seen when 
biofilm preparations were viewed under a scanning electron microscope (Fig. 
60). Although the chemical composition of the biofilm matrix of C. albicans has 
been investigated (Baillie and Douglas, 2000), at the outset of this project no 
comparable studies had been done with C. tropicaZis. The matrix of C. albicans 
biofilms contains mainly carbohydrate and protein, with a relatively high 
proportion (16%) of glucose (Baillie and Douglas, 2000). Recent work with p. 
aeruginosa has led to the identification of periplasmic glucans in biofilm cells 
which appear to sequester antibiotics and slow their diffusion, perhaps 
preventing them from reaching their sites of action in the cytoplasm (Mah et aI., 
2003). It has also been postulated that the nature and amounts of extracellular 
glucans produced by oral streptococci from sucrose in dental plaque are major 
determinants retarding acid diffusion (Rojo et aI., 1976). Unexpectedly, the 
matrix material of C. tropicaZis biofilms has hexosamine, not glucose, as its 
major component (Table 13). These observations suggest that the nature and 
amount of matrix material could play a minor role in the drug resistance of C. 
tropicalis biofilms by slowing the diffusion of antifungal agents. 
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Recently, Jefferson and colleagues (2005) analyzed the diffusion of the 
glycopeptide antibiotic vancomycin into S. au reus biofilms using confocal 
scanning laser microscopy and a fluorescently labelled vancomycin derivative 
BodipyFL-vancomycin. They found that binding of vancomycin to bacterial cells 
within the deepest layers of biofilm was not detected for nearly 60 min, whereas 
the antibiotic bound to planktonic cells within 5 min. These results indicate that 
the antibiotic diffuses into the depths of the biofilm but that the rate is 
significantly reduced as compared with diffusion through planktonic cell 
suspensions. This gradual exposure of microorganisms in the deeper layers of the 
biofilm might therefore allow them to undergo stress-induced metabolic or 
transcriptional changes that increase resistance to the antimicrobial agents 
(J efferson et al., 2005). 
All four antifungal agents tested diffused very slowly through mixed-
species biofilms containing C. albicans and either the wild-type or M7 mutant 
strain of S. epidennidis. In most cases, diffusion was slower with biofilms 
containing S. epidennidis RP62A, the wild-type, slime-producing strain. 
Curiously, however, amphotericin B penetrated biofilms containing the M7 
mutant more slowly. In all of these experiments with mixed fungal-bacterial 
biofilms, the drug concentrations reaching the distal edges of the biofilms 
substantially exceeded the MIC for C. albicans. Thus, although the presence of 
bacteria and bacterial matrix material undoubtedly retarded the diffusion of the 
antifungal agents, poor penetration does not account for the drug resistance of 
Candida biofilm cells, even in these mixed species biofilms. 
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The chemical composition of the extracellular matrix of S. epidermidis 
biofilms is not fully established. It appears to contain a polymer of ~-1,6-linked 
N-acetylglucosamine residues with some deacetylated amino groups, as well as 
succinate and phosphate substituents (the intercellular polysaccharide adhesin 
[PIA]) (Mack et ai., 1996). However, early work by Hussain et ai.(1993) found 
that the slime is a mixture of about 80% (w/w) teichoic acid and 20% protein. A 
140-kDa accumulation-associated protein has also been identified (Hussain et ai., 
1997). The M7 mutant, which fails to accumulate on glass surfaces 
(Schumacherperdreau et ai., 1994) but which does form biofilms on polyvinyl 
chloride catheter disks (Adam et ai., 2002), has been reported to lack this protein 
but nevertheless synthesizes PIA (Hussain et ai., 1997). Interactions between 
these polymers and those produced by C. albicans in mixed-species biofilms 
might result in a more viscous matrix. Rheological interactions between matrix 
polysaccharides from Pseudomonas cepacia and P. aeruginosa have been shown 
to decrease the rates of diffusion and antimicrobial activities of antibiotics 
(Allison and Matthews, 1992). On the other hand, a recent study of oral biofilms 
containing six microbial species, including C. albicans, suggested that retarded 
diffusion of fluorescent probes through the biofilm was due to tortuosity, i.e., the 
convoluted paths traversed by macromolecules during biofilm penetration 
(Thurnheer et aI., 2003). 
Biofilm cells appear to grow slowly because of the limited availability of 
nutrients, especially at the base of the biofilm. Growth rate has therefore been 
considered as an important modulator of drug activity in biofilms (Gilbert et ai., 
2002; Douglas, 2003). A perfused fermentor was used to generate C. albicans 
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biofilms at different growth rates, and the susceptibility of the biofilm cells to 
amphotericin B was compared with that of planktonic organisms grown at the 
same rates in a chemostat. The results indicated that biofilms were resistant to the 
drug at all growth rates tested, whereas planktonic cells were resistant only at 
low growth rates (Baillie and Douglas, 1998a). An alternative mechanism of 
drug resistance might be upregulation of genes coding for multidrug efflux 
pumps in biofilm cells. C. aibicans possesses two different types of efflux pump: 
ATP-binding cassette transporters and major facilitators, which are encoded by 
CDR and MDR genes, respectively. Recent work has shown that genes encoding 
both types of pump are indeed upregulated during biofilm formation and 
development. However, mutants carrying single or double deletion mutations in 
some of these genes were highly susceptible to fluconazole when they were 
growing planktonically but retained the resistant phenotype during biofilm 
growth (Ramage et aI., 2002b) . Overall, it seems probable that drug resistance in 
Candida biofilms, like that in bacterial biofilms, is a complex process involving 
more than one mechanism. 
2 Drug susceptibility of Candida biofilms grown statically and 
under conditions of continuous flow 
It is known that the architecture of biofilms can depend on the flow 
conditions that prevail in the liquid in which they are grown. The present study 
set out to compare the drug susceptibility of Candida biofilms grown in two 
different models: one was under continuous flow and the other static. The static 
biofilm model was based on a method described by Prosser et ai. (1987), 
previously used for Escherichia coli and other gram-negative bacteria. This 
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involved growing adherent populations of biofilms on the surfaces of small disks 
cut from polyvinylchloride (PVC) catheter material in static conditions. Biofilm 
activity was assessed quantitatively by a colorimetric tetrazolium salt reduction 
assay (XTT) and visualised using scanning electron microscopy (SEM). This 
simple static model is also inexpensive, rapid, and facilitates accurate testing of 
the in vitro susceptibility of Candida biofilms to antifungal agents. 
To allow comparison with statically cultured Candida biofilms, biofilms 
were grown under conditions of continuous flow using a modified Robbins 
device (MRD). Over the years, several systems have been developed in vitro to 
study the biofilm mode of growth under flow conditions but the MRD remains 
one of the most widely used and well-known. It has been used successfully by 
many researchers for the study of bacterial adhesion and biofilm formation 
(Linton et ai., 1999; Hoiby et ai., 2001). For this reason, their methods were 
adapted to study the growth of C. albicans biofilms under flow conditions. 
Biofilm formation on PVC catheter sampling studs within the chamber of the 
MRD was monitored at different time intervals. The MRD is recognised as a 
good model which mimics intravenous delivery of planktonic microorganisms 
that eventually adhere to and colonise available plastic surfaces such as catheters 
within patients. One of the drawbacks of this system is that it is difficult to 
sterilize before use. It is recommended that the MRD is sterilized using ethylene 
oxide (Jass and Lappin-Scott, 1992; Kharazmi et ai., 1999) although in the 
present study sterilization was achieved using 0.05 % hibitane. There is also an 
increased risk of contamination, especially when removing sampling studs. In 
addition, the MRD requires the use of much larger quantities of material such as 
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standardized cell suspension and growth medium, and takes longer to set up than 
static models. However, on the plus side, the MRD has the advantage of allowing 
a large number of samples to be assessed at anyone time by arranging several 
MRDs in parallel. It has been recommended that this in vitro model should be 
considered for comparative evaluation of biomaterial candidates for medical 
device use in the urinary tract (Tunney et aI., 1997). 
2.1 Drug susceptibility of C. albicans biofilms grown under static and flow 
conditions 
Biofilms of C. albicans grown under static conditions on small PVC disks 
(surface area, 0.5 cm2) were exposed to different concentrations of amphotericin 
B at 3TC for 5 or 24 h. After incubation, the metabolic activity of the sessile 
cells was assessed by the tetrazolium reduction assay. The effect of the 
antifungal agent was calculated in terms of the percentage inhibition of formazan 
formation by biofilms compared with values obtained for control biofilms 
incubated in the absence of the drug (Table 7). The results showed that statically 
grown biofilms treated with amphotericin B at a concentration of 6.5 ~g/m1 (5 
times the MIC) or 39 ~g/ml (30 times the MIC) showed partial resistance to the 
drug. The first investigation of biofilm formation by Candida species developed 
on the surface of catheter material used the same system (Hawser and Douglas, 
1994b), and the authors went on to show that the biofilms formed were resistant 
to the action of five clinically important antifungal agents (Hawser and Douglas, 
1995b). These early studies were therefore the first to indicate that, as is the case 
with bacterial biofilms, the Candida biofilm phenotype confers resistance to 
antifungal drug therapy and they have subsequently been confirmed by other 
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workers (Chandra et ai., 2001b). They were also consistent with the clinical 
observation that current antifungal therapy has poor activity against Candida 
species embedded in a biofilm matrix (Lewis et ai., 1998). 
C. albicans biofilms grown under flow conditions were highly resistant to 
amphotericin B at a concentration five times the MIC; exposure for 24 h had no 
effect on metabolic activity. At an even higher drug concentration (30 times the 
MIC), with a shorter exposure time (5 h), the biofilms were rather less resistant. 
However, for both drug treatments, biofilms formed under flow conditions were 
significantly more resistant than those grown statically (Table 7). These results 
differ from those obtained in a previous study in which flow conditions were 
achieved by gentle shaking of biofilms during incubation, a procedure which 
promotes the synthesis of matrix material (Hawser et ai., 1998b). Biofilms grown 
with or without shaking did not exhibit significant differences in susceptibility to 
flucytosine, fluconazole or amphotericin B (Baillie and Douglas, 2000). A 
possible explanation for this is that the shaking procedure, which produced 
conditions of turbulent flow, was less effective at stimulating matrix synthesis 
than the laminar flow system provided by the MRD. The morphology and 
physical properties of some bacterial biofilms are strongly influenced by the 
magnitude of the shear stresses under which the biofilms are formed (Stoodley, 
2000). For example, the total number of cells producing matrix material is higher 
in Pseudomonas fluorescens biofilms growing under laminar flow than in 
biofilms formed under turbulent flow (Pereira et ai., 2002). The results presented 
here for C. albicans indicate that a constant flow (60 ml h- l ) of liquid across the 
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developing biofilm promotes matrix synthesis to an extent that significantly 
enhances resistance to amphotericin B. 
2.2 Drug susceptibility of C. tropicalis biofilms grown under static or flow 
conditions 
Since the late 1970s, several researchers have highlighted the potential of 
C. tropicalis to cause severe invasive disease (Wingard et aI., 1979; Flynn et aI., 
1993). C. tropicalis has an apparently higher capacity than C. albicans to invade 
the deep tissues of the immunocompromised host; many reports have shown 
positive surveillance cultures for C. tropicalis to be highly predictive of 
subsequent systemic infection (Komshian et aI., 1989). 
In the present, study attempts for the first time to grow biofilms of C. 
tropicalis AAHB 73 under flow conditions in the MRD were unsuccessful. This 
organism grew on, and rapidly blocked, the silicone tubing leading to the device, 
apparently by producing large amounts of slime. Biofilms of C. tropicalis grown 
statically were totally resistant to the action of both amphotericin B and 
fluconazole when exposed to high concentrations of the drugs for either 5 or 24 h 
(Table 8). Rates of drug diffusion through statically grown Candida biofilms 
were determined using a filter disk assay (Section 1). Of several Candida species 
and strains tested, the slowest penetration was observed with C. tropicalis AAHB 
73. In view of the analytical data on matrix preparations (Table 13), this suggests 
that drug resistance could be affected not only by the overall extent of matrix 
formation but also by its composition. Biofilms of C. tropicalis, with an 
extensive, hexosamine-rich matrix, were poorly penetrated by antifungal agents. 
On the other hand, biofilms of C. albicans, with a less-extensive glucose-rich 
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matrix, were more readily penetrated by drugs (Table 12). Several reports 
indicate that in bacteria, possession of a mucoid phenotype is associated with 
decreased susceptibility to antibiotics. For example, biofilms of a mucoid clinical 
isolate of P. aeruginosa are substantially less susceptible to the quinolone 
antibiotic ciprofloxacin than biofilms of a non-mucoid isolate (Evans et a!., 
1991). Similarly, biofilms produced by an alginate-overproducing strain of P. 
aeruginosa exhibit a highly structured architecture and are significantly more 
resistant to tobramycin than biofilms formed by an isogenic non-mucoid strain 
(Hentzer et a!., 2001). 
2.3 Drug susceptibility of mixed fungal-bacterial biofilms grown under 
static and flow conditions 
It is now known that the complex architecture of most biofilms is 
intrinsically stratified into spatially organized populations of mixed species 
communities with a degree of interspecies interaction (EI-Azizi et a!., 2004). A 
number of investigators have studied the phenomenon of co aggregation and 
co adhesion between Candida and different bacteria and the effect of modulating 
factors including saliva, sugars, and pH (Grimaudo et a!., 1996; O'Sullivan et a!., 
2000). An earlier study by Holmes et a!. (1995) demonstrated that adhesion of C. 
albicans to Streptococcus gordonii immobilized on microtitre plates was 
increased when either the yeasts were suspended in saliva, or when the bacteria 
were pretreated with saliva. 
Various clinical studies have revealed that fungal oropharynx infections 
ill combination with adhering bacteria are very common in bone marrow 
transplant patients (Hsu et a!., 1990) as well as in patients with autoimmune 
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deficiency disease (Torssander et al., 1987; Coleman et at., 1993). Silicon rubber 
voice prostheses in laryngectomized patients have to be frequent! y replaced 
because of the adhesion of Candida together with oral and skin commensal 
organisms on the surface of the device (Mahieu et at., 1986). Baena-Monroy and 
colleagues (2005) identified a significant association between C. albicans and 
Staphylococcus aureus in patients suffering from atrophic denture stomatitis. 
These co-species communities, probably existing as mixed fungallbacterial 
biofilms, are difficult to treat with both antibiotics and antifungals (Baena-
Monroy et at., 2005). Moreover, many reports on implant-related infections have 
shown that the frequent incidence of mixed-species biofilms on the surface of 
catheters can enhance resistance against antifungal agents (Crump and Collignon, 
2000; Ramage et at., 2005). 
Previous work with statically grown C. albicans biofilms has indicated 
that the presence of bacteria (S. epidermidis) can enhance biofilm resistance to 
antifungal agents (Adam et at., 2002). In this study, the drug susceptibility of 
mixed fungallbacterial biofilms grown under static and flow conditions was 
compared. As before, two strains of S. epidermidis were used: a slime-producing 
wild-type (RP62A) and a slime-negative mutant (M7). Strain RP62A produces 
the intercellular adhesin PIA; M7 is a mutant of strain RP62A that also produces 
PIA but lacks a 140 kDa antigen termed accumulation-associated protein 
(Hussain et al., 1997; Gotz, 2002). The mutant strain is able to form biofilms on 
PVC disks (Adam et at., 2002), although it was originally reported as being 
unable to accumulate on glass surfaces (Schumacherperdreau et at., 1994). 
However, the extent of biofilm formation (or production of matrix material) by 
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the mutant is less than that of the wild-type strain, as judged by both SEM and 
quantitative assays (Adam et aI., 2002). The M7 mutant is also more easily 
eradicated in vitro and in animal models by various antibiotics than is the wild-
type strain (Schwank et aI., 1998). 
In the present study, mixed-species biofilms of C. albicans and S. 
epidermidis RP62A grown statically, or under flow conditions in the MRD, were 
highly resistant to both amphotericin B and fluconazole (Table 9). These results 
contrast with those obtained for single-species C. albicans biofilms treated with 
amphotericin B, for which biofilms grown statically were more susceptible to the 
drug (Table 2). They suggest that the slime produced by S. epidermidis RP62A 
might partially protect C. albicans from amphotericin B in these statically grown, 
mixed species biofilms. Preparations of matrix material (slime) from clinical 
isolates of S. epidermidis have been shown to reduce the efficacy of some 
antibiotics when mixed with the drugs in zone-of-inhibition bioassays (Souli and 
Giamarellou, 1998). Similar results were obtained when staphylococcal slime 
was mixed with planktonic bacteria in susceptibility testing using a broth-dilution 
method (Konig et aI., 2001). However, attempts to correlate the hydrophobicity 
or charge of each antibiotic tested with loss of activity due to the slime were 
unsuccessful (Souli and Giamarellou, 1998). 
Mixed-species biofilms containing the slime-negative mutant M7 grown 
under flow conditions were highly resistant to amphotericin B and fluconazole at 
both exposure times (5 and 24 h), despite the high drug concentration used (30 
times MIC; Table 10). They were, however, slightly less resistant than biofilms 
containing the slime-producing S. epidermidis RP62A treated in the same way 
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(Table 9). For both drug treatments, mixed-species biofilms containing M7 and 
developed under static conditions were significantly more susceptible than those 
grown under conditions of continuous flow. The difference was particularly 
marked for biofilms treated with fluconazole (Table 10). These findings suggest 
that under flow conditions, enhanced production of matrix material by either C. 
albicans or M7, or both organisms, might afford some protection against 
antifungal agents. 
2.4 General conclusions on drug susceptibility of biofilms 
Overall, these results indicate that drug resistance of C. albicans biofilms 
may be significantly enhanced by increased production of matrix material under 
flow conditions in the MRD, or by the presence of one or more matrix polymers 
of S. epidermidis in mixed-species biofilms. Biofilms of C. tropicalis, on the 
other hand, are less susceptible to antifungal agents than C. albicans biofilms, 
even when grown statically. A possible explanation for this might be the 
synthesis of a hexosamine-containing matrix polymer similar to S. epidermidis 
PIA. Drug diffusion through C. albicans / S. epidermidis biofilms (Fig. 37, 43, 
49 and 55) grown statically on cellulose filters is slower than that through C. 
albicans biofilms or even C. tropicalis biofilms alone, as described in earlier 
sections of this study. Interactions between different matrix polymers in these 
mixed-species biofilms could produce a more viscous matrix. Such a finding was 
reported by Skillman et al. (1999) during a study of Enterobacter 
agglomeranslKlebsiella pneumoniae biofilms; increased matrix viscosity was 
advanced as a possible explanation for enhanced resistance to disinfection. 
Similarly, rheological interactions between matrix polysaccharides from 
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Pseudomonas (now Burkholderia) cepacia and P. aeruginosa have been shown 
to decrease the rates of diffusion and antimicrobial activities of antibiotics 
(Allison and Matthews, 1992). Undoubtedly, matrix polymers do contribute 
towards drug resistance in both single-species and mixed-species biofilms 
containing Candida, especially under the flow conditions that prevail in many 
implant infections. However, biofilm resistance overall is likely to be 
multifactorial involving, in addition, drug-resistant physiologies such as dormant 
'quiescent' cells and expression of efflux pumps (Gilbert et ai., 2002). 
2.5 Scanning electron microscopy (SEM) of biofilms grown statically and 
under conditions of continuous flow 
SEM showed that biofilms formed by C. albicans incubated statically on 
catheter disks consisted of a dense network of yeasts, germ tubes, hyphae and 
pseudohyphae. As reported previously (Hawser et ai., 1998b), relatively little 
matrix material was visible in these biofilms, even when samples were prepared 
using a freeze-drying technique that gives improved preservation of the matrix. 
However, biofilms grown in the MRD under flow conditions had an extensive 
matrix as revealed by SEM (Fig. 65). This confirmed earlier findings which 
demonstrate that biofilms subjected to a liquid flow produce substantially more 
matrix material than those incubated statically (Hawser et ai., 1998b). In contrast 
with C. albicans, biofilms of C. tropicalis synthesized large amounts of 
extracellular material even during growth under static conditions, and many of 
the cells were almost hidden by the enveloping matrix (Fig. 66). At high 
magnification, matrix material was clearly visible on the surface of the cells (Fig. 
67). 
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3 Isolation and analysis of matrix material from Candida 
biofilms 
3.1 Isolation of matrix material 
To study the chemical composition of the biofilm matrix an extraction 
procedure which can separate cells from the matrix material without cell 
destruction is desirable. Although several extraction methods have been 
developed, there is no standard method universally accepted by researchers and a 
variety of physical and chemical extractions have been reported (Azeredo et al., 
1999; Liu and Fang, 2002; Azeredo et al., 2003). Many of these methods 
promote leakage of intracellular material (Azeredo et al., 1999). In this 
investigation, matrix material was prepared from biofilms of two different 
Candida species, C. albicans GDH 2346 and C. tropicalis AAHB 73. A physical 
extraction process was used which involved adapting the method described by 
Baillie and Douglas (2000) in an attempt to minimize leakage. This consisted of 
gentle sonication, vortexing and centrifugation of biofilms formed on sections of 
catheter tubing. Two separate preparative procedures were carried out for each 
organism to provide sufficient material for chemical analysis. The yield from 
biofilms of C. tropicalis was much higher than that from biofilms of C. albicans 
(Table 11). 
3.2 Chemical composition of the biofilm matrix 
For years, carbohydrate was considered to be the predominant constituent 
III extracellular material produced by many pure cultures (Sutherland and 
Kennedy, 1996; Sutherland, 1997; Cescutti et al., 1999). Generally, matrix 
material secreted by bacteria during growth on a surface is mainly composed of 
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carbohydrate and protein, plus small quantities of uromc acid and 
deoxyribonucleic acid (Ross et aI., 1991; Marty et aI., 1992; Wingender et aI., 
2001; Liu and Fang, 2002; Tsuneda et aI., 2003). In this study, matrix isolated 
from C. albicans biofilms consisted of carbohydrate, together with small 
amounts of protein, hexosamine, phosphorus and uronic acid (Table 12). These 
values largely confirm those reported in an earlier analysis from this laboratory 
which also revealed the presence of small amounts of mannose and galactose in 
the matrix (Baillie and Douglas, 2000). Both studies demonstrate that glucose is 
the major sugar component of C. albicans matrix material. However, glucose 
accounted for a larger proportion of the matrix dry weight in the present 
investigation. This could be due to a difference in the growth medium: galactose 
was used as the carbon source in the previous study but was replaced here by 
glucose. 
By contrast, matrix from C. tropicalis biofilms consisted mainly of 
hexosamine, with smaller amounts of carbohydrate including glucose, protein 
and phosphorus (Table 13). It is also noteworthy that the C. tropicalis matrix 
contained slightly more uronic acid than that of C. albicans. The major 
difference between the two preparations, however, was that in C. tropicalis, 
hexosamine appeared to replace glucose as the main identifiable sugar 
component in the matrix (Table 13). This is the first reported analysis of the 
biofilm matrix of C. tropicalis. However, a number of bacteria are known to 
produce similarly large amounts of hexosamine as a matrix component. The best-
studied example is S. epidennidis. The extracellular antigenic markers of this 
organism were isolated and studied independently by different research groups 
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(Tojo et ai., 1988; Christensen et ai., 1990). Tojo et ai. (1988) first isolated an 
extracellular capsular polysaccharide adhesin (PSI A) from culture supernatant of 
S. epidermidis strain RP62A. PS/A has been reported (McKenney et ai., 1998) to 
be the component of the bacterial cell surface and biofilms that mediates cell 
adherence to biomaterials and protects the bacterial cells from host defences. In 
subsequent studies, Christensen and co-workers (1990) described a slime-
associated antigen (SAA) isolated from the same strain that had a similar 
function. However, after investigation of the chemical composition of SAA, 
Baldassarri et ai., (1996) suggested that SAA and a hexosamine-containing 
polysaccharide intercellular adhesin (PIA) of S. epidermidis strain RP62A, 
described by Mack et al. (1994), could be the same antigenic molecule. Later, 
Mack et al. (1996) elucidated the chemical structure of PIA and identified it as a 
polysaccharide of ,B-l,6-linked N-acetylglucosamine residues containing some 
deacetylated amino groups, and succinate and phosphate substituents. Recently, 
Sadovskaya and colleagues (2005) found another carbohydrate-containing 
polymer, extracellular teichoic acid (EC TA), to be an essential component of S. 
epidermidis RP62A biofilms. They also studied the relative amounts of 
extracellular PIA and EC T A produced by the same strain. Production depended 
on the growth conditions; static culture or moderate shaking in TSB medium 
favoured PIA synthesis, while more EC TAwas produced in brain heart infusion 
medium (Sadovskaya et ai., 2005). PIA mediates cell-cell interactions within the 
biofilm (Gotz, 2002) and its production has been related to S. epidermidis 
virulence in catheter-infection models in animals. 
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P. aeruginosa has become a model organism in biofilm research and 
biofilms of this organism have been intensively studied during the last decade. P. 
aeruginosa is well characterized with respect to its molecular genetics, 
biochemistry, and physiology (Costerton et aI., 1999). During chronic 
colonization in cystic fibrosis patients, P. aeruginosa undergoes conversion from 
a nonmucoid to a mucoid phenotype (Hentzer et aI., 2001). The most 
characteristic feature of the mucoid phenotype is the secretion of large amounts 
of highly viscous exopolysaccharides. Alginate from P. aeruginosa is a high 
molecular-weight O-acetylated a-1,4-linked random polymer of mannuronic and 
guluronic acids similar in structure to seaweed alginate (Evans and Linker, 1973; 
Marty et aI., 1992; Grobe et aI., 1995; Rehm and Valla, 1997). In addition to 
alginate, nucleic acid represents approximately 20 % of the total weight of the 
biofilm matrix, and is composed of both DNA and RNA. Proteins and several 
sugars are also present including glucose, mannose, fucose, galactose, ribose and 
rhamnose, together with the hexosamines (glucosamine) and galactosamine 
(O'Toole and Kolter, 1998; Costerton et aI., 1999; Hentzer et aI., 2001). 
Recently, it was noted that a nonmucoid wild type, as well as alginate-negative 
mutants of P. aeruginosa are also able to form biofilms. These nonmucoid 
biofilms showed a different architecture from that of biofilms formed by 
alginate-overproducing, mucoid P. aeruginosa (Nivens et aI., 2001). 
Another study demonstrated that the matrix material isolated from 
Helicobacter pylori biofilms consisted of fucose, glucose, galactose, and glycero-
mannoheptose, N-acetylglucosamine and N-acetylmuramic acid and the author 
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concluded that these sugars were by far the major components of the biofilm 
matrix material (Stark et ai., 1999). 
4 Enzymatic detachment of Candida biofilms 
Biofilm accumulation is determined by the balance of attachment, 
growth, and detachment processes. Of these phenomena, the least understood is 
detachment. Detachment refers to the release of microbial cells and their 
associated matrix polymers from the biofilm to the bulk fluid of growth media. 
Moreover, detachment is of fundamental importance to the dissemination of 
infection and to contamination in both clinical (Nickel et ai., 1994) and public 
health settings (Walker et ai., 1995). However, detachment is the least-studied 
biofilm process and remains poorly understood (Stewart, 1993). 
Some factors such as heat, detergents, sonication, and agitation have been 
suggested to be important in biofilm detachment in vitro. Other detachment 
promoters include matrix-degrading enzymes (Allison et ai., 1998; Vats and Lee, 
2000; Kaplan et ai., 2003b), microbially generated gas bubbles (Ohashi and 
Harada, 1994), nutrient levels and microbial growth status (Applegate and 
Bryers, 1991; Stewart, 1993; Sawyer and Hermanowicz, 1998; Jackson et ai., 
2002; Hunt et ai., 2004), availability of multivalent cross-linking cations 
(Turakhia et aI., 1983; Applegate and Bryers, 1991), fluid shear stress 
(Picioreanu et aI., 2001; Stoodley et aI., 2001), contact attrition (Chang et aI., 
1991), quorum-sensing signals (Hentzer et ai., 2002), and the activation of a lytic 
bacteriophage (Webb et ai., 2003). Stewart et al. (2000) described several 
strategies to eradicate unwanted biofilms that may be applied to a particular 
system, depending on its characteristics. These include (i) mechanical cleaning, 
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(ii) the use of antimicrobial agents, (iii) stopping biofilm growth by removing 
essential nutrients, (iv) inhibiting microbial attachment to a surface and (v) 
promoting biomass detachment which is the least investigated of the possible 
strategies to remove unwanted biofilms. Several enzymes have been observed to 
induce detachment by destroying the physical integrity of the biofilm matrix. 
This would be an attractive procedure for both medical and industrial 
applications where complete biofilm removal is essential. It might involve acting 
on the matrix by depolymerizing either polysaccharides (Allison et a!., 1998; 
Chen and Stewart, 2000; Itoh et a!., 2005) or extracellular DNA (Whitchurch et 
ai., 2002). A number of detachment studies have been performed with bacterial 
biofilms (Boyd and Chakrabarty, 1994; Stoodley et aI., 2001; Hunt et aI., 2004; 
Kaplan et a!., 2004; Marion et aI., 2006). Currently, there are no reports of 
detachment studies with Candida biofilms. 
The aim of the work presented here was to investigate further the biofilm 
matrix by determining whether Candida biofilms could be enzymically detached 
from plastic surfaces by degradation of the matrix polymers. An assay devised by 
Kaplan and co-workers (2004) for S. epidermidis biofilms was used together with 
a collection of commercially available enzymes of known specificity. Both C. 
albicans and C. tropicalis biofilms were examined. 
The results clearly showed that biofilms of C. albicans were unaffected 
by lipase type VII, phospholipase A2 and protease type XIV. However, treatment 
with proteinase K, chitinase, DNase I and ,B-N-acetylglucoaminidase resulted in a 
significant decrease in optical density suggesting that these enzymes partially 
degraded matrix material and caused some biofilm detachment from the surfaces 
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of the wells. It is known that the yeast lytic activity can be attributed to a fJ-l,3-
glucanase, although lytic fJ-l,6-glucanases have been characterized (Rombouts 
and Phaff, 1976). Interestingly, the lyticase enzyme, which hydrolyses fJ-l,3 
glucan, had by far the greatest effect, causing an 85% reduction in optical density 
(Table 14). This result suggests that some of the glucose present in the C. 
albicans matrix could be present as fJ-l,3 glucan, a polysaccharide which is also 
a major structural component of the cell wall. 
Biofilms of C. tropicalis responded rather differently to the enzyme 
treatments (Table 15). Phospholipase A2, protease type XIV, proteinase K, 
DNase I and j3-N-acetylglucosaminidase all had no significant effect. By 
contrast, treatment with lipase type VII and chitinase did appear to produce some 
biofilm detachment. Chitinase had a similar effect with biofilms of both C. 
tropicalis and C. albicans, indicating that most of the hexosamine present in the 
C. tropicalis matrix was unlikely to be chitin. It could, instead, be in the form of 
a chitinase-resistant fJ-l,6 linked polysaccharide like that found in S. epidermidis 
and other biofilm-forming bacteria (Mack et a!., 1996; Cramton et a!., 1999; 
Stark et a!., 1999; Kaplan et a!., 2003b). 
Related studies by Kaplan et al. (2003b) have identified a family 20 
glycosyl hydrolase produced by Actinobacillus actinomycetemcomitans that 
causes the detachment of cells from A. actinomycetemcomitans biofilms grown 
and attached to plastic surfaces. This enzyme, called dispersin B, is an N-
acetylglucosaminidase, which degrades an N-acetylglucosamine-containing 
extracellular polysaccharide that mediates A. actinomycetemcomitans 
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intercellular adhesion. The same enzyme also rapidly and efficiently removed S. 
epidermidis biofilms from plastic surfaces (Kaplan et aI., 2003a). 
The greatest effect on C. tropicalis biofilms was again observed with 
lyticase, which caused a reduction in optical density of over 53% (Table 15). 
However, lyticase had less effect on these biofilms than on those of C. albicans 
whose matrix material contains substantially more glucose (Table 14). 
Further experiments were carried out to investigate possible lysis of 
Candida biofilm cells during their exposure to lyticase by resuspending the cells 
after enzyme treatment in 1 M sorbitol buffer, and comparing the optical density 
with that of suspensions of control (untreated) biofilm cells. With C. albicans, 
exposure to lyticase reduced the optical density readings of the suspensions, 
suggesting that there could have been some cell lysis during the enzyme 
treatment. Alternatively, the reduction in optical density could simply have been 
due to dissolution of some of the matrix material. The latter explanation seems 
more likely, since suspensions of C. tropicalis showed no such reduction, even 
though lyticase is known to induce protoplast formation with this organism (Su 
and Meyer, 1991). 
It is generally assumed that nucleic acids are localized inside living cells 
and that their primary function is the storage of information; extracellular DNA 
(eDNA) is mainly considered to be a remnant of lysed cells. Early studies 
suggested that P. aeruginosa excretes large amounts of eDNA through a 
mechanism independent of cellular lysis and that appeared to involve the release 
of small vesicles from the outer membrane (Hara and Veda, 1981; Muto and 
Goto, 1986). P. aeruginosa produces a large amount of eDNA during alginate 
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biosynthesis, and this is clearly essential for the initial stages of biofilm 
formation (Steinberger et al., 2002; Whitchurch et al., 2002). A recent 
publication by Allesen-Holm et al. (2006) demonstrated that eDNA in P. 
aeruginosa biofilms and cultures is generated via lysis of a subpopulation of the 
bacteria. The authors also found a link between DNA release and quorum 
sensing in planktonic cultures. Their results indicated that the eDNA is generated 
via a mechanism which is dependent on acyl homo serine lactone and 
Pseudomonas quinolone signalling, as well as on flagella and type IV pili. 
Microscopic investigation of flow chamber-grown biofilms revealed that the 
eDNA was located mainly in the stalks of mushroom-shaped multicellular 
structures with a high concentration particularly in the outer part of the stalks 
forming a border between the stalk-forming bacteria and the cap-forming 
bacteria (Alles en-Holm et al., 2006). 
Whitchurch and his colleagues (2002) previously showed that eDNA is 
essential for biofilm stability during the early stages of biofilm growth. On the 
other hand, Molin and Tolker-Nielsen (2003) noted that the eDNA may enhance 
gene transfer between biofilm constituent organisms; it may also provide 
nutrition during oligotrophic conditions (Finkel and Kolter, 2001). Petersen et al. 
(2005) studied the importance of eDNA in the growth of biofilms of 
Streptococcus mutans. The authors found that the addition of synthetic 
competence signalling peptide (sCSP) to biofilms caused an increase in the 
growth of biofilms (biomass); however, the addition of DNase I enzyme reversed 
the effect of the addition of sCSP, showing the importance of DNA for increased 
biomass (Petersen et al., 2005). As a result of all these investigations, it has been 
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concluded that DNA is a major structural component of the extracellular matrix 
of bacterial biofilms (Starkey et al., 2004; Spoering and Gilmore, 2006). 
The results of the present study indicate that DNase I had no effect on C. 
tropicalis biofilms but did cause some detachment of C. albicans biofilms. The 
presence of DNA in the C. albicans matrix would be consistent with the higher 
phosphorus content of the matrix of this organism (Table 12). Biofilms of C. 
tropicalis, but not those of C. albicans, were partially detached by treatment with 
lipase type VII, but both were resistant to the action of phospholipase A2• In this 
context, it is interesting to note that C. tropicalis is capable of producing a 
fibrillar layer containing mannoprotein with covalently-linked fatty acids 
(Kappeli and Fiechter, 1977; Kappeli et al., 1984). 
Other studies have shown that not only is DNA continuously present in 
the matrix material of P. aeruginosa biofilms but in fact is the most abundant 
constituent polymer (Steinberger and Holden, 2004). Interestingly, P. aeruginosa 
biofilm formation was inhibited by addition of DNase I, although DNase I did 
not inhibit planktonic bacterial growth. This observation implies that DNA 
provides an important structural component for biofilm formation (Whitchurch et 
al., 2002). It is possible that, eDNA occurring in vivo might derive from 
neutrophils. Analysis of cystic fibrosis (CF) sputum demonstrated high 
concentrations of granule proteins, actin, and DNA released from necrotic 
neutrophils (Goldstein and Doring, 1986; Sheils et al., 1996). Neutrophil actin 
and DNA have been observed to bind together, forming polymers that increase 
the viscosity of the sputum (Lethem et al., 1990). A recent study showed that the 
presence of neutrophils enhances initial P. aeruginosa biofilm formation through 
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the formation of polymers comprised of actin and DNA. The authors reported 
that the addition of DNase I abolished much of the neutrophil-induced 
enhancement of biofilm formation without significantly inhibiting bacterial 
growth or neutrophil survival (Walker et ai., 2005). Several researchers 
(Whitchurch et ai., 2002; Gibson et ai., 2003) have suggested that DNase I 
treatment in combination with antibiotics might be beneficial as a early 
prophylatic measure to prevent the establishment of infection in CF patients by 
inhibiting biofilm formation. 
5 Concluding remarks 
This study has shown that a variety of antifungal agents are able to 
penetrate biofilms of C. albicans and other Candida species at different rates and 
reach high concentrations (many times the MIC) at the distal edge of the biofilm. 
However, durg penetration fails to produce complete killing of biofilm cells 
suggesting that poor antifungal penetration is not a major drug resistance 
mechanism for Candida biofilms formed under static conditions. On the other 
hand, the drug resistance of C. albicans biofilms can be significantly enhanced 
by increased production of matrix material under flow conditions in the MRD, 
and by the presence of one or more matrix polymers of S. epidermidis in mixed 
species biofilms. Moreover, biofilms of C. tropicalis whose matrix material 
contains hexosamine as the major sugar substituent are less susceptible to 
antifungal agents than C. albicans biofilms where hexosamine is replaced by 
glucose. Overall, the results demonstrate that the matrix can make a significant 
contribution to drug resistance in Candida biofilms, especially under conditions 
similar to those found in catheter infections in vivo, and that the composition of 
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the matrix material is an important determinant in resistance. However, the 
mechanism of biofilm drug resistance is likely to be multifactorial involving, in 
addition, drug-resistance physiologies such as dormant 'quiescent' cells and 
expression of efflux pumps. 
To extend this study further, it would be interesting to investigate the 
matrix composition of some of the other non-Co albicans Candida species. It 
could be predicted, for example, that C. parapsilosis matrix, like that of C. 
tropicalis, contains mainly hexosamine since biofilms of both these species show 
poor drug penetration. On the other hand, biofilms of C. krusei and C. glabrata 
which, like those of C. albicans strains, are penetrated fairly rapidly by 
antifungal drugs might be expected to contain glucose as a major matrix 
component. 
Investigation by viscometry of possible rheological interactions between 
matrix polymers produced by C. albicans and S. epidermidis might also prove 
informative. Such interactions could produce a more viscous matrix thereby 
further inhibiting drug penetration. Rheological interactions between matrix 
polysaccharides from Pseudomonas (now Burkholderia) cepacia and P. 
aeruginosa have previously been shown to decrease the rates of diffusion and 
antimicrobial activities of antibiotics (Allison and Matthews, 1992). Similar 
studies with C. albicans and S. epidermidis matrix polymers should provide 
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Appendix 1. Medium 
1.1 Yeast Nitrogen Base (YNB) 






















































1.2 Sabouraud Dextrose Agar (SDA) 











Autoc1aved for 15 min at 15 lbs pressure (121 °C). Final pH 5.6 ± 0.2 at 25°C. 
1.3 Tryptic Soy Broth (TSB) 













Sterilization was by autoc1aving for at 121°C for 15 minutes. Final pH 7.3 ± 0.2 at 
25°C. 
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Appendix 2. Buffers 
2.1 0.15 M Phosphate-buffered saline (PBS) 
Phosphate buffered saline tablet 
Chemical 






Phosphate buffered saline tablets were used. Each tablet added to 200 ml distilled 
water yields 0.01 M phosphate buffer, 0.0027 M potassium chloride and 0.137 M 
sodium chloride. The solution was autoc1aved at 121°C for 15 min. The pH of the 
subsequent solution was 7.2, at 25°C. 
2.2 0.1 M citric acid - 0.2 M disodium hydrogen phosphate buffer (pH 5 and 
pH 6) 
Chemical 
Solution (A) 0.1 M citric acid 
C6Hs07H20 
Distilled water 








Solutions were made up and mixed to give the appropriate pH. 
• To prepare 0.1 M citric acid - 0.2 M disodium hydrogen phosphate buffer (pH 
5),48.50 ml of solution A was mixed with 51.50 ml of solution B. 
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• To prepare 0.1 M citric acid - 0.2 M disodium hydrogen phosphate buffer (pH 
6),36.85 ml of solution A was mixed with 63.15 ml of solution B. 
2.3 0.2 M disodium hydrogen phosphate - sodium dihydrogen phosphate 
buffer (pH 7) 
Chemical 
Solution (A) 0.2 M disodium hydrogen phosphate 
Na2HP04 
Distilled water 








Solutions were made up and mixed to give the appropriate pH. 
To prepare 0.2 M disodium hydrogen phosphate - sodium dihydrogen phosphate 
buffer (pH 7),30.50 ml of solution A was mixed with 19.50 ml of solution B. 
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2.4 0.2 M Tris maleate - sodium hydroxide buffer (pH 8) 
Chemical Quantity 
Solution (A) 0.2 M tris-maleate 
Tris 2.40 g 
Maleic acid 23.2 g 
Distilled water 1000 ml 
Solution (B) 0.2 M Na OH 
NaOH 8.0 g 
Distilled water 1000 ml 
To obtain (pH 8), 25 ml of solution A was mixed with 34.50 ml of solution B. 
Appendix 3. Antimicrobial disinfectant 
3.1 0.05 % Chlorhexidine gluconate 
Antimicrobial prepared for cleaning and sterilising MRD 
Chemical 






Appendix 4. Chemical analysis of extracellular polymeric 
substances (EPS) 
4.1 Estimation of total carbohydrate by the phenol-sulphuric acid method 
(Dubois et al. 1956) 
Reagents: 
(A) Concentrated sulphuric acid 
(B) 80% (w/v) phenol 
Procedure: 
Carbohydrate samples containing 10-70 Ilg of sugar in 2 ml were used; 0.05 
ml of the phenol reagent was added to each solution, followed by the rapid 
addition of 5.0 ml of concentrated sulphuric acid. Samples were left at room 
temperature for at least 30 min and the absorbance at 485 nm recorded. 
4.2 Estimation of total protein using the Lowry method (Lowry et al. 1951) 
Reagents: 
(A) 2% Na2S03 in O.lM NaOH 
(B) 0.5% CuS04.5H20 in 1 % sodium tartrate (separate double strength solutions 
mixed 1: 1 before use) 
(C) Folin-Ciocalteau reagent diluted 1:1 with distilled water 
(D) 50 volumes of reagent A mixed with 1.0 volume of reagent (B), renewed 
daily. 
Procedure: 
Protein samples containing 25 to 100 Ilg protein in 1.0 ml were used. 
Solution D (5ml) was added to each tube and the contents mixed and allowed to 
stand at room temperature for at least 10 min. Solution C (0.5 ml) was added 
rapidly with immediate mixing. All solutions were allowed to stand for 30 min at 
room temperature before their absorbance at 750 nm was recorded. 
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4.3 Estimation of phosphorus (Chen et al. 1956) 
Reagents required: 
1. Digestion mixture: Conc. H2S04: 60% HCI04 (3:2; v / v) 
2. Colour reagent: 
1 volume 6 M sulphuric acid 
2 volumes distilled water 
1 volume 2.5 % (w / v) ammonium molybdate 
1 volume 10 % (w / v) ascorbic acid 
• Reagent should be prepared fresh, just before use. 
Appendices 
3. Standard KH2P04 solution (10 /J.g P/ ml). Dissolve 87.8 mg KH2P04 and make 
up to 100 ml with distilled water. Then dilute 5 ml from the concentrated solution 
KH2P04 and make up to 100 ml with distilled water; the solution contains lO/J.g 
phosphorus/m!. 
Digestion procedure: 
A few carborundum chips were added to duplicate samples of EPS solutions 
in pyrex tubes. The samples were evaporated to dryness in an oven set at 140°C 
for 1 h. Digestion mixture (0.1 ml) was added to each tube and the mixture was 
heated again for 1 h at 140°C. The tubes were allowed to cool for the estimation 
of phosphorus in the digestion mixture. 
Assay procedure: 
To the digestion mixture, 3.9 ml of water was added followed by 4.0 ml 
colour reagent, and samples were mixed by inversion. Tubes were incubated at 
37°C for 1.5-2 h, and the absorbance at 820 nm recorded. 
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4.4 Estimation of uronic acid (Bitter and Muir, 1962) 
Reagents: 
(A) 0.025 M sodium tetraborate - lOHzO in concentrated sulphuric acid. 
(B) 0.125 % carbazole in absolute ethanol. 
Procedure: 
Solution A (3 ml) was placed in tubes, cooled to 4°C, and 0.5 ml of sample, 
containing 4-40 f.1.g uronic acid, carefully layered on top. Tubes were closed with 
ground glass stoppers and shaken gently at first, then vigorously, with constant 
cooling. Tubes were heated for 10 min in a boiling water bath and then cooled to 
room temperature. Carbazole reagent (0.1 ml) was added and the tubes were 
shaken, and then heated in a boiling water bath for a further 15 min. After cooling, 
the absorbance of each solution at 530 nm was recorded. 
4.5 Estimation of hexosamine (Blumenkrantz and Asboehansen, 1976) 
Reagents: 
Acetylacetone: 3.5 % (v/v) in sodium phosphate-potassium tetraborate solution 
(98 ml of 1M trisodium phosphate + 2 ml of O.5M potassium tetraborate). 
Ehrlich's reagent: 3.2 g p-dimethylaminobenzaldehyde dissolved in 30 ml of 
concentrated HCI and diluted with 210 ml propan-2-ol. 
Preparation of sample: 
Prior to analysis, samples (50f.1.1) were hydrolysed in sealed ampoules with 
equal an volume of 4 M HCI for 12-14 h at 100°C. After hydrolysis, the 
hydrochloric acid was neutralized with 0.5 NaOH for and the samples were dried 
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overnight (over NaOH pellets) at room temperature. Samples were redissolved in 
distilled water ready for analysis. 
Procedure: 
Samples containing 20-80 Ilg hexosamine in 0.8 ml were added to 0.6 ml of 
acetylacetone reagent in glass-stoppered tubes and the mixture heated for 30 min 
in a boiling water bath. Ehrlich's reagent (2.0 ml) was added to each tube and the 
absorbance at 535 nm measured. 
4.6 Enzymic determination of glucose (Glucose (GO) assay kit; Sigma) 
Reagents: 
1. Glucose oxidase / peroxidase reagent: 
Each capsule contains 500 units of glucose oxidase (Aspergillus niger), 100 
purpurogallin units of peroxidase (horseradish) and buffer salts; the contents of 
the capsule are dissolved in 39.2 ml of deionized water. 
2. 0-Dianisidine reagent: 
Vial contains 5 mg of o-dianisidine dihydrochloride. Reconstitute the vial with 1.0 
m1 of deionized water. Invert the vial several times to completely dissolve. 
3. Assay reagent: 
This is prepared by adding 0.8 ml of the o-dianisidine reagent to the glucose 
oxidase/peroxidase reagent. Invert bottle several times to mix properly. 
4. Glucose standard solution: 
D-Glucose, 1.0 mg/ml in 0.1 % benzoic acid. Supplied ready to use. 
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Sample preparation: 
Prior to glucose analysis, EPS samples from C. albicans GDH 2346 (0.5 ml 
of 2 mg/ml solution of EPS) were hydrolysed in 1.0 M HCI (0.5ml) for 5 h in 
sealed ampoules at 100°C then neutralized with 0.5 M NaOH (l.Oml). For C. 
tropicalis AAHB 73, samples (0.25m1 of 5.9 mg/ml solution of EPS) were 
hydrolysed in l.0 M HCI (0.25m1) for 5 h in sealed ampoules at 100°C then 
neutralized with 0.5 M NaOH (0.5ml). Glucose contents of samples were 
estimated by using glucose (GO) assay kit. 
Procedure: 
Samples contained 20-80 Ilg glucose in 1.0 m1 of deionized water. At zero 
time, the reaction was started by adding 2.0 m1 of assay reagent to the first tube 
and mixing. Intervals of 30 seconds were allowed between additions of assay 
reagent to each subsequent tube. The tubes were incubated for 30 min at 37°C, 
and then 2.0 ml of 12 M H2S04 was added to each tube to stop the reaction. After 
careful mixing, the absorbance of each mixture was measured against the reagent 
blank at 540 nm. 
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Appendix 5. Standard curves for chemical analysis of EPS 
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Poster abstract 
THE CANDIDA BIOFILM MATRIX: COMPOSITION AND ROLE IN 
DRUG RESISTANCE * 
J. Douglas. M. Al-Fattani: University of Glasgow, Glasgow, UNITED KINGDOM. 
One of the most distinctive features of microbial biofilms is that the 
microorganisms are embedded in an extracellular matrix. Relatively little is 
known about the composition of the matrix, even in well-studied biofilm systems, 
although it is generally considered to contain one or more exopolysaccharides as 
major components. In this study, the chemical composition of matrix material 
from Candida albicans GDH 2346 was compared with that of matrix material 
from Candida tropicalis AAHB 73. A physical extraction process was used which 
involved sonication, vortexing and centrifugation of biofilms formed on sections 
of catheter tubing. The yield of matrix material from biofilms of C. tropicalis was 
substantially higher than that from biofilms of C. albicans. C. tropicalis AAHB 
73 was originally isolated from a line infection and had a very slimy appearance 
on solid medium, suggestive of the production of copious amounts of extracellular 
polymer. Matrix material isolated from biofilms of both Candida species 
contained carbohydrate, protein, hexosamine, phosphorus and uronic acid. 
However, in C. albicans, glucose was the major sugar component, whereas in C. 
tropicalis this was replaced by hexosamine. Biofilms of C. albicans were grown 
under conditions of continuous flow (60 ml/h) in a modified Robbins device 
(MRD) which is an in-vitro system used for modelling catheter infections. These 
biofilms produced more matrix material than those grown statically, as 
determined by scanning electron microscopy, and were significantly more 
resistant to amphotericin B (at up to 30 times the MIC). Biofilms of C. tropicalis 
could not be grown in the MRD because the copious amounts of extracellular 
material synthesized by this organism blocked the liquid flow. However, biofilms 
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of C. tropicalis produced large amounts of matrix material even when grown 
statically, and such biofilms were completely resistant to amphotericin B. Mixed-
species biofilms of C. albicans and a slimy strain of Staphylococcus epidermidis 
(RP62A), when grown in the MRD, were also completely resistant to 
amphotericin B. The matrix material of S. epidermidis, like that of C. tropicalis, 
contains large amounts of hexosamine present as a polysaccharide of beta 1-6 
linked N-acetylglucosamine residues, and production of this polymer has been 
related to S. epidermidis virulence in catheter infection models in animals. 
Overall, our results demonstrate the importance of matrix production and 
composition, and its contribution to drug resistance in Candida biofilms under 
conditions similar to those found in catheter infections in vivo. 
Presented at 8th ASM conference on Candida and Candidiasis, Denver, Colorado, 
March 2006. 
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Penetration of Candida Biofilms by Antifungal Agents 
Mohammed A. Al-Fattani and L. Julia DougJas* 
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of 
Glasgow, Glasgow, United Kingdom 
Received 20 April 2004/Returned for modification 4 May 2004/Accepted 25 May 2004 
A filter disk assay was used to investigate the penetration of antifungal agents through biofilms containing 
single and mixed-species biofilms containing Candida. Fluconazole permeated all single-species Candida 
biofilms more rapidly than flucytosine. The rates of diffusion of either drug through biofilms of three strains 
of Candida albicans were similar. However, the rates of drug diffusion through biofilms of C. glabrata or C. krusei 
were faster than those through biofilms of C. parapsilosis or C. tropicalis. In all cases, after 3 to 6 h the drug 
concentration at the distal edge of the biofilm was very high (many times the MIC). Nevertheless, drug 
penetration failed to produce complete killing of biofilm cells. These results indicate that poor antifungal 
penetration is not a major drug resistance mechanism for Candida biofilms. The abilities of flucytosine, 
fluconazole, amphotericin B, and voriconazole to penetrate mixed-species biofilms containing C. albicans and 
Staphylococcus epidermidis (a slime-producing wild-type strain, RP62A, and a slime-negative mutant, M7) were 
also investigated. All four antifungal agents diffused very slowly through these mixed-species biofilms. In most 
cases, diffusion was slower with biofilms containing S. epidermidis RP62A, but amphotericin B penetrated 
biofilms containing the M7 mutant more slowly. However, the drug concentrations reaching the distal edges of 
the biofilms always substantially exceeded the MIC. Thus, although the presence of bacteria and bacterial 
matrix material undoubtedly retarded the diffusion of the antifungal agents, poor penetration does not account 
for the drug resistance of Candida biofilm cells, even in these mixed-species biofilms. 
Candida albicans is the major fungal pathogen of humans 
(10). During recent years this organism, together with related 
Candida species, has become one of the commonest agents of 
hospital-acquired infections (18). Many of these are implant-
associated infections, in which adherent microbial populations, 
or biofilms, are found on the surfaces of devices, including 
catheters, prosthetic heart valves, endotracheal tubes, and joint 
replacements (15, 17). Such infections can be caused by a 
single microbial species or by a mixture of fungal or bacterial 
species (13, 28). Individual organisms in biofilms are embed-
ded within a matrix of frequently slimy, extracellular polymers 
and typically display a phenotype that is very different from 
that of planktonic (free-floating) cells. In particular, biofilm 
cells are significantly less susceptible to antimicrobial agents 
(16, 17, 19, 34). As a result, drug therapy for an implant 
infection may be futile, and often, the only solution is mechan-
ical removal of the implant (13). 
Various model systems have been used to investigate the 
properties of Candida biofilms in vitro (17). These range from 
simple assays with catheter disks to more complex flow sys-
tems, such as the perfused biofilm fermentor (7). Biofilms of C. 
albicans usually consist of a mixture of yeasts, hyphae, and 
pseudohyphae and may have a basal yeast layer that anchors 
the biofilm to the surface (8). The cells are surrounded by a 
matrix of extracellular polymeric material, the synthesis of 
which markedly increases when developing biofilms are ex-
posed to a liquid flow (24). Results from several studies have 
shown that Candida biofilms are resistant to clinically impor-
* Corresponding author. Mailing address: Division of Infection and 
Immunity, Institute of Biomedical and Life Sciences, University of 
Glasgow, Glasgow G12 8QQ, United Kingdom. Phone: 44 141 330 
5842. Fax: 44 141 3304600. E-mail: J.Douglas@bio.gla.ac.uk. 
3291 
tant antifungal agents, including amphotericin B, fluconazole, 
flucytosine, itraconazole, and ketoconazole (6, 11, 12, 23, 31, 
37,38). Newer azoles (voriconazole and ravuconazole) are also 
ineffective against biofilms (29), although some antibiofilm ac-
tivity has been demonstrated with the echinocandin caspofun-
gin in vitro (4, 29, 39). Mixed Candida-Staphylococcus biofilms 
are similarly resistant to fluconazole, and there is evidence that 
the bacteria can enhance Candida resistance (1). 
The mechanisms of biofilm resistance to antimicrobial 
agents are not fully understood. One long-standing hypothesis 
for the resistance of bacterial biofilms is that the matrix mate-
rial restricts drug penetration by forming a reaction-diffusion 
barrier (19) and that only the surface layers of a biofilm are 
exposed to a lethal dose of antibiotic. The extent to which the 
matrix acts as a barrier to drug diffusion would depend on the 
chemical nature of both the antimicrobial agent and the matrix 
material. Several research groups have investigated antibiotic 
penetration in Pseudomonas aeruginosa biofilms (26, 30, 42, 
44). The overall conclusion from that work was that fluoro-
quinolones penetrate P. aeruginosa biofilms readily, whereas 
the penetration of aminoglycosides is retarded. Further studies 
suggested that aminoglycosides diffuse more slowly because 
they bind to matrix polymers such as alginate (20, 21, 36). 
Analogous investigations with Candida species have not been 
reported. However, the drug susceptibility profiles of C. albi-
cans biofilms incubated statically (which have relatively little 
extracellular matrix material) were compared with those of 
biofilms incubated with gentle shaking (which produce much 
more matrix material). Biofilms grown with or without shaking 
did not exhibit significant differences in susceptibilities to am-
photericin B, flucytosine, or fluconazole, suggesting that drug 
resistance is unrelated to the extent of matrix formation (9). 
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tration of antifungal agents through Candida biofilms using a 
filter disk assay adapted from the technique reported by 
Ander! et al. (3) for bacterial biofilms. The abilities of flucy-
tosine and fluconazole to permeate biofilms of C. albicans and 
related Candida species were evaluated in this way. In parallel, 
the viabilities of drug-treated biofilm cells were determined. 
The drug penetration of mixed-species biofilms containing C. 
albicans and Staphylococcus epidennidis (a slime-producing 
wild-type strain and a slime-negative mutant) was also as-
sessed. S. epidennidis is the organism most frequently isolated 
from bacterial implant-associated infections and has also been 
found in polymicrobial infections with C. albicans (28). Vori-
conazole and amphotericin B, as well as flucytosine and flu-
conazole, were used in these mixed-species experiments. 
MATERIALS AND METHODS 
Organisms. C. albicans GDH 2346 (NCYC 1467) and GDH 2023 were orig-
inally obtained from patients with denture stomatitis at Glasgow Dental Hospi-
tal; strain GRI 682 was from a vaginal smear at Glasgow Royal Infirmary. C. 
glabrata AAHB 12, C. tropicalis AAHB 73, and C. parapsilosis AAHB 4479 were 
isolated from patients with line infections at Crosshouse Hospital, Kilmarnock, 
Scotland. C. krusei was obtained from a clinical specimen and came from the 
Regional Mycology Reference Laboratory, Glasgow, Scotland. All strains were 
maintained on slopes of Sabouraud dextrose agar (Difco) and were subcultured 
monthly. Every 2 months, cultures were replaced by new ones freshly grown from 
freeze-dried stocks. 
Two strains of S. epidermidis (RP62A and M7) were maintained on Colombia 
blood agar (Oxoid). Strain RP62A (ATCC 35984) is a known slime producer; 
strain M7 is a slime· negative mutant obtained after chemical mutagenesis of S. 
epidermidis RP62A with mitomycin C (41). The growth rate, initial adherence, 
cell wall composition, surface characteristics, and antimicrobial susceptibility 
profile of strain M7 are indistinguishable from those of wild-type strain RP62A 
( 41). 
Medium and culture conditions. All Candida species were grown in yeast 
nitrogen base (YNB) medium (Difco) containing 50 mM glucose. Batches of 
medium (50 ml in 250-ml Erlenmeyer flasks) were inoculated from fresh slopes 
and incubated at 37°C for 24 h in an orbital shaker at 60 rpm. Cells were 
harvested and washed twice in 0.15 M phosphate-buffered saline (PBS; pH 7.2). 
Before use in biofilm experiments, all washed cell suspensions were adjusted to 
an optical density at 600 nm of 0.2. 
Tryptic soy broth (Difco) was selected as the liquid medium best able to 
support the growth of both fungi and bacteria. C. albicans GDH 2346 and the two 
strains of S. epidermidis (strains RP62A and M7) grew at similar rates in this 
medium (1). Cultures were inoculated from fresh slopes and incubated with 
shaking at 3rC for 24 h. Cells were harvested, washed twice in PBS, and 
suspended to an optical density at 600 nm of 0.2 prior to use in biofilm experi-
ments. For mixed-species biofilms, equal volumes of the standardized suspension 
of each organism were mixed immediately before use. 
Biofilm formation. Biofilms were grown on membrane filters resting on agar 
culture medium in petri dishes. For experiments with Candida species, polycar-
bonate membrane filters (diameter, 25 mm; pore size 0.2 J1m; Whatman) were 
sterilized by exposure to UV radiation for 15 min on both sides prior to inocu-
lation and were then placed on the surface of YNB agar containing 50 mM 
glucose. Tryptic soy agar was used for S. epidermidis and mixed-species biofilms. 
A standardized cell suspension (50 J11) was applied to the surface of each sterile 
membrane. All plates were incubated at 3rC for 24 h. The membrane-supported 
biofilms were then transferred to fresh agar for a further 24 h, giving a total 
incubation time of 48 h for biofilm formation. 
Penetration of biofilms by antifungal agents. Four clinically important anti-
fungal agents were used in this study. Flucytosine and amphotericin B were 
obtained from Sigma. Fluconazole and voriconazole were kindly donated by 
Pfizer Limited. All drug solutions were prepared immediately before use. Flucy-
tosine and fluconazole were dissolved in sterile distilled water and then added to 
molten culture medium at 50°C by use of a sterile filtration unit (Sartorius) to 
create antifungal agent-supplemented agar for the biofilm experiments. Vori-
conazole and amphotericin B were dissolved in dimethyl sulfoxide and filtered 
into the growth medium. The medium was buffered to pH 7 with 0.165 M 
morpholinepropanesulfonic acid buffer (Sigma). High drug concentrations were 
used in the antifungal agent-supplemented agar. They were selected on the basis 
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of their ability to give large zones of growth inhibition in control assays for drug 
penetration outlined below. The concentrations used were as follows: flucytosine, 
6 J1g!ml (30 times the MIC for planktonic C. albicans GDH 2346); fluconazole, 
24 J1g!ml (60 times the MIC); voriconazole 10 J1g!ml (220 times the MIC); and 
amphotericin B, 78 J1g!ml (60 times the MIC). 
Penetration of antifungal agents through biofilms was assessed by a modifica-
tion of the filter disk technique described previously for bacterial biofilms (3). 
After biofilm formation on membrane filters, smaller polycarbonate membrane 
filters (diameter, 13 mm; pore size, 0.2 J1m; Whatman) were sterilized by expo-
sure to UV radiation for 15 min on both sides and were then carefully placed on 
top of the 48-h-old biofilms. Paper concentration disks (diameter, 6 mm; Becton 
Dickinson) were also sterilized by exposure to UV radiation for 15 min per side 
and then moistened with growth medium (normally 29 J11) prior to placement on 
top of the 13-mm-diameter membranes. Because of an occasional variation in 
disk thickness, a slightly higher or lower volume of medium was sometimes 
required to saturate the disks. Wetting of the disks helped prevent the capillary 
action of the antifungal medium through the biofilms. Biofilms sandwiched 
between the membranes and moistened disks were transferred to antifungal 
agent-containing agar medium. All plates were incubated for specified exposure 
times, namely, 60, 90, 120, 180, 240, or 360 min. 
The amount of antifungal agent which had penetrated each biofilm and which 
had reached the concentration disk was determined by using the disk in a 
standard drug diffusion assay. Plates of YNB agar containing 200 mM glucose 
were seeded with 150 J11 of a standardized suspension of planktonic C. albicans 
GDH 2346 (used here as an indicator organism and adjusted to an optical density 
at 520 nm of 1.0). After the appropriate exposure time, concentration disks were 
removed from the biofilm "sandwiches" and placed on the seeded plates, which 
were then incubated at 3rC for 24 h. The zones of growth inhibition were 
measured and used to determine the concentration of active antifungal agent in 
the disks by reference to a standard curve prepared by using drug solutions of 
different concentrations but fixed volumes. All drug penetration assays were 
carried out in duplicate on at least two separate occasions. In control assays, 
concentration disks were placed on the two-membrane system to which no cells 
had been added, i.e., the unit without the biofilm. The drug concentration that 
penetrated the biofilms (C) was divided by the drug concentration determined 
for the controls (Co) to provide a normalized penetration curve (3). 
Viable counts of biofilm cells exposed to antifungal agents. After biofilm 
formation on 25-mm-diameter membrane filters, biofilms were capped with 
sterile, 13-mm-diameter filters, transferred to antifungal agent-containing agar, 
and incubated at 37°C for 6 h (the maximum exposure period in drug penetration 
assays) or 24 h. After incubation, biofilm cells were gently scraped from the 
membranes with a sterile scalpel and resuspended in 10 ml of PBS. Serial 
dilutions (10-1 to 10-6) of each biofilm cell suspension were then prepared. 
Triplicate samples (0.1 ml) of the 10-4, 10-5, and 10-6 dilutions were spread on 
YNB agar containing 200 mM glucose, and the plates were incubated at 37°C for 
24 h. In control assays, the membranes were transferred to growth medium 
containing no antifungal agent. 
Scanning electron microscopy (SEM). Biofilms of C. tropicalis and mixed-
species biofilms of C. albicans GDH 2346 and S. epidermidis M7 formed on 
polycarbonate membranes were fixed with glutaraldehyde and then treated with 
osmium tetroxide and uranyl acetate as described previously (22). After dehy-
dration in a series of ethanol solutions, samples were air dried in a desiccator for 
48 h, coated with gold with a Polaron coater, and viewed under a Philips 500 
scanning electron microscope. 
RESULTS 
In this study, we adapted a novel, filter disk assay devised by 
Ander! et al. (3) to investigate the penetration of antifungal 
agents through single- and mixed-species biofilms containing 
Candida. The technique involves the formation of a 48-h-old 
colony biofilm on a polycarbonate membrane filter and the 
capping of this biofilm with a second, smaller membrane filter 
and then a wetted paper disk of the type used in zone-of-
inhibition bioassays. The assembly, which represents a primi-
tive diffusion cell, is transferred to agar medium containing the 
antifungal agent. During subsequent incubation, the drug dif-
fuses out of the agar and through the biofilm sandwich to the 
moistened paper disk. The drug concentration in the disk can 
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FIG. 1. Penetration of f1ucytosine through biofilms of C. albicans 
GDH 2346 (closed triangles), C. albicans GDH 2023 (open squares), 
and C. albicans G RI 682 (open circles) ( a) and through biofilms of C. 
krusei (open squares), C. glabrata (open diamonds), C. parapsilosis 
(closed triangles), and C. tropicalis ( closed circles) (b). Error bars 
indicate the standard errors of the means. The mean Co after 6 h was 
22.7 fLg of f1ucytosine/mi. 
tion that it produces on medium seeded with an indicator 
strain of C. albicans in standard bioassays. The great advantage 
of this system is that because there is physical access to both 
sides of the biofilm, the penetration of solutes can be measured 
directly. Moreover, colony biofilms appear to lack the water 
channels that typically surround matrix-enclosed microcolonies 
in many other biofilms (46). The possibility that drugs simply 
move through water channels without reaching cells deep 
within the microcolonies is therefore largely eliminated by 
using this model system. 
Flucytosine penetration through Candida biofilms. The lev-
els of flucytosine penetration of biofilms of three C. albicans 
strains were similar, but they were initially lower with strain 
GDH 2346 (Fig. la). The drug concentration at the distal edge 
of the biofilm (Le., distal with respect to the agar) was approx-
imately 50% of that of the control value after 180 min. After 
240 min it had reached 63 to 78% of that of the control value 
(Fig.la). 
When biofilms of other Candida species were used, there 
was rapid penetration of the drug (approximately 50% of that 
for the control after 60 min) through both C. glabrata and C. 
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FIG. 2. Penetration of fluconazole through biofilms of C. albicans 
strain GDH 2346 (closed triangles), C. albicans GDH 2023 (open 
squares), and C. albicans GRI 682 (open circles) (a) and through 
biofilms of C. krusei (open squares), C. glabrata (open diamonds), C. 
parapsilosis (closed triangles), and C. tropicalis (closed circles) (b). 
Error bars indicate the standard errors of the means. The mean Co 
after 6 h was 26.6 fLg of f1uconazole/mi. 
imately 30% after 120 to 360 min. By contrast, there was slow 
diffusion through C. parapsilosis biofilms (25% by 360 min; Fig. 
1b). However, the slowest penetration was observed with C. 
tropicalis biofilms (approximately 15% after 360 min; Fig. 1b). 
Enzymatic degradation of flucytosine by C. glabrata and C. 
krusei did not occur. This was demonstrated by removing mem-
brane-supported biofilms from antifungal agent-containing 
plates and spreading a sensitive strain (strain GDH 2346) of C. 
albicans onto the plates. These indicator organisms were un-
able to grow on any part of the plate, including the location 
that had been beneath the biofilm (results not shown). 
Fluconazole penetration through Candida biofilms. Flucon-
azole penetration was similar and rapid for three C. albicans 
strains (approximately 90% of that for the control after 60 min; 
Fig. 2a). There was then a slight decrease and a leveling off at 
70% of the control value after 360 min. Interestingly, diffusion 
was much more rapid with fluconazole than with ftucytosine, 
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FIG. 3. Penetration of fiucytosine (a) and amphotericin B (b) 
through single- and mixed-species biofilms of C. albicans and S. epi-
dermidis. Biofilms contained C. albicans GDH 2346 (closed triangles), 
S. epidermidis RP62A (closed circles), S. epidermidis M7 (closed 
squares), C. albicans GDH 2346 and S. epidermidis RP62A (open 
circles), and C. albicans GDH 2346 and S. epidermidis M7 (open 
squares). Error bars indicate the standard errors of the means. Mean 
Cos after 6 h were 24.2 f.Lg of fiucytosine/ml and 120.6 f.Lg of ampho-
tericin B/m!. 
min (Fig. la and 2a). However, this represents a higher drug 
concentration with fluconazole. 
When non-Co albicans Candida species were used, there was 
rapid fluconazole penetration through biofilms of either C. 
glabrata or C. krusei, followed by a decrease to roughly 70% of 
the control value (Fig. 2b). The level of drug penetration 
through C. parapsilosis biofilms was zero after 60 min but then 
rose rapidly and leveled off at 65% of the control value. The 
slowest penetration was again with C. tropicalis biofilms (Fig. 
2b). For all non-Co albicans species, the overall level of pene-
tration of fluconazole (55 to 85%) was higher than that of 
flucytosine (15 to 50%; Fig. Ib and 2b). 
Penetration of antifungal agents through single- and mixed-
species biofilms of C. albicans and S. epidermidis. Flucytosine 
diffused through biofilms of C. albicans GDH 2346 fairly 
slowly, as noted above, with penetration of about 50% of the 
control value after 360 min (Fig. 3a). This value was slightly 
lower than that shown in Fig. la (65% after 360 min). In these 
experiments, however, the C. albicans biofilms, like the mixed-
species biofilms, were grown on tryptic soy agar rather than 
YNB agar. By contrast, the drug penetrated S. epidermidis 
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biofilms very poorly (Fig. 3a); there was approximately 12% 
penetration after 180 min for slime-negative mutant M7 and 
10% penetration after 240 min for wild-type strain RP62A. 
Mixed fungal-bacterial biofilms showed similarly slow and poor 
drug penetration, although diffusion was more rapid with Can-
dida-M7 biofilms than with Candida-RP62A biofilms (Fig. 3a). 
Despite its low solubility in water, amphotericin B diffused 
rapidly through biofilms of C. albicans GDH 2346 (65% of the 
control value after 60 min; Fig. 3b). Penetration through S. 
epidermidis biofilms was slower and less extensive. With mixed 
fungal-bacterial biofilms, drug diffusion was also slow and 
poor, but in this instance diffusion was faster through biofilms 
containing wild-type strain RP62A than through those contain-
ing slime-negative mutant M7 (Fig. 3b). Surprisingly, the Co of 
amphotericin B (Fig. 3 legend), like that of flucytosine (Fig. 1 
legend), was higher than the drug concentration in the agar. 
The reason for this is not clear. However, it is conceivable that 
during the drug penetration assay some drugs bind to the disk 
cellulose (thus effectively reducing their concentration in solu-
tion) but then are released during the zone-of-inhibition assay. 
Both fluconazole and the newer azole voriconazole diffused 
rapidly through biofilms of C. albicans GDH 2346, although 
penetration by fluconazole was more extensive (Fig. 4a and b). 
There was slower and poorer penetration of S. epidermidis 
biofilms. These drugs also diffused through mixed fungal-bac-
terial biofilms slowly, but fluconazole penetrated mixed bio-
films to a greater extent than any other antifungal agent tested 
(Fig. 4a). The diffusion of both azoles, like that of flucytosine, 
was more rapid with biofilms containing S. epidermidis M7 than 
with those containing wild-type strain RP62A (Fig. 4a and b). 
Effects of antifungal agents on the viability of biofilm cells. 
To assess the effects of the antifungal agents on biofilm cells, 
biofilms sandwiched between the two membranes, as in the 
drug penetration assay, were exposed to antifungal agent-con-
taining agar at 37°C for 6 h (the time period during which drug 
penetration was determined) or 24 h. Antifungal agents (flucy-
tosine or fluconazole) were present at concentrations identical 
to those used in the drug penetration assay. After incubation, 
the numbers of viable biofilm cells were determined by a stan-
dard procedure of serial dilution followed by plating. In no 
case did drug penetration result in the complete killing of 
biofilm cells (Table 1). C. glabrata AAHB 12 was wholly unaf-
fected by fluconazole after 6 h, but many strains of this species 
are known to be resistant to fluconazole even when they are 
grown in planktonic culture (14). The results with fluconazole 
overall were not unexpected, despite the high concentration 
used, since this drug is generally considered to be fungistatic 
only. However, a recent study (35) has demonstrated that flu-
conazole can be fungicidal under certain conditions. 
SEM. Biofilms of C. tropicalis had a very slimy appearance, 
suggestive of an extensive matrix, and were poorly penetrated 
by both flucytosine and fluconazole. C. tropicalis, whose ability 
to produce biofilms has received little attention, is able to grow 
in the form of yeast cells or filaments. Examination of the 
biofilms by SEM showed that they consisted of a dense cell 
network containing both morphological types. Many of the 
filaments appeared to lie parallel to each other in the form of 
bundles (Fig. 5). The procedure used for sample preparation 
allows clear visualization of biofilm cells but normally fails to 
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FIG. 4. Penetration of fluconazole (a) and voriconazole (b) 
through single- and mixed-species biofilms of C. albicans and S. epi-
dermidis. Biofilms contained C. albicans GDH 2346 (closed triangles), 
S. epidermidis RP62A (closed circles), S. epidermidis M7 (closed 
squares), C. albicans GDH 2346 and S. epidermidis RP62A (open 
circles), and C. albicans GDH 2346 and S. epidermidis M7 (open 
squares). Error bars indicate the standard errors of the means. Mean 
Cos after 6 h were 27.0 fLg of fluconazole/ml and 7.9 fLg of voricon-
azole/m1. 
material could still be seen adhering to and linking some of the 
cells, a finding consistent with the slimy appearance of C. 
tropicalis biofilms. 
Previous work (1) demonstrated that both strains of S. epi-
dennidis used here formed thick biofilms on catheter disks. 
However, wild-type strain RP62A, unlike mutant M7, pro-
duced abundant matrix material, or slime. The physical inter-
actions between staphylococci and C. albicans were more easily 
seen with the slime-free mutant (1). A similar examination of 
mixed-species biofilms of C. albicans GDH 2346 and S. epider-
midis M7 grown on polycarbonate membranes in this study 
also revealed multiple, adhesive interactions between bacterial 
and fungal cells. Staphylococci were clearly adherent to both 
yeasts and hyphae (Fig. 6). 
DISCUSSION 
The mechanisms that protect microorganisms in biofilms 
from antibiotics and biocides are still being elucidated. Cur-
rently, four mechanisms are under study: (i) slow penetration 
of the antimicrobial agent into the biofilm, (ii) an altered 
TABLE 1. Viability of biofilm cells of Candida species after 
exposure to flucytosine or fluconazole for 6 or 24 ha 
Viability (%) 
Organism Fiucytosine (6 11g1m1) Fluconazole (24 l1g1ml) 
6h 24 h 6h 24 h 
C. albicans 34.0 ± 2.3 28.9 ± 0.5 64.1 ± 1.7 81.0 ± 1.5 
GDH 2346 
C. albicans 45.6 ± 1.5 29.9 ± 1.6 73.0 ± 2.0 62.1 ± 1.4 
GDH2023 
C. albicans 38.2 ± 2.2 29.4 ± 0.9 67.6 ± 1.6 78.7 ± 2.9 
GRI682 
C. glabrata 15.8 ± 1.2 24.2 ± 0.6 101.7±1.1 81.1 ± 1.5 
AAHB 12 
C. krusei 71.3 ± 1.3 66.9 ± 0.5 74.4 ± 0.6 47.8 ± 1.2 
C. parapsilosis 74.9 ± 0.7 62.1 ± 1.5 67.4 ± 3.0 51.1 ± 1.2 
AAHB 479 
C. tropicalis 65.0 ± 1.8 40.5 ± 1.4 49.6 ± 0.9 37.7 ± 2.1 
AAHB73 
U Viability is expressed as a percentage of that of control cells incubated under 
identical conditions in the absence of antifungal agent. The results are means ::!: 
standard errors of the means of triplicate determinations. 
chemical microenvironment within the biofilm leading to zones 
of slow or no growth, (iii) adaptive responses to environmental 
stress, and (iv) the existence of persister cells that are pro-
tected from all types of antimicrobial insult (43). Almost all of 
this work is being done with bacterial biofilms. At present, no 
single mechanism seems to account for the exceptional resis-
tance of biofilm cells to a wide variety of antimicrobial agents. 
Instead, it is likely that two or more mechanisms operate to-
gether. All four mechanisms appear to depend on the multi-
cellular nature of biofilms. For example, when an antimicrobial 
agent fails to penetrate a biofilm, it is because the drug is 
reactively neutralized as it diffuses into a cell cluster. This 
process may involve enzymatic degradation of the drug or drug 
FIG. 5. Scanning electron micrograph of a 48-h-old colony (mem-
brane-supported) biofilm of C. tropicalis. Arrows indicate extracellular 
matrix material. Bar, 10 fLm. 
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FIG. 6. Scanning electron micrograph of a 48-h-old colony (mem-
brane-supported) biofilm of C. albicans GDH 2346 and S. epidermidis 
M7. Bar, 10 /-Lm. 
binding to charged extracellular polymers, but it is effective 
only when microorganisms are aggregated and exert their col-
lective neutralizing activity (43). 
In this study, we have investigated the penetration of anti-
fungal agents through single- and mixed-species biofilms 
formed by fungal pathogens in the genus Candida. Our results 
demonstrated that fluconazole permeated all single-species 
Candida biofilms more rapidly than f1ucytosine. The rates of 
diffusion of either drug through biofilms of three strains of C. 
albicans were similar. On the other hand, the rates of drug 
diffusion through biofilms of C. glabrata and C. krusei were 
faster than those through biofilms of C. parapsilosis and C. 
tropicalis. In all cases, the drug concentration reached at the 
distal edge of the biofilm was very high. However, drug pene-
tration failed to produce complete killing of biofilm cells even 
when the incubation period was extended from 6 to 24 h. These 
results indicate that poor drug penetration is not a major 
resistance mechanism for Candida biofilms. 
The biofilms showing the lowest levels of drug penetration, 
particularly with f1ucytosine, were those formed by C. para psi-
losis and C. tropicalis. The strain of C. tropicalis used in these 
experiments, a clinical isolate, had a very slimy appearance on 
solid medium, and some of this slime, or matrix material, could 
be seen when biofilm preparations were viewed under a scan-
ning electron microscope. As yet, nothing is known of the 
chemical composition of this material, but it could playa minor 
role in the drug resistance of C. tropicalis biofilms by slowing 
the diffusion of antifungal agents. The matrix of C. albicans 
biofilms has been isolated and shown to contain mainly carbo-
hydrate and protein, with a relatively high proportion (16%) of 
glucose (9). Recent work with P. aeruginosa has led to the 
identification of periplasmic glucans in biofilm cells which ap-
pear to sequester antibiotics and slow their diffusion, perhaps 
preventing them from reaching their sites of action in the 
ANTIMICROB. AGENTS CHEMOTHER. 
cytoplasm (33). It has also been postulated that the nature and 
amounts of extracellular glucans produced by oral streptococci 
from sucrose in dental plaque are major determinants retard-
ing acid diffusion (25). It will be interesting to determine 
whether the matrix material of C. tropicalis biofilms is espe-
cially rich in glucan polysaccharides. 
All four antifungal agents tested diffused very slowly through 
mixed-species biofilms containing C. albicans and either the 
wild-type or M7 mutant strain of S. epidennidis. In most cases, 
diffusion was slower with biofilms containing S. epidennidis 
RP62A, the wild-type, slime-producing strain. Curiously, how-
ever, amphotericin B penetrated biofilms containing the M7 
mutant more slowly. In all of these experiments with mixed 
fungal-bacterial biofilms, the drug concentrations reaching the 
distal edges of the biofilms substantially exceeded the MIC for 
C. albicans. Thus, although the presence of bacteria and bac-
terial matrix material undoubtedly retarded the diffusion of the 
antifungal agents, poor penetration does not account for the 
drug resistance of Candida biofilm cells, even in these mixed-
species biofilms. 
The nature of the extracellular matrix of S. epidennidis bio-
films is not fully established. It appears to contain a polymer of 
j3-1,6-linked N-acetylglucosamine residues with some deacety-
lated amino groups, as well as succinate and phosphate sub-
stituents (the intercellular polysaccharide adhesin) (32). A 
140-kDa accumulation-associated protein has also been iden-
tified (27). The M7 mutant, which fails to accumulate on glass 
surfaces (41) but which does form biofilms on polyvinyl chlo-
ride catheter disks (1), has been reported to lack this protein 
but nevertheless synthesizes intercellular polysaccharide adhe-
sin (27). Interactions between these polymers and those pro-
duced by C. albicans in mixed-species biofilms might result in 
a more viscous matrix. Rheological interactions between ma-
trix polysaccharides from Pseudomonas cepacia and P. aerugi-
nosa have been shown to decrease the rates of diffusion and 
antimicrobial activities of antibiotics (2). On the other hand, a 
recent study of oral biofilms containing six microbial species, 
including C. albicans, suggested that retarded diffusion of flu-
orescent probes through the biofilm was due to tortuosity, i.e., 
the convoluted paths traversed by macromolecules during bio-
film penetration (45). 
Biofilm cells appear to grow slowly because of the limited 
availability of nutrients, especially at the base of the biofilm. 
Growth rate has therefore been considered as an important 
modulator of drug activity in biofilms (17, 19). A perfused 
fermentor was used to generate C. albicans biofilms at different 
growth rates, and the susceptibility of the biofilm cells to am-
photericin B was compared with that of planktonic organisms 
grown at the same rates in a chemostat. The results indicated 
that biofilms were resistant to the drug at all growth rates 
tested, whereas planktonic cells were resistant only at low 
growth rates (5). An alternative mechanism of drug resistance 
might be upregulation of genes coding for multidrug efflux 
pumps in biofilm cells. C. albicans possesses two different types 
of efflux pump: ATP-binding cassette transporters and major 
facilitators, which are encoded by CDR and MDR genes, re-
spectively. Recent work has shown that genes encoding both 
types of pump are indeed upregulated during biofilm forma-
tion and development. However, mutants carrying single or 
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susceptible to fluconazole when they were growing planktoni-
cally but retained the resistant phenotype during biofilm 
growth (40). Overall, it seems probable that drug resistance in 
Candida biofilms, like that in bacterial biofilms, is a complex 
process involving more than one mechanism. 
ACKNOWLEDGMENTS 
Mohammed Al-Fattani is the recipient of a research studentship 
from the Ministry of Health of Saudi Arabia. 
We are indebted to Margaret Mullin for expert assistance with 
electron microscopy and to Pfizer Limited for a supply of fluconazole 
and voriconazole. 
REFERENCES 
1. Adam, B., G. S. Baillie, and L. J. Douglas. 2002. Mixed species biofilms of 
Candida albicans and Staphylococcus epidennidis. J. Med. Microbiol. 51:344-
349. 
2. Allison, D. G., and M. J. Matthews. 1992. Effect of polysaccharide interac-
tions on antibiotic susceptibility of Pseudomonas aeruginosa. J. Appl. Bacte-
riol. 73:484--488. 
3. Ander!, J. N., M. J. Franklin, and P. S. Stewart. 2000. Role of antibiotic 
penetration limitation in Klebsiella pneumoniae biofilm resistance to ampi-
cillin and ciprofloxacin. Antimicrob. Agents Chemother. 44:1818-1824. 
4. Bachmann, S. P., K. VandeWalle, G. Ramage, T. F. Patterson, B. L. Wickes, 
J. R. Graybill, and J. L. Lopez-Ribot. 2002. In vitro activity of caspofungin 
against Candida albicans biofilms. Antimicrob. Agents Chemother. 46:3591-
3596. 
5. Baillie, G. S., and L. J. Douglas. 1998. Effect of growth rate on resistance of 
Candida albicans biofilms to antifungal agents. Antimicrob. Agents Che-
mother. 42:1900-1905. 
6. Baillie, G. S., and L. J. Douglas. 1998. Iron-limited biofilms of Candida 
alMcans and their susceptibility to amphotericin B. Antimicrob. Agents Che-
mother. 42:2146-2149. 
7. Baillie, G. S., and L. J. Douglas. 1999. Candida biofilms and their suscepti-
bility to antifungal agents. Methods Enzymo!. 310:644--656. 
8. Baillie, G. S., and L. J. Douglas. 1999. Role of dimorphism in the develop-
ment of Candida albicans biofilms. J. Med. Microbiol. 48:671-679. 
9. Baillie, G. S., and L. J. Douglas. 2000. Matrix polymers of Candida biofilms 
and their possible role in biofilm resistance to antifungal agents. J. Antimi-
crob. Chemother. 46:397-403. 
10. Calderone, R. A. (ed.). 2002. Candida and candidiasis. ASM Press, Wash-
ington, D.C. 
11. Chandra, J., P. K. Mukherjee, S. D. Leidich, F. F. Faddoul, L. L. Hoyer, L. J. 
Douglas, and M. A. Ghannoum. 2001. Antifungal resistance of candidal 
biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908. 
12. Chandra, J., D. M. Kuhn, P. K. Mukherjee, L. L. Hoyer, T. McCormick, and 
M. A. Ghannoum. 2001. Biofilm formation by the fungal pathogen Candida 
albicans: development, architecture, and drug resistance. J. Bacteriol. 183: 
5385-5394. 
13. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: 
a common cause of persistent infections. Science 284:1318-1322. 
14. Cox, G. M., and J. R. Perfect. 1993. Fungal infections. Curro Opin. Infect. 
Dis. 6:422-426. 
15. Donlan, R. M. 2001. Biofilms and device-associated infections. Emerg. In-
fect. Dis. 7:277-281. 
16. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of 
cJinicaJly relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. 
17. Douglas, L. J. 2003. Candida biofilms and their role in infection. Trends 
Microbio!. 11:30-36. 
18. Fridkin, S. K., and W. R. Jarvis. 1996. Epidemiology of nosocomial fungal 
infections. Clin. Microbio!' Rev. 9:499-511. 
19. Gilbert, P., T. Maira-Litran, A. J. McBain, A. H. Rickard, and F. W. Whyte. 
2002. The physiology and coJlective recalcitrance of microbial biofilm com-
munities. Adv. Microb. Physio!. 46:203-256. 
20. Gordon, C. A., N. A. Hodges, and C. Marriott. 1988. Antibiotic interaction 
and diffusion through alginate and exopolysaccharide of cystic fibrosis-de-
rived Pseudomonas aeruginosa. J. Antimicrob. Chemother.22:667-674. 
21. Hatch, R. A., and N. L. Schiller. 1998. Alginate lyase promotes diffusion of 
aminoglycosides through the extraceJlular polysaccharide of mucoid Pseudo-
monas aeruginosa. Antimicrob. Agents Chemother. 42:974-977. 
22. Hawser, S. P., and L. J. Douglas. 1994. Biofilm formation by Candida species 
on the surface of catheter materials in vitro. Infect. Immun. 62:915-921. 
23. Hawser, S. P., and L. J. Douglas. 1995. Resistance of Candida albicans 
biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 39: 
2128-2131. 
24. Hawser, S. P., G. S. Baillie, and L. J. Douglas. 1998. Production of extra-
cellular matrix by Candida alMcans biofilms. J. Med. Microbiol. 47:253-256. 
25. Hojo, S., M. Hugochi, and S. Araya. 1976. Glucan inhibition of diffusion in 
plaque. J. Dent. Res. 55:169. 
26. Hoyle, B. D., J. Alcantara, and J. W. Costerton. 1992. Pseudomonas aerug;-
nosa biofilm as a diffusion barrier to piperacillin. Antimicrob. Agents Che-
mother. 36:2054-2056. 
27. Hussain, M., M. Herrman, C. von Eilf, F. Perdreau-Remington, and G. 
Peters. 1997. A 140-kilodalton extracellular protein is essential for the ac-
cumulation of Staphylococcus epidennidis strains on surfaces. Infect. Immun. 
65:519-524. 
28. Jenkinson, H. F., and L. J. Douglas. 2002. Interactions between Candida 
species and bacteria in mixed infections, p. 357-373. In K. A. Brogden and 
J. M. Guthmiller (ed.), Polymicrobial diseases. ASM Press, Washington, 
D.C. 
29. Kuhn, D. M., T. George, J. Chandra, P. K. Mukherjee, and M. A. Ghan-
noum. 2002. Antifungal susceptibility of Candida biofilms: unique efficacy of 
amphotericin B lipid formulations and echinocandins. Antimicrob. Agents 
Chemother.46:1773-1780. 
30. Kumon, H., K. Tomochika, T. Matunuaga, M. Ogawa, and H. Ohmori. 1994. 
A sandwich cup method for the penetration assay of antimicrobial agents 
through Pseudomonas exopolysaccharides. Microbiol. Immuno!. 38:615-619. 
31. Lewis, R. E., D. P. Kontoyiannis, R. O. Darouiche, I. I. Raad, and R. A. 
Prince. 2002. Antifungal activity of amphotericin B, fluconazole, and vori-
conazole in an in vitro model of Candida catheter-related bloodstream in-
fection. Antimicrob. Agents Chemother. 46:3499-3505. 
32. Mack, D., W. Fischer, A. Krokotsch, K. Leopold, R. Hartmann, H. Egge, and 
R. Laufs. 1996. The intercellular adhesin involved in biofilm accumulation of 
Staphylococcus epidennidis is a linear ~-1,6-linked glucoaminoglycan: purifi-
cation and structural analysis. J. Bacteriol. 178:175-183. 
33. Mah, T.-F., B. Pitts, B. Pelloek, G. C. Walker, P. S. Stewart, and G. A. 
O'Toole. 2003. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic 
resistance. Nature 426:306--310. 
34. Mah, T.-F. C., and G. A. O'Toole. 2001. Mechanisms of biofilm resistance to 
antimicrobial agents. Trends Microbiol. 9:34-39. 
35. Moosa, M.-Y. S., J. D. Sobel, H. Elhalis, W. Du, and R. A. Akins. 2004. 
Fungicidal activity of fluconazole against Candida albicans in a synthetiC 
vagina-simulative medium. Antimicrob. Agents Chemother. 48:161-167. 
36. Nichols, W. W., S. M. Dorrington, M. P. E. Slack, and H. L. Walmsley. 1988. 
Inhibition of tobramycin diffusion by binding to alginate. Antimicrob. Agents 
Chemother. 32:518-523. 
37. Ramage, G., K. VandeWalle, B. L. Wickes, and J. L. Lopez-Ribot. 2001. 
Standardized method for in vitro antifungal susceptibility testing of Candida 
albicans biofilms. Antimicrob. Agents Chemother. 45:2475-2479. 
38. Ramage, G., K. VandeWalle, B.L. Wickes, and J. L. Lopez-Ribot. 2001. 
Biofilm formation by Candida dubliniensis. J. Clin. Microbiol. 39:3234-3240. 
39. Ramage, G., K. VandeWalle, S. P. Bachmann, B. L. Wickes, and J. L. 
Lopez-Ribot. 2002. In vitro pharmacodynamic properties of three antifungal 
agents against preformed Candida albicans biofilms determined by time-kill 
studies. Antimicrob. Agents Chemother. 46:3634-3636. 
40. Ramage, G., S. Bachmann, T. F. Patterson, B. L. Wickes, and J. L. Lopez-
Ribot. 2002. Investigation of multidrug efflux pumps in relation to flucon-
azole resistance in Candida albicans biofilms. J. Antimicrob. Chemother. 
49:973-980. 
41. Schumacher-Perdreau, F., C. Heilmann, G. Peters, F. Gotz, and G. Pulverer. 
1994. Comparative analysis of a biofilm-forming Staphylococcus epidennidis 
strain and its adhesion-positive, accumulation-negative mutant M7. FEMS 
Microbio!. Lett. 117:71-78. 
42. Shigeta, M., G. Tanaka, H. Komatsuzawa, M. Sugai, H. Suginaka, and T. 
Usui. 1997. Permeation of antimicrobial agents through Pseudomonas aerugi-
nosa biofilms: a simple method. Chemotherapy (Basel) 43:340-345. 
43. Stewart, P. S. 2003. Multicellular nature of biofilm protection from antimi-
crobial agents, p. 181-189. In A. McBain, D. Allison, M. Brading, A. Rick-
ard, J. Verran, and J. Walker (ed.), Biofilm communities: order from chaos? 
BioLine, Cardiff, United Kingdom. 
44. Suci, P., M. W. Mittelman, F. P. Yu, and G. G. Geesey. 1994. Investigation 
of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimi-
crob. Agents Chemother. 38:2125-2133. 
45. Thurnheer, T., R. GmuT, S. Shapiro, and B. Guggenheim. 2003. Mass trans-
port of macromolecules within an in vitro model of supragingival plaque. 
Appl. Environ. Microbio!. 69:1702-1709. 
46. Walters, M. C., III, F. Roe, A. Bugnicourt, M. J. Franklin, and P. S. Stewart. 
2003. Contributions of antibiotic penetration, oxygen limitation, and low 
metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to cipro-















































ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, OCt. 2004, p. 4073 
0066-4804/04/$08.00+0 DOl: 1O.1128/AAC.48.1O.4073.2004 
ERRATUM 
Penetration of Candida Biofilms by Antifungal Agents 
Mohammed A. Al-Fattani and L. Julia Douglas 
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, 
University of Glasgow, Glasgow, United Kingdom 
Vol. 48, No. 10 
Volume 48, no. 9, p. 3291-3297, 2004. Page 3291: The first sentence of the abstract should read "A filter disk assay was used 














































Journal of Medical Microbiology (2006), 55, 999-1008 001 10.1 099/jmm.0.46569-0 
Correspondence 
L Julia Douglas 
J.Douglas@bio.gla.ac.uk 
Received 9 February 2006 
Accepted 18 April 2006 
INTRODUCTION 
Biofilm matrix of Candida albicans and Candida 
tropicalis: chemical composition and role in drug 
resistance 
Mohammed A. AI-Fatlani and L. Julia Douglas 
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, Joseph Black 
Building, University of Glasgow, Glasgow G 12 800, UK 
Matrix material was extracted from biofilms of Candida albicans and Candida tropicalis and 
analysed chemically. Both preparations contained carbohydrate, protein, hexosamine, phosphorus 
and uronic acid. However, the major component in C. albicans matrix was glucose (32 %), whereas 
in C. tropicalis matrix it was hexosamine (27 %). Biofilms of C. albicans were more easily 
detached from plastic surfaces by treatment with the enzyme Iyticase (j3-1 ,3-glucanase) than were 
those of C. tropicalis. Biofilms of C. albicans were also partially detached by treatment with 
proteinase K, chitinase, DNase I, or fl-N-acetylglucosaminidase, whereas C. tropicalis biofilms were 
only affected by lipase type VII or chitinase. To investigate a possible role for the matrix in 
biofilm resistance to antifungal agents, biofilms of C. albicans were grown under conditions of 
continuous flow in a modified Robbins device (MRD). These biofilms produced more matrix material 
than those grown statically, and were significantly more resistant to amphotericin B. Biofilms of 
C. tropicalis synthesized large amounts of matrix material even when grown statically, and such 
biofilms were completely resistant to both amphotericin B and fluconazole. Mixed-species biofilms 
of C. albicans and a slime-producing strain of Staphylococcus epidermidis (RP62A), when grown 
statically or in the MRD, were also completely resistant to amphotericin B and fluconazole. 
Mixed-species biofilms of C. albicans and a slime-negative mutant of S. epidermidis (M7), on the 
other hand, were completely drug resistant only when grown under flow conditions. These results 
demonstrate that the matrix can make a significant contribution to drug resistance in Candida 
biofilms, especially under conditions similar to those found in catheter infections in vivo, and that the 
composition of the matrix material is an important determinant in resistance. 
Candida albicans and a small number of related Candida 
species are known to be important agents of hospital-
acquired infections. Many of these are implant-associated 
infections in which the micro-organisms form adherent 
biofilms on the surfaces of catheters, joint replacements, 
prosthetic heart valves and other medical devices (Donlan, 
2001; Douglas, 2003). Candida septicaemias, for example, 
now rank as the fourth most common type of nosocomial 
bloodstream infection and are usually catheter-related 
(Calderone, 2002). Biofilm cells on implants are organized 
into structured communities embedded within a matrix 
of extracellular material. They are phenotypically distinct 
from planktonic or suspended cells; in particular, they are 
significantly less susceptible to antimicrobial agents (Donlan 
& Costerton, 2002; Gilbert et al., 2002). As a result, implant 
infections are difficult to treat and usually the implant must 
be removed (Costerton et aI., 1999). 
The matrix is one of the most distinctive features of a 
microbial biofilm. It forms a three-dimensional, gel-like, 
highly hydrated and locally charged environment in which 
the micro-organisms are largely immobilized (Flemming 
et aI., 2000). Matrix-enclosed micro colonies, sometimes 
described as 'stacks' or 'towers', are separated by water 
channels which provide a mechanism for nutrient circula-
tion within the biofilm (Donlan & Costerton, 2002). The 
composition of the matrix varies according to the nature 
of the organisms present. Matrix polymers of bacterial 
biofilms are primarily exopolysaccharides, and many are 
negatively charged due to the presence of carboxyl, sul-
phate or phosphate groups. Smaller amounts of proteins, 
nucleic acids and lipids can also be present. Two of the best-
characterized matrix polysaccharides in bacteria are algi-
nate (a polymer of mannuronic acid and guluronic acid) 
produced by Pseudomonas aeruginosa, and poly fl-1,6-linked 
N-acetylglucosamine secreted by Staphylococcus epidermidis 
Abbreviations: MRD, modified Robbins device; PIA, intercellular 
polysaccharide adhesin; SEM, scanning electron microscopy; XTT, 2,3-
bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide. 
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and Staphylococcus aureus (Starkey et aI., 2004; Gotz, 2002). 
Synthesis of both polysaccharides has been related to 
bacterial virulence. 
The recalcitrance of biofilms to antimicrobial agents is 
often attributed to the failure of these agents to penetrate 
the biofilm matrix. However, a number of studies have 
demonstrated that reductions in the diffusion coefficients of 
antibiotics within biofilms are insufficient to account solely 
for the observed changes in susceptibility (Gilbert et aI., 
2002). Drug access is also assisted by the presence of water 
channels in the biofilm structure. Nevertheless, matrix 
components could retard access to such an extent that cells 
lying deep within a micro colony escape exposure. This 
would occur via drug adsorption or neutralization, and 
would depend on the thickness of the biofilm and on the 
chemical nature of both the antimicrobial agent and the 
matrix material. It is known, for example, that fluoro-
quinolones penetrate P. aeruginosa biofilms readily, whereas 
penetration by positively charged aminoglycosides is 
retarded (Drenkard, 2003). Similarly, fluconazole per-
meates single-species Candida biofilms more rapidly than 
flucytosine (Al-Fattani & Douglas, 2004). Rates of drug 
diffusion through biofilms of Candida glabrata or Candida 
krusei are faster than those through biofilms of Candida 
parapsilosis or Candida tropicalis, while drug diffusion 
through mixed-species biofilms of C. albicans and S. 
epidermidis is very slow. 
During a previous investigation in this laboratory, the 
matrix of C. albicans biofilms was isolated and its com-
position compared with that of extracellular polymeric 
material obtained from culture supernatants of planktoni-
cally grown organisms (Baillie & Douglas, 2000). Both 
preparations contained carbohydrate, protein, phosphorus 
and hexosamine, but the matrix had significantly less 
carbohydrate (41 %) and protein (5 %). It also had a higher 
proportion of glucose (16 %) than mannose, unlike plank-
tonic extracellular material (McCourtie & Douglas, 1985). 
To investigate whether the matrix plays a role in the resis-
tance of biofilms to antifungal agents, susceptibility pro-
files of biofilms incubated statically (which have relatively 
little matrix) were compared with those of biofilms incu-
bated with gentle shaking (which produce much more 
matrix material). Biofilms grown with or without shaking 
did not exhibit significant differences in susceptibility to 
any of the drugs tested, suggesting that drug resistance is 
unrelated to the extent of matrix formation (Baillie & 
Douglas, 2000). On the other hand, earlier studies with a 
perfused biofilm fermenter (Baillie & Douglas, 1998a) and 
a cylindrical filter model system (Baillie & Douglas, 1998b) 
showed that resuspended biofilm cells (which presumably 
had lost most of their matrix) were some 20 % less resis-
tant to amphotericin B than intact C. albicans biofilms, 
indicating that the matrix could have a contributory role in 
drug resistance. These findings with resuspended biofilm 
cells were subsequently confirmed elsewhere (Ramage et aI., 
2002). 
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In the study described here, we have isolated and chemically 
analysed matrix material from biofilms of both C. albicans 
and C. tropicalis. Further characterization of matrix com-
position was achieved by enzymic digestion of biofilms. In 
a series of experiments designed to investigate biofilm 
drug resistance, Candida biofilms were grown statically and 
under flow conditions in a modified Robbins device (MRD) 
to model catheter infections; the susceptibilities of both 
types of biofilm to antifungal agents were then tested. 
Mixed-species biofilms of C. albicans and S. epidermidis 
were also assayed for antifungal susceptibility after growth 
under the same static and flow conditions. S. epidermidis is 
the organism most frequently isolated from bacterial 
implant infections and has been found in polymicrobial 
infections with C. albicans (Jenkinson & Douglas, 2002). 
METHODS 
Organisms. Two Candida species were used in this study. C. aibi-
cans GDH 2346 (NCYC 1467) was originally isolated at Glasgow 
Dental Hospital from a patient with denture stomatitis. C. tropicaiis 
AAHB 73 was isolated from a patient with a line infection at 
Crosshouse Hospital, Kilmarnock, Scotland. Both strains were main-
tained on slopes of Sabouraud dextrose agar (Difco) and subcul-
tured monthly. Every 2 months, cultures were replaced by new ones 
freshly grown from freeze-dried stocks. 
Two strains of S. epidermidis (RP62A and M7) were maintained on 
Colombia blood agar (Oxoid). Strain RP62A (ATCC 35984) is a known 
slime producer; strain M7 is a slime-negative mutant obtained after 
chemical mutagenesis of S. epidermidis RP62A with mitomycin C 
(Schumacher-Perdreau et ai., 1994). The growth rate, initial adherence, 
cell-wall composition, surface characteristics and antimicrobial-
susceptibility profile of strain M7 are indistinguishable from those of 
the wild-type (Schumacher-Perdreau et ai., 1994). 
Medium and culture conditions. Both Candida species were 
grown in yeast nitrogen base (YNB) medium (Difco) containing 
50 mM glucose. Batches of medium (50 mI, in 250 mI Erlenmeyer 
flasks) were inoculated from fresh slopes and incubated at 37°C 
for 24 h in an orbital shaker at 60 r.p.m. Cells were harvested and 
washed twice in 0·15 M PBS, pH 7'2. Before use in biofilm experi-
ments, all washed cell suspensions were adjusted to ODS20 0'8. 
Tryptic soy broth (Difco) was selected as the liquid medium best 
able to support the growth of both fungi and bacteria. C. aibicans GDH 
2346 and the two strains of S. epidermidis (RP62A and M7) grow 
at similar rates in this medium (Adam et ai., 2002). Cultures were 
inoculated from fresh slopes and incubated with shaking at 3rC 
for 24 h. Cells were harvested, washed twice in PBS and suspended 
to ODS20 0·8 prior to use in biofilm experiments. For mixed-species 
biofilms, equal volumes of the standardized suspension of each 
organism were mixed immediately before use. 
Isolation of matrix material. Biofilms grown for the extraction of 
matrix material were formed on sections (4 cm long) of polyvinyl 
chloride (PVC) Faucher tubes (French gauge 36; Vygon) that had 
been cut into three equal concave strips. The strips were sterilized 
by exposure to ultraviolet radiation for 15 min on each side. 
Standardized cell suspension was added to the concave surface of 
each strip, and the strips were incubated for 1 h at 37°C. After 
removal of non-adherent cells by washing, the strips were trans-
ferred to wide-neck 250 ml Erlenmeyer flasks (six strips per flask) 
Journal of Medical Microbiology 55 
containing YNB (50 ml) with 50 mM glucose. They were then incu-
bated at 37°C for 48 h in an orbital shaker operating at 60 r.p.m. 
for biofilm formation. 
Biofilm matrix material was isolated using a slight modification of a 
protocol described previously (Baillie & Douglas, 2000). Catheter strips 
with their adherent biofilms were transferred to universal bottles (six 
strips per bottle) each containing 10 ml distilled water. The bottles 
were sonicated for 5 min in an ultrasonic water bath and vortexed 
vigorously for 1 min to disrupt the biofilms. Cell suspensions were 
then pooled and centrifuged. The supernatants were concentrated to 
one-tenth of the original volume using an Amicon DC2 hollow-fibre 
system with a 3·0 kDa molecular weight cut-off filter (Millipore) and 
dialysed at 4°C for 3 days (3'5 kDa molecular weight cut-off dialysis 
membrane; Pierce) against five changes (5 I each) of distilled water. 
The retentates were freeze-dried. 
Chemical analysis of matrix material. Protein was determined 
by the Lowry method, phosphorus by the method of Chen et al. 
(1956), and uronic acid by the method of Bitter & Muir (1962). 
Total carbohydrate was estimated according to the procedure of 
Dubois et al. (1956), using glucose as a standard. Glucose content 
was determined enzymically using a glucose oxidase/peroxidase 
assay kit (Sigma) after hydrolysis of samples in 0·5 M HCI at 100°C 
for 5 h. Hexosamine was estimated by the method of Blumenkrantz 
& Asboe-Hansen (1976) using glucosamine as a standard; before 
analysis, samples were hydrolysed in 4 M HCI at 100°C for 12 h. 
Enzymic detachment of biofilms. Eight enzymes (all from Sigma) 
were tested for their ability to detach Candida biofilms from plastic 
surfaces. The enzymes used were: proteinase K extracted from 
Tritirachium album; protease type XIV from Streptomyces griseus; 
deoxyribonuclease 1 type IV from bovine pancreas; N-acetylglucosa-
minidase from Canavalia ensiformis (Jack bean); chitinase from 
Strep. griseus; lipase type VII from Candida rugosa; phospholipase 
A2 from bovine pancreas; and lyticase from Arthrobacter luteus. All 
enzyme solutions were prepared immediately before use. Proteinase 
K, protease type XIV and lyticase were in Na2HPOJNaH2PO. 
buffer, pH 7'5; deoxyribonuclease 1 type IV and N-acetylglucosamini-
dase were in citric acid/NazHPO. buffer, pH 5·0; lipase type VII 
was in NazHPO./NaH2PO. buffer, pH 7'2; phospholipase A2 was in 
Tris/maleate/NaOH buffer, pH 8'0; and chitinase was in citric acid/ 
Na2HPO. buffer, pH 6'0. 
The detachment assay used was based on that reported by Kaplan et al. 
(2004) for S. epidermidis biofilms. Aliquots (100 J.il) of standardized 
Candida cell suspension were added to the wells of 96-well polystyrene 
microtitre plates, and the plates were incubated at 37°C for 48 h to 
allow biofilm formation. The growth medium was removed from each 
well and replaced by an equal volume (100 J.il) of test enzyme used at a 
final concentration of 50 Jlg ml- I . Control wells received an equal 
volume of buffer without enzyme. Plates were incubated for 2 hat 25 or 
37°C according to the temperature optimum for the enzyme being 
tested. Following incubation, biofilms were stained with crystal violet 
(2 g crystal violet, 0·8 g ammonium oxalate, and 20 ml ethanol per 
100 ml) for 2 min, and then twice washed gently with 200 J.il distilled 
water and left to dry. The optical densities of the wells were determined 
with a Bio-Rad Benchmark microplate reader set to 570 nm. 
Biofilm formation under static conditions on PVC catheter 
disks. Biofilms were formed on small disks (diameter, 0·8 cm) cut 
from PVC Faucher tubes (French gauge 36; Vygon), as described 
previously (Hawser & Douglas, 1994; Baillie & Douglas, 1999). 
Sterile disks were placed in wells of 24-well Nunclon tissue culture 
plates, and 80 J.il of standardized cell suspension was added to 
each one. After incubation for 1 h at 37°C (adhesion period), non-
adherent organisms were removed by washing with PBS. The disks 
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were then incubated in the wells of fresh plates containing 1 ml 
YNB with 50 mM glucose, or 1 ml TSB, for 48 h at 37"C for biofilm 
formation. 
Biofilm formation under flow conditions using the MRD. The 
MRD is one of the most widely used systems for studying biofilm 
growth under conditions of continuous flow. It is an artificial multi-
port sampling catheter, constructed of a perspex block, 41' 5 cm 
long, with a rectangular lumen containing 25 evenly spaced sample 
ports (Lappin-Scott et a/., 1993). The sample studs, also made of 
perspex, fit tightly into the ports. Each stud has at its bottom end a 
1 mm rim into which a catheter disk can be inserted. During incu-
bation, biofilms are formed on these disks and can be removed asep-
tically by simply taking out the sample studs. 
In the experiments described here, a reservoir containing a 
standardized suspension of the test organism(s) was connected to a 
peristaltic pump and the MRD via silicone tubing. The entire apparatus 
was incubated at 37°C. Cell suspension was pumped through the MRD 
at a flow rate of 60 ml h -I for 1 h to allow cells to adhere to each of 
the 25 catheter disks attached to the sample studs. Upon leaving the 
MRD, the cell suspension was collected in an effluent container. Fresh 
growth medium (either YNB with 50 mM glucose, or TSB) was then 
continuously pumped through the MRD at the same flow rate for 
48 h. After this time, biofilms formed on the catheter disks could 
be retrieved by removing the sample studs from the MRD. Following 
the completion of each experiment, the MRD was sterilized with 
0'05 % hibitane, which was pumped through at 60 ml h -I for 1 h. 
Sterile distilled water was finally pumped through at a rate of 
200 ml h -I for 1 h to remove any traces of hibitane. 
Susceptibility of biofilms to antifungal agents. After growth 
under static or flow conditions, Candida biofilms and Candida/ 
Staphylococcus biofilms were treated with amphotericin B (Sigma) or 
fluconazole (Pfizer) by a procedure described earlier (Hawser & 
Douglas, 1995; Adam et al., 2002). Freshly prepared stock solutions 
of the drugs were diluted in growth medium (YNB with 50 mM glu-
cose, or TSB) buffered to pH 7 with 0·165 M MOPS buffer (Sigma). 
Biofilms (48 h) grown statically or under flow conditions on cathe-
ter disks were transferred to wells of 24-well Nunclon plates contain-
ing 1 ml of this buffered medium with the test antifungal agent, and 
incubated for 5 or 24 h at 37°C. Two different concentrations of 
amphotericin B (6'5 and 39 Jlg ml-\ 5 and 30 times the MIC) were 
used for biofilms of C. albicans GDH 2346. Biofilms of C. tropicalis 
AAHB 73 and Candida/Staphylococcus biofilms were treated with 
a single concentration of amphotericin B and fluconazole (39 and 
12 Jlg ml- I , respectively; 30 times the MIC for C. albicans GDH 
2346). Following the drug treatment, biofilms were washed in 
PBS and biofilm activity was assessed by the 2,3-bis(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduc-
tion assay (Baillie & Douglas, 1999; Adam et a/., 2002) after transfer 
of the disks to new wells. The effect of an antifungal agent was mea-
sured in terms of XTT reduction by biofilms as compared with 
values obtained for control biofilms incubated for 5 h in the absence 
of the agent. 
Scanning electron microscopy (SEM). Biofilms were examined 
by SEM after processing of samples by a freeze-drying tech-
nique (Hawser et a/., 1998; Baillie & Douglas, 1999), which gives 
improved preservation of the biofilm matrix. Biofilms formed on 
catheter disks were fixed with glutaraldehyde (2'5%, v/v, in 0'1 M 
cacodylate buffer, pH 7·0), washed gently three times in distilled 
water, and then plunged into a liquid propane/isopentane mix-
ture (2: 1, v/v) at -196°C before freeze-drying under vacuum 
(10-6 torr, 1·3 x 10-4 Pal. Samples were finally coated with gold 
with a Polaron coater and viewed under a Philips 500 scanning elec-
tron microscope. 
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RESULTS AND DISCUSSION 
Isolation of matrix material from Candida 
biofilms 
Matrix material was prepared from biofilms of two different 
Candida species, C. albicans GDH 2346 and C. tropicalis 
AAHB 73. There is no standard extraction procedure for 
biofilm matrix, and a variety of physical and chemical 
extractions have been reported (Liu & Fang, 2002; Azeredo 
et al., 1999). Many of these methods promote leakage of 
intracellular material (Azeredo et ai., 1999). In this study, 
a physical extraction process was used in an attempt to 
minimize leakage. This involved gentle sonication, vortex-
ing and centrifugation of biofilms formed on sections of 
catheter tubing. Two separate preparative procedures were 
carried out for each organism to provide sufficient material 
for chemical analysis. The yield from biofilms of C. tropicalis 
(16·5 and 23·6 mg) was much higher than that from 
biofilms of C. albicans (10'7 and 9·4 mg). 
Chemical composition of the biofilm matrix 
Preparations of biofilm matrix material were analysed for 
carbohydrate, glucose, protein, hexosamine, phosphorus 
and uronic acid by colorimetric or enzymic methods. Matrix 
isolated from C. albicans biofilms consisted of carbohydrate 
(39'6 %, including 32'2 % glucose), together with small 
amounts of protein (5'0 %), hexosamine (3'3 %), phos-
phorus (0'5 %) and uronic acid (0'1 %; Table 1). These 
values largely confirm those reported in an earlier analysis 
from this laboratory which also revealed the presence of 
small amounts of mannose and galactose in the matrix 
(Baillie & Douglas, 2000). Both studies demonstrate that 
glucose is the major sugar component of C. albicans matrix 
material. However, glucose accounted for a larger propor-
tion of the matrix dry weight in the present investigation. 
This could be due to a difference in the growth medium: 
Table 1. Analysis of matrix material extracted from biofilms 
of C. albicans GDH 2346 and C. tropicalis AAHB 73 
The data are mean±SEM for two independent experiments (with 
two different matrix preparations) carried out in duplicate or 
triplicate. 
Component Percentage composition of biofilm matrix for: 
C. albicans C. tropicalis 
Carbohydrate 39-6±O'3 3'3±O'O 
Glucose 32'2±1'5 O'5±O'O 
Hexosamine 3'3±O'6 27'4±O'2 
Phosphorus O'5±O'O O'2±O'O 
Protein 5'O±O'1 3'3±O'O 
Uronic acid O'l±O'O l-6±O'O 
1002 
galactose was used as the carbon source in the previous study 
but was replaced here by glucose. 
By contrast, matrix from C. tropicalis biofilms consisted 
mainly of hexosamine (27'4 %), with smaller amounts of 
carbohydrate (3'3 %, including 0'5 % glucose), protein 
(3'3 %) and phosphorus (0'2 %; Table 1). The C. tropicalis 
matrix also contained slightly more uronic acid (1'6 %) than 
that of C. albicans. The major difference between the two 
preparations, however, was that in C. tropicalis, hexosamine 
appeared to replace glucose as the main identifiable sugar 
component in the matrix (Table 1). As far as we are aware, 
this is the first reported analysis of the biofilm matrix of C. 
tropicalis. However, a number of bacteria are known to 
produce similarly large amounts of hexosamine as a matrix 
component. The best-studied example is S. epidermidis, 
in which hexosamine is present as a polysaccharide of 
fJ-1,6-linked N-acetylglucosamine residues containing some 
deacetylated amino groups, and succinate and phosphate 
substituents (Mack et ai., 1996). This polymer, which is 
sometimes referred to as the intercellular polysaccharide 
adhesin (PIA), mediates cell-cell interaction within the 
biofilm (Gotz, 2002) and its production has been related to 
S. epidermidis virulence in catheter-infection models in 
animals. 
Enzymic detachment of Candida biofilms 
An assay devised by Kaplan et al. (2004) for S. epidermidis 
biofilms was used to investigate whether Candida biofilms 
could be enzymically detached from plastic surfaces by 
degradation of the matrix polymers. A range of commer-
cially available enzymes of known specificity was tested. 
Biofilms were grown in the wells of 96-well polystyrene 
microtitre plates and then treated with different test 
enzymes at 37 or 25°C (according to the temperature 
optimum) for 2 h at a final enzyme concentration of 
50 ).lg ml- I . After washing, the remaining organisms were 
stained with crystal violet and the ODs7o measured using a 
microtitre plate reader. 
Biofilms of C. albicans were unaffected by lipase type 
VII, phospholipase A2 and protease type XN (Table 2). 
Treatment with proteinase K, chitinase, DNase I or fJ-N-
acetylglucosaminidase resulted in a significant decrease in 
ODs7o, suggesting that these enzymes partially degraded 
matrix material and caused some biofilm detachment from 
the surfaces of the wells. Interestingly, lyticase, which hydro-
lyses fJ-1,3 glucan, had by far the greatest effect, causing 
an 85 % reduction in optical density (P< 0'001; Table 2). 
This result suggests that some of the glucose present in 
the C. albicans matrix could be present as fJ-1,3 glucan, a 
polysaccharide which is also a major structural component 
of the cell wall. 
Biofilms of C. tropicalis responded rather differently to the 
enzyme treatments. Phospholipase A2, protease type XN, 
proteinase K, DNase I and fJ-N-acetylglucosaminidase had 
no significant effect (Table 2). By contrast, treatment with 
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Table 2. Detachment of Candida biofilms after exposure to different test enzymes 
Enzyme* Biofilm ODS70 as a percentage of control valuet 
Lipase type VII 
Phospholipase A2 
























* All enzyme treatments were carried out for 2 h at 37 or 25°C with a final enzyme concentration of 
50 Ilg ml- 1• 
tThe data are mean±sEM of two independent experiments each carried out twice with 36 replicates for 
every enzyme tested. Control ODs7o values ranged from 0'1l9±0'01 to 0'169±0'01 for C. albicans 
biofilms, and from 0'274±0'02 to O'319±0'01 for C. tropicalis biofilms. 
:j:Value significantly different at P<O'05 from that for the control. 
§Value significantly different at P<O'OOI from that for the control. 
lipase type VII and chitinase did appear to produce some 
biofilm detachment (P< 0'05). Chitinase had a similar effect 
on biofiIms of both C. tropicalis and C. albicans, indicating 
that most of the hexosamine present in the C. tropicalis 
matrix was unlikely to be in the form of chitin. It could, 
instead, be in the form of a chitinase-resistant f3-1,6-linked 
polysaccharide like that found in S. epidermidis and other 
biofilm-forming bacteria. The greatest effect on C. tropicalis 
biofilms was again observed with lyticase, which caused 
a reduction in optical density of over 53 % (P< 0'001; 
Table 2). However, lyticase had less effect on these biofilms 
than on those of C. albicans, whose matrix material contains 
substantially more glucose (Table 1). 
Possible lysis of biofilm cells during their exposure to lyti-
case was investigated by resuspending the cells after enzyme 
treatment in 1 M sorbitol buffer, and comparing the optical 
density with that of suspensions of control (untreated) 
biofiIm cells. With C. albicans, exposure to lyticase reduced 
the optical density readings of the suspensions, suggesting 
that there could have been some cell lysis during the enzyme 
treatment (results not shown). Alternatively, the reduction 
in optical density could simply have been due to dissolu-
tion of some of the matrix material. The latter explanation 
seems more likely, since suspensions of C. tropicalis showed 
no such reduction, even though lyticase is known to induce 
protoplast formation with this organism (Su & Meyer, 
1991). 
DNA is now known to be a major matrix component in 
some bacterial biofilms (Starkey et aI., 2004). DNase I 
had no effect on C. tropicalis biofiIms, but did cause some 
detachment of C. albicans biofilms. The presence of DNA 
in the C. albicans matrix would be consistent with the 
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higher phosphorus content of the matrix of this orga-
nism (Table 1). Biofilms of C. tropicalis, but not those of 
C. albicans, were partially detached by treatment with 
lipase type VII, but both were resistant to the action of 
phospholipase A2. In this context, it is interesting that 
C. tropicalis is capable of producing a fibrillar layer that 
contains mannoprotein with covalently linked fatty acids 
(Kappeli & Fiechter, 1977; Kappeli et al., 1984). 
SEM of biofilms grown statically and under 
conditions of continuous flow 
The model system used for static biofilm culture involved 
the growth of adherent populations for 48 h on the surface 
of small disks cut from catheters. This model has been 
well characterized and is known to give reproducible bio-
film populations (Hawser & Douglas, 1994; Baillie & 
Douglas, 1999). To produce flow conditions, an MRD 
was used. 
SEM showed that biofiIms formed by C. albicans incubated 
statically on catheter disks consisted of a dense network of 
yeasts, germ tubes, hyphae and pseudo hyphae. As reported 
previously (Hawser et aI., 1998), relatively little matrix 
material was visible in these biofilms, even when samples 
were prepared using a freeze-drying technique that gives 
improved preservation of the matrix. However, biofilms 
grown in the MRD under flow conditions had an exten-
sive matrix as revealed by SEM (Fig. 1A). This confirmed 
earlier findings which demonstrate that biofilms subjected 
to a liquid flow produce substantially more matrix material 
than those incubated statically (Hawser et aI., 1998). In 
contrast with C. albicans, biofilms of C. tropicalis synthe-
sized large amounts of extracellular material even during 
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Fig. 1. Scanning electron micrographs of biofilm formation by C. albicans (A) and C. tropicalis (B, C) on PVC catheter disks. 
Biofilms were incubated under flow conditions in the MRD (A), or statically (B, C), for 48 h in YNB medium containing 50 mM 
glucose. Arrows indicate matrix material. Bars, 20 f.lm (A); 10 f.lm (B); 2 f.lm (C). 
growth under static conditions, and many of the cells were 
almost hidden by the enveloping matrix (Fig. IE). At high 
magnification, matrix material was clearly visible on the 
surface of the cells (Fig. 1 C). 
Drug susceptibility of biofilms grown under 
static or flow conditions 
Biofilms of C. albicans grown under static and flow con-
ditions were exposed to different concentrations of ampho-
tericin B at 37°C for 5 or 24 h. After incubation, the 
metabolic activity of the biofilms, as measured by XTT 
reduction, was compared with that of control biofilms 
incubated in the absence of the drug (Table 3). C. albicans 
biofilms grown under flow conditions were highly resistant 
to amphotericin B at a concentration five times the MIC; 
exposure for 24 h had no effect on metabolic activity. At 
an even higher drug concentration (30 times the MIC), with 
a shorter exposure time (5 h), the biofilms were rather 
less resistant. However, for both drug treatments, biofilms 
formed under flow conditions were significantly more 
resistant than those grown statically (Table 3). These results 
differ from those obtained in a previous study in which 
flow conditions were achieved by gentle shaking of bio-
films during incubation, a procedure which promotes the 
synthesis of matrix material (Hawser et aI., 1998). Biofilms 
grown with or without shaking did not exhibit significant 
differences in susceptibility to flucytosine, fluconazole or 
amphotericin B (Baillie & Douglas, 2000). A possible expla-
nation for this is that the shaking procedure, which pro-
duced conditions of turbulent flow, was less effective at 
stimulating matrix synthesis than the laminar flow sys-
tem provided by the MRD. The morphology and physical 
properties of some bacterial biofilms are strongly influenced 
by the magnitude of the shear stresses under which the bio-
films are formed (Stoodley et aI., 2000). Our present results 
with C. albicans indicate that a constant flow (60 ml h -1) 
of liquid across the developing biofilm promotes matrix 
synthesis to an extent that significantly enhances resistance 
to amphotericin B. 
Table 3. Effect of amphotericin B on C. albicans GDH 2346 biofilms grown under static and 
flow conditions 
Drug treatment"" 
5 X MIC (24 h) 
30x MIC (5 h) 










Percentage of control 
99'4± 1·2 
54'6±7'4 
*Biofilms were treated with amphotericin B at five times MIC for 24 h or 30 times MIC for 5 h. 
tThe data are mean±SEM of two independent experiments carried out in quadruplicate. 
:j:Results for biofilms grown statically were significantly different from those for biofilms grown under flow 
conditions (P<O·OOl). 
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Attempts to grow biofilms of C. tropicalis AAHB 73 under 
flow conditions in the MRD were unsuccessful. This orga-
nism grew on, and rapidly blocked, the silicone tubing lead-
ing to the device, apparently by producing large amounts 
of slime. Biofilms of C. tropicalis grown statically were 
totally resistant to the action of both amphotericin Band 
fluconazole when exposed to high concentrations of the 
drugs for either 5 or 24 h (Table 4). Rates of drug diffusion 
through statically grown Candida biofilms have been 
determined recently using a filter disk assay (Al-Fattani & 
Douglas, 2004). Of several Candida species and strains 
tested, the slowest penetration was observed with C. 
tropicalis AAHB 73. In view of our analytical data on 
matrix preparations (Table 1), this suggests that drug 
resistance could be affected not only by the overall extent 
of matrix formation but also by its composition. Biofilms of 
C. tropicalis, with an extensive, hexosamine-rich matrix, 
were poorly penetrated by antifungal agents. On the other 
hand, biofilms of C. albicans, with a less-extensive glucose-
rich matrix, were more readily penetrated by drugs. Several 
reports indicate that in bacteria, possession of a mucoid 
phenotype is associated with decreased susceptibility to 
antibiotics. For example, biofilms of a mucoid clinical 
isolate of P. aeruginosa are substantially less susceptible to 
the quinolone antibiotic ciprofloxacin than biofilms of a 
non-mucoid isolate (Evans et al., 1991). Similarly, biofilms 
produced by an alginate-overproducing strain of P. 
aeruginosa exhibit a highly structured architecture and are 
significantly more resistant to tobramycin than biofilms 
formed by an isogenic non-mucoid strain (Hentzer et ai., 
2001). 
Drug susceptibility of mixed fungal/bacterial 
biofilms grown under static and flow conditions 
Previous work with statically grown C. albicans biofilms has 
indicated that the presence of bacteria (S. epidermidis) can 
enhance biofilm resistance to antifungal agents (Adam et ai., 
Matrix material of Candida biofilms 
2002). In this study, the drug susceptibility of mixed fungal/ 
bacterial biofilms grown under static and flow conditions 
was compared. As before, two strains of S. epidermidis were 
used: a slime-producing wild-type (RP62A) and a slime-
negative mutant (M7). Strain RP62A produces the inter-
cellular adhesin PIA; M7 is a mutant of strain RP62A that 
also produces PIA but lacks a 140 kDa antigen termed 
accumulation-associated protein (Hussain et ai., 1997; Gotz, 
2002). The mutant is able to form biofilms on PVC disks 
(Adam et ai., 2002), although it was originally reported as 
being unable to accumulate on glass surfaces (Schumacher-
Perdreau et al., 1994). However, the extent of biofilm 
formation (or production of matrix material) by the mutant 
is less than that of the wild-type strain, as judged by both 
SEM and quantitative assays (Adam et ai., 2002). The M7 
mutant is also more easily eradicated in vitro and in animal 
models by various antibiotics than is the wild-type strain 
(Schwank et ai., 1998). 
Mixed-species biofilms of C. albicans and S. epidermidis 
RP62A grown statically, or under flow conditions in the 
MRD, were highly resistant to both amphotericin Band 
fluconazole (Table 5). At exposure times of 5 and 24 h, the 
drugs had no effect on the metabolic activity of the biofilms, 
despite the high drug concentration used (30 times MIC). 
Moreover, biofilms produced statically were just as resis-
tant as those grown under flow conditions (Table 5). These 
results contrast with those obtained for single-species C. 
albicans biofilms treated with amphotericin B, for which 
biofilms grown statically were more susceptible to the 
drug (Table 3). They suggest that the slime produced by 
S. epidermidis RP62A might partially protect C. albicans 
from amphotericin B in these statically grown, mixed-
species biofilms. Preparations of matrix material (slime) 
from clinical isolates of S. epidermidis have been shown to 
reduce the efficacy of some antibiotics when mixed with the 
drugs in zone-of-inhibition bioassays (Souli & Giamarellou, 
1998). Similar results were obtained when staphylococcal 
Table 4. Effect of amphotericin B and fluconazole on biofilms of C. tropicalis AAHB 73 
NO, Not determined. 
Antifungal agent* XTT fonnazan formationt 
Static conditions:j: Flow conditions 
Amphotericin B (5 h) 
Amphotericin B (24 h) 
Fluconazole (5 h) 











*Amphotericin B was used at a concentration of 39 /-lg ml- 1 and fluconazole at 12 /-lg ml- 1• Exposure to 
each drug was for 5 or 24 h. 
tThe data are mean±SEM of two independent experiments carried out in quadruplicate. 
:j:Results not significantly different from those of the controls (P> 0·05). 
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Table 5. Effect of amphotericin B and fluconazole on mixed-species biofilms of C. albicans 
GDH 2346 and S. epidermidis RP62A grown under static or flow conditions 
Antifungal agent* XTT fonnazan fonnationt 
Static conditions:j: Flow conditions:j: 
OD492 Percentage of control OD492 Percentage of control 
Amphotericin B (5 h) 2·86±0·03 98'9±1'0 2'31 ±0'16 105'8±7'3 
Amphotericin B (24 h) 2'87±0'05 99'8±1'7 2'97±0'06 93'2±1'9 
Fluconazole (5 h) 2'76±0'06 95'5±2'1 2'18±0'06 100'1±2'8 
Fluconazole (24 h) 2·95±0·02 102'4±0'7 3'04±0'06 95'3±1'9 
'The concentrations of the two drugs used in this assay were equivalent (30 times MIC). Exposure to each 
drug was for 5 or 24 h. 
tThe data are mean±sEM of two independent experiments carried out in quadruplicate. 
:j:Results not significantly different (P> 0'05) for biofilms grown under static and flow conditions with 
identical drug treatments. 
slime was mixed with planktonic bacteria in susceptibility 
testing using a broth-dilution method (Konig et al., 2001). 
However, attempts to correlate the hydrophobicity or 
charge of each antibiotic tested with loss of activity 
due to the slime were unsuccessful (Souli & Giamarellou, 
1998). 
biofilms treated with fluconazole (Table 6). These findings 
suggest that under flow conditions, enhanced production 
of matrix material by either C. aibicans or M7, or both 
organisms, might afford some protection against antifungal 
agents. 
Mixed-species biofilms contammg the slime-negative 
mutant M7 grown under flow conditions were highly resis-
tant to amphotericin B and fluconazole at both exposure 
times (5 and 24 h), despite the high drug concentration used 
(30 times MIC; Table 6). They were, however, slightly less 
resistant than biofilms containing the slime-producing 
S. epidermidis RP62A treated in the same way (Table 5). For 
both drug treatments, mixed-species biofilms containing 
M7 and developed under static conditions were significantly 
more susceptible than those grown under conditions of 
continuous flow. The difference was particularly marked for 
Overall, our results indicate that drug resistance of C. 
aibicans biofilms may be significantly enhanced by increased 
production of matrix material under flow conditions in 
the MRD, or by the presence of one or more matrix 
polymers of S. epidermidis in mixed-species biofilms. 
Biofilms of C. tropicalis, on the other hand, are less 
susceptible to antifungal agents than C. aibicans biofilms, 
even when grown statically, possibly due to the synthesis 
of a hexosamine-containing matrix polymer similar to S. 
epidermidis PIA. Drug diffusion through C. albicans/S. 
epidermidis biofilms grown statically on cellulose filters is 
slower than that through C. aibicans biofilms or even C. 
Table 6. Effect of amphotericin B and fluconazole on mixed-species biofilms of C. albicans 
GDH 2346 and S. epidermidis M7 grown under static or flow conditions 
Antifungal agent* 
Amphotericin B (5 h) 
Amphotericin B (24 h) 
Fluconazole (5 h) 
Fluconazole (24 h) 
XTT fonnazan fonnationt 
Static conditions:j: Flow conditions:j: 
OD492 Percentage of control OD492 Percentage of control 
2'05±0'03 88'7±1-3 2'73±0'01 99'0±0'4 
1'69±0'09 71'8±3'8 2'94±0'09 91'9±2'8 
1'53±0'07 66'4±3'0 2'58±0'1l 93'5±3'9 
1'59±0'1l 67'2±4'6 2'92±O'04 91'5±1'3 
'The concentrations of the two drugs used in this assay were equivalent (30 times MIC). Exposure to each 
drug was for 5 or 24 h. 
tThe data are mean±SEM of two independent experiments carried out in quadruplicate. 
:j:Results are significantly different at P<O'Ol for biofilms grown under static and flow conditions with 
identical drug treatments. 
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tropicalis biofilms (Al-Fattani & Douglas, 2004). Inter-
actions between different matrix polymers in these mixed-
species biofilms could produce a more viscous matrix. Such 
a finding was reported by Skillman et ai. (1999) during a 
study of Enterobacter agglomeransl Klebsiella pneumoniae 
biofilms; increased matrix viscosity was advanced as a pos-
sible explanation for enhanced resistance to disinfection. 
Similarly, rheological interactions between matrix poly-
saccharides from Pseudomonas (now Burkholderia) cepacia 
and P. aeruginosa have been shown to decrease the rates of 
diffusion and antimicrobial activities of antibiotics (Allison 
& Matthews, 1992). Clearly, matrix polymers do contribute 
towards drug resistance in both single-species and mixed-
species biofilms containing Candida, especially under the 
flow conditions which prevail in many implant infections. 
However, biofilm resistance overall is likely to be multi-
factorial, involving, in addition, drug-resistant physiologies 
such as dormant 'quiescent' cells and expression of efflux 
pumps (Gilbert et aI., 2002). 
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